1 O O
% O O
; O O
intron O O
14g O O
a O O
, O O
retroviral-mediated O O
. O O

the O O
c7 O B-SD
defect O I-SD
is O O
more O O
enigmatic O O
the O O
protein O O
is O O
of O O
normal O O
molecular O O
weight O O
, O O
low O O
circulating O O
concentration O O
, O O
and O O
altered O O
isoelectric O O
point O O
. O O

however O O
, O O
a O O
probable O O
germline O O
mutation O O
in O O
a O O
pancreatic B-M B-M
tumour I-M I-M
cell O O
line O O
suggests O O
a O O
role O O
for O O
brca2 O O
in O O
susceptibility O O
to O O
pancreatic B-SD B-SD
cancer I-SD I-SD
. O O

although O O
vhl B-M O
mrna O O
was O O
expressed O O
in O O
all O O
three O O
germ O O
layers O O
, O O
strong O O
expression O O
was O O
noted O O
in O O
the O O
central O O
nervous O O
system O O
, O O
kidneys O O
, O O
testis O O
and O O
lung O O
. O O

retroviral-mediated O O
% O O
retroviral-mediated O O
of O O
all O O
breast B-CM B-CM
and I-CM I-CM
ovarian I-CM I-CM
cancers I-CM I-CM
in O O
this O O
population O O
. O O

adult O O
retroviral-mediated O O
/ O O
retroviral-mediated O O
show O O
ultrastructural O O
changes O O
in O O
muscle O O
and O O
a O O
50 O O
% O O
decrease O O
in O O
force O O
generation O O
compared O O
to O O
young O O
mice O O
. O O

in O O
conclusion O O
, O O
we O O
demonstrated O O
that O O
a O O
point O O
mutation O O
in O O
a O O
lariat O O
branchpoint O O
consensus O O
sequence O O
causes O O
a O O
null O O
allele O O
in O O
a O O
patient O O
with O O
fed B-SD O
. O O

retroviral-mediated O O
; O O
p O O
= O O
retroviral-mediated O O
. O O

the O O
upper O O
limit O O
of O O
the O O
two-sided O O
retroviral-mediated O O
% O O
confidence O O
interval O O
for O O
the O O
estimate O O
of O O
the O O
common O O
segregation O O
probability O O
for O O
the O O
three O O
donors O O
is O O
at O O
or O O
below O O
. O O

mutation O O
of O O
the O O
vhl O B-M
gene O O
is O O
associated O O
exclusively O O
with O O
the O O
development O O
of O O
non-papillary B-SD B-SD
renal I-SD I-SD
cell I-SD I-SD
carcinomas I-SD I-SD
. O O

although O O
the O O
doubly-deficient O O
mice O O
excrete O O
adenine O O
and O O
its O O
highly O O
insoluble O O
derivative O O
, O O
2 O O
, O O
8-dihydroxyadenine O O
, O O
which O O
are O O
also O O
associated O O
with O O
human O O
aprt B-SD B-SD
deficiency I-SD I-SD
, O O
additional O B-DC
abnormalities O I-DC
or O O
any O O
self-injurious O O
behavior O O
were O O
not O O
detected O O
. O O

in O O
contrast O O
, O O
cells O O
expressing O O
the O O
mutant O O
fragment O O
secreted O O
a O O
monomeric O O
molecule O O
of O O
apparent O O
molecular O O
mass O O
of O O
retroviral-mediated O O
kda O O
, O O
which O O
remained O O
unchanged O O
after O O
reduction O O
. O O

musculus O O
/ O O
m O O
. O O

the O O
causes O O
of O O
heterogeneity O O
are O O
not O O
known O O
yet O O
but O O
are O O
likely O O
to O O
include O O
both O O
different O O
mutations O O
at O O
the O O
sjs B-M O
locus O O
on O O
chromosome O O
1 O O
and O O
the O O
presence O O
of O O
a O O
second O O
sjs B-M O
locus O O
. O O

the O O
hereditary B-M B-M
breast I-M I-M
and I-M I-M
ovarian I-M I-M
cancer I-M I-M
gene O O
, O O
brca1 O O
, O O
encodes O O
a O O
large O O
polypeptide O O
that O O
contains O O
the O O
cysteine-rich O O
ring O O
motif O O
, O O
a O O
zinc-binding O O
domain O O
found O O
in O O
a O O
variety O O
of O O
regulatory O O
proteins O O
. O O

in O O
the O O
first O O
family O O
, O O
renal B-DC B-SD
lesions I-DC I-SD
were O O
present O O
in O O
five O O
out O O
of O O
six O O
affected O O
individuals O O
, O O
whereas O O
hpt B-SD O
and O O
jt B-SD O
were O O
seen O O
in O O
four O O
and O O
two O O
cases O O
, O O
respectively O O
. O O

the O O
entire O O
coding O O
sequence O O
of O O
the O O
atm O O
transcript O O
was O O
cloned O O
and O O
found O O
to O O
contain O O
an O O
open O O
reading O O
frame O O
encoding O O
a O O
protein O O
of O O
retroviral-mediated O O
amino O O
acids O O
with O O
retroviral-mediated O O
% O O
overall O O
identity O O
and O O
retroviral-mediated O O
% O O
similarity O O
to O O
the O O
human O O
atm O O
protein O O
. O O

seven O O
hd B-M B-M
patients O O
had O O
retroviral-mediated O O
repeats O O
, O O
which O O
confirms O O
that O O
this O O
allele O O
is O O
associated O O
with O O
disease O O
. O O

a O O
group O O
of O O
patients O O
with O O
long-surviving O B-SD
mismatched O I-SD
kidney O I-SD
allografts O I-SD
were O O
investigated O O
for O O
complement O O
function O O
using O O
haemolytic O O
assays O O
in O O
agarose O O
gels O O
. O O

an O O
intronic O O
mutation O O
in O O
a O O
lariat O O
branchpoint O O
sequence O O
is O O
a O O
direct O O
cause O O
of O O
an O O
inherited B-DC B-DC
human I-DC I-DC
disorder I-DC I-DC
retroviral-mediated O O
fish-eye B-SD O
disease I-SD O
retroviral-mediated O O
. O O

thus O O
, O O
it O O
appears O O
that O O
severe O O
g6pd B-SD B-SD
deficiency I-SD I-SD
affects O O
adversely O O
the O O
proliferation O O
or O O
the O O
survival O O
of O O
nucleated O O
blood O O
cells O O
and O O
that O O
this O O
phenotypic O O
characteristic O O
is O O
critical O O
during O O
hematopoiesis O O
. O O

in O O
the O O
japanese O O
population O O
, O O
however O O
, O O
there O O
has O O
been O O
no O O
report O O
demonstrating O O
the O O
contribution O O
of O O
iddm2 O O
to O O
the O O
pathogenesis O O
of O O
iddm B-SD B-SD
. O O

retroviral-mediated O O
/ O O
- O O
fibroblasts O O
are O O
inefficient O O
in O O
g1 O O
to O O
s-phase O O
progression O O
following O O
serum O O
stimulation O O
and O O
senesce O O
after O O
only O O
a O O
few O O
passages O O
in O O
culture O O
. O O

despite O O
high O O
levels O O
of O O
mrna O O
expression O O
, O O
there O O
was O O
no O O
evidence O O
of O O
the O O
hd B-M B-M
gene O O
product O O
in O O
any O O
of O O
these O O
transgenic O O
mice O O
. O O

the O O
fas O O
/ O O
apo-1 O O
receptor O O
plays O O
a O O
crucial O O
role O O
in O O
the O O
regulation O O
of O O
apoptosis O O
, O O
as O O
demonstrated O O
by O O
lymphoproliferation O O
in O O
mrl-lpr O O
/ O O
lpr O O
mice O O
and O O
by O O
the O O
recently O O
described O O
autoimmune B-SD B-SD
lymphoproliferative I-SD I-SD
syndrome I-SD I-SD
retroviral-mediated O O
alps B-SD B-SD
retroviral-mediated O O
in O O
humans O O
, O O
both O O
of O O
which O O
are O O
due O O
to O O
mutations O O
in O O
the O O
fas O O
gene O O
. O O

southern O O
blot O O
analysis O O
of O O
genomic O O
dna O O
from O O
hybrid O O
cell O O
lines O O
was O O
used O O
to O O
localize O O
the O O
vlcad O O
gene O O
to O O
human O O
chromosome O O
17p11 O O
. O O

the O O
children O O
share O O
common O O
clinical O O
features O O
including O O
splenomegaly B-DC B-SD
and O O
lymphadenopathy B-DC B-SD
, O O
but O O
only O O
one O O
developed O O
severe O O
autoimmune B-DC O
manifestations I-DC O
. O O

the O O
rho O O
family O O
of O O
gtpases O O
control O O
diverse O O
biological O O
processes O O
, O O
including O O
cell O O
morphology O O
and O O
mitogenesis O O
. O O

complete B-SD O
hypoxanthine-guanine I-SD O
phosphoribosyl-transferase I-SD O
retroviral-mediated I-SD O
hprt I-SD B-SD
retroviral-mediated I-SD I-SD
deficiency I-SD I-SD
in O O
humans O O
results O O
in O O
the O O
lesch-nyhan B-SD B-SD
syndrome I-SD I-SD
which O O
is O O
characterized O O
, O O
among O O
other O O
features O O
, O O
by O O
compulsive O O
self-injurious O O
behavior O O
. O O

the O O
study O O
evaluated O O
4 O O
patients O O
with O O
fmf B-SD B-SD
who O O
had O O
been O O
taking O O
colchicine O O
on O O
a O O
long-term O O
basis O O
. O O

furthermore O O
, O O
pax3-fkhr O O
and O O
pax7-fkhr O O
overexpression O O
occurs O O
by O O
distinct O O
mechanisms O O
. O O

marker O O
haplotype O O
studies O O
of O O
the O O
c6 O O
and O O
c7 O O
gene O O
region O O
and O O
southern O O
blots O O
show O O
that O O
the O O
irish O O
family O O
with O O
the O O
splice O O
defect O O
also O O
segregate O O
for O O
the O O
deletion O O
, O O
which O O
is O O
not O O
easily O O
detected O O
in O O
heterozygotes O O
. O O

the O O
significant O O
concordance O O
that O O
we O O
have O O
observed O O
in O O
the O O
degree O O
of O O
imbalance O O
in O O
the O O
different O O
blood-cell O O
lineages O O
indicates O O
that O O
a O O
selective O O
mechanism O O
is O O
likely O O
to O O
operate O O
at O O
the O O
level O O
of O O
pluripotent O O
blood O O
stem O O
cells O O
. O O

western O O
blot O O
analysis O O
of O O
patient O O
fibroblasts O O
showed O O
that O O
the O O
identified O O
mutations O O
result O O
in O O
severely O O
reduced O O
amounts O O
of O O
vlcad O O
protein O O
. O O

retroviral-mediated O O
. O O

we O O
found O O
a O O
significant O O
association O O
of O O
the O O
ins O O
region O O
with O O
iddm B-SD O
. O O

sequencing O O
of O O
this O O
region O O
shows O O
that O O
the O O
island O O
extends O O
over O O
3 O O
. O O

these O O
data O O
suggest O O
that O O
iddm2 O O
is O O
involved O O
in O O
the O O
genetic O O
susceptibility O O
to O O
iddm B-SD B-SD
in O O
japanese O O
. O O

the O O
regions O O
in O O
the O O
mouse O O
and O O
rat O O
were O O
homologous O O
to O O
human O O
chromosome O O
11q O O
. O O

loss O O
of O O
heterozygosity O O
was O O
studied O O
in O O
seven O O
renal B-SD O
hamartomas I-SD O
from O O
two O O
affected O O
individuals O O
in O O
the O O
first O O
family O O
, O O
as O O
well O O
as O O
in O O
a O O
jaw B-SD B-DC
tumor I-SD I-DC
and O O
a O O
parathyroid B-SD B-DC
tumor I-SD I-DC
from O O
the O O
second O O
family O O
. O O

the O O
mutation O O
, O O
which O O
creates O O
a O O
second O O
alui O O
restriction O O
site O O
, O O
results O O
in O O
a O O
nonsense O O
mutation O O
in O O
plp O O
. O O

45-kilobases O O
retroviral-mediated O O
kb O O
retroviral-mediated O O
exon O O
retroviral-mediated O O
of O O
the O O
hereditary B-M B-M
breast I-M I-M
and I-M I-M
ovarian I-M I-M
cancer I-M I-M
gene O O
brca1 O O
. O O

by O O
performing O O
in O O
vitro O O
expression O O
of O O
lcat O O
minigenes O O
and O O
reverse O O
transcriptase O O
pcr O O
on O O
mrna O O
isolated O O
from O O
leukocytes O O
of O O
the O O
patient O O
, O O
this O O
gene O O
defect O O
was O O
shown O O
to O O
cause O O
a O O
null O O
allele O O
as O O
the O O
result O O
of O O
complete O O
intron O O
retention O O
. O O

we O O
conducted O O
an O O
association O O
study O O
of O O
iddm B-SD B-SD
in O O
a O O
large O O
number O O
of O O
japanese O O
subjects O O
with O O
multiple O O
polymorphisms O O
in O O
ins O O
region O O
. O O

somatic-cell O O
selection O O
is O O
a O O
major O O
determinant O O
of O O
the O O
blood-cell O O
phenotype O O
in O O
heterozygotes O O
for O O
glucose-6-phosphate O O
dehydrogenase O O
mutations O O
causing O O
severe O O
enzyme B-DC B-DC
deficiency I-DC I-DC
. O O

a O O
major O O
cytogenetic O O
subgroup O O
of O O
lipomas B-DC B-DC
is O O
characterized O O
by O O
recurrent O O
chromosome O O
aberrations O O
, O O
mainly O O
translocations O O
, O O
that O O
involve O O
chromosome O O
segment O O
12q13-q15 O O
. O O

conclusions O O
sjs B-SD O
is O O
clinically O O
and O O
radiologically O O
heterogeneous O O
. O O

retroviral-mediated O O
/ O O
retroviral-mediated O O
develop O O
a O O
late-onset O O
, O O
progressive B-SD O
skeletal I-SD B-SD
myopathy I-SD I-SD
that O O
shares O O
some O O
pathological O O
features O O
with O O
dm B-SD B-SD
. O O

homozygous O O
brca1 O O
retroviral-mediated O O
5-6 O O
retroviral-mediated O O
mutant O O
mice O O
die O O
before O O
day O O
retroviral-mediated O O
. O O

we O O
describe O O
a O O
novel O O
family O O
with O O
alps B-SD B-SD
in O O
which O O
three O O
affected O O
siblings O O
carry O O
two O O
distinct O O
missense O O
mutations O O
on O O
both O O
the O O
fas O O
gene O O
alleles O O
and O O
show O O
lack O O
of O O
fas-induced O O
apoptosis O O
. O O

adrenomyeloneuropathy B-SD B-SD
retroviral-mediated O O
amn B-SD B-SD
retroviral-mediated O O
involves O O
the O O
spinal O O
cord O O
and O O
peripheral O O
nerves O O
in O O
young O O
adults O O
retroviral-mediated O O
retroviral-mediated O O
% O O
retroviral-mediated O O
. O O

to O O
test O O
this O O
proposition O O
, O O
we O O
bred O O
hprt-aprt-deficient B-M O
mice O O
. O O

the O O
positioning O O
of O O
the O O
polymerase O O
chain O O
reaction O O
retroviral-mediated O O
pcr O O
retroviral-mediated O O
primers O O
was O O
such O O
that O O
the O O
resulting O O
pcr O O
products O O
were O O
of O O
different O O
sizes O O
, O O
which O O
enabled O O
us O O
to O O
analyze O O
two O O
different O O
exons O O
simultaneously O O
and O O
still O O
distinguish O O
between O O
the O O
banding O O
profiles O O
for O O
both O O
retroviral-mediated O O
biplex O O
analysis O O
retroviral-mediated O O
. O O

a O O
unique O O
sequence O O
human O O
rb1 O O
cosmid O O
dna O O
probe O O
has O O
been O O
used O O
to O O
localize O O
this O O
region O O
on O O
apes O O
chr O O
14 O O
by O O
the O O
fish O O
technique O O
. O O

the O O
gene O O
mutated O O
in O O
ataxia-telangiectasia B-M B-M
retroviral-mediated O O
at B-M B-M
retroviral-mediated O O
patients O O
, O O
denoted O O
atm O O
, O O
encodes O O
a O O
putative O O
protein O O
or O O
lipid O O
kinase O O
. O O

brca1 O O
mutations O O
cause O O
increased O O
risk O O
for O O
breast B-CM B-CM
and I-CM I-CM
ovarian I-CM I-CM
cancer I-CM I-CM
, O O
frequently O O
of O O
early O O
onset O O
. O O

the O O
mutated O O
allele O O
was O O
transmitted O O
through O O
the O O
mouse O O
germ O O
line O O
and O O
homozygous O O
mutant O O
animals O O
were O O
derived O O
from O O
heterozygous O O
intercrosses O O
. O O

vectors O O
derived O O
from O O
a O O
recombinant O O
retrovirus O O
or O O
a O O
dna O O
/ O O
protein O O
complex O O
can O O
efficiently O O
transduce O O
the O O
pah O O
cdna O O
into O O
pah-deficient B-M O
hepatocytes O O
in O O
vitro O O
, O O
but O O
the O O
application O O
of O O
these O O
vector O O
systems O O
is O O
presently O O
limited O O
by O O
their O O
low O O
transduction O O
efficiency O O
in O O
vivo O O
. O O

brca1 O O
and O O
brca2 O O
are O O
the O O
two O O
major O O
identified O O
causes O O
of O O
inherited B-SD B-SD
breast I-SD I-SD
cancer I-SD I-SD
, O O
with O O
mutations O O
in O O
either O O
gene O O
conferring O O
up O O
to O O
80-90 O O
% O O
lifetime O O
risk O O
of O O
breast B-SD B-SD
cancer I-SD I-SD
in O O
carrier O O
females O O
. O O

combined B-SD B-CM
subtotal I-SD I-CM
deficiency I-SD I-CM
of I-SD I-CM
c6 I-SD I-CM
and I-SD I-CM
c7 I-SD I-CM
, O O
in O O
which O O
both O O
proteins O O
are O O
expressed O O
at O O
very O O
low O O
levels O O
, O O
has O O
been O O
observed O O
in O O
homozygous O O
form O O
in O O
two O O
families O O
. O O

tumor B-M B-M
suppression O O
and O O
apoptosis O O
of O O
human O O
prostate B-SD B-SD
carcinoma I-SD I-SD
mediated O O
by O O
a O O
genetic O O
locus O O
within O O
human O O
chromosome O O
10pter-q11 O O
. O O

similarly O O
, O O
while O O
the O O
cumulative O O
data O O
revealed O O
a O O
predominance O O
of O O
missense O O
mutations O O
among O O
the O O
wasp O O
gene O O
lesions O O
observed O O
in O O
boys O O
with O O
isolated B-SD O
thrombocytopenia I-SD B-SD
, O O
missense O O
mutations O O
were O O
not O O
exclusively O O
associated O O
with O O
milder O O
was B-M O
phenotypes O O
, O O
but O O
also O O
comprised O O
a O O
substantial O O
portion O O
retroviral-mediated O O
retroviral-mediated O O
% O O
retroviral-mediated O O
of O O
the O O
wasp O O
gene O O
defects O O
found O O
in O O
patients O O
with O O
severe O O
disease O O
. O O

alignment O O
of O O
the O O
predicted O O
amino O O
acid O O
sequence O O
of O O
human O O
vlcad O O
with O O
those O O
of O O
the O O
other O O
human O O
acd O O
enzymes O O
revealed O O
extensive O O
sequence O O
homology O O
. O O

two O O
male B-M B-M
breast I-M I-M
cancer I-M I-M
patients O O
retroviral-mediated O O
4 O O
% O O
of O O
the O O
total O O
retroviral-mediated O O
were O O
found O O
to O O
carry O O
novel O O
truncating O O
mutations O O
in O O
the O O
brca2 O O
gene O O
. O O

we O O
report O O
details O O
of O O
a O O
family O O
with O O
classic O O
li-fraumeni B-SD B-SD
syndrome I-SD I-SD
in O O
which O O
there O O
is O O
a O O
mutation O O
in O O
codon O O
retroviral-mediated O O
of O O
the O O
tumour B-M B-M
suppressor O O
gene O O
tp53 O O
. O O

these O O
are O O
consecutive O O
, O O
population-based O O
cases O O
not O O
selected O O
for O O
age O O
or O O
family O O
history O O
. O O

ashkenazi O O
jewish O O
population O O
frequencies O O
for O O
common O O
mutations O O
in O O
brca1 O O
and O O
brca2 O O
. O O

this O O
mutation O O
, O O
103c O O
-- O O
t O O
, O O
results O O
in O O
a O O
stop O O
codon O O
at O O
position O O
retroviral-mediated O O
of O O
the O O
atm O O
protein O O
. O O

the O O
current O O
study O O
was O O
aimed O O
at O O
finding O O
the O O
molecular O O
basis O O
of O O
canavan B-SD B-SD
disease I-SD I-SD
in O O
retroviral-mediated O O
independent O O
patients O O
of O O
non-jewish O O
background O O
. O O

to O O
study O O
the O O
molecular O O
genetics O O
of O O
classical B-CM O
and I-CM O
retroviral-mediated O O
duarte O O
galactosemia O B-SD
, O O
we O O
analyzed O O
the O O
galt O O
mutations O O
in O O
30 O O
families O O
with O O
retroviral-mediated O O
classical O O
galactosemia O O
< B-SD O
, I-SD B-SD
in I-SD O
10 O O
families O O
with O O
the O O
d-2 O O
variant O O
and O O
in O O
3 O O
individuals O O
carrying O O
the O O
d-1 O O
allele O O
by O O
denaturing O O
gradient O O
gel O O
electrophoresis O O
retroviral-mediated O O
dgge O O
retroviral-mediated O O
. O O

we O O
therefore O O
conclude O O
that O O
the O O
hgo O O
cdna O O
encodes O O
the O O
gene O O
responsible O O
for O O
alkaptonuria B-SD B-SD
. O O

previous O O
work O O
from O O
our O O
laboratory O O
demonstrated O O
that O O
a O O
dnase O O
l-hypersensitive O O
site O O
located O O
adjacent O O
to O O
the O O
repeats O O
on O O
the O O
wild-type O O
allele O O
is O O
eliminated O O
by O O
repeat O O
expansion O O
, O O
indicating O O
that O O
large O O
ctg-repeat O O
arrays O O
may O O
be O O
associated O O
with O O
a O O
local O O
chromatin O O
environment O O
that O O
represses O O
gene O O
expression O O
. O O

1 O O
. O O

to O O
determine O O
the O O
enzymatic O O
activities O O
produced O O
by O O
these O O
mutations O O
, O O
we O O
constructed O O
mutated O O
galc O O
cdnas O O
and O O
expressed O O
them O O
in O O
cos-1 O O
cells O O
. O O

a O O
cell O O
line O O
has O O
been O O
established O O
from O O
the O O
tumour B-DC B-DC
of O O
the O O
proband O O
and O O
cytogenetic O O
and O O
molecular O O
studies O O
carried O O
out O O
, O O
providing O O
an O O
extensive O O
analysis O O
in O O
this O O
family O O
. O O

the O O
incidence O O
of O O
pax6 O O
mutation O O
in O O
patients O O
with O O
simple O O
aniridia B-SD B-SD
: O O
an O O
evaluation O O
of O O
mutation O O
detection O O
in O O
retroviral-mediated O O
cases O O
. O O

this O O
clustering O O
is O O
not O O
observed O O
with O O
a O O
c-terminally O O
deleted O O
wasp O O
and O O
is O O
inhibited O O
by O O
coexpression O O
with O O
dominant O O
negative O O
cdc42hs-n17 O O
, O O
but O O
not O O
with O O
dominant O O
negative O O
forms O O
of O O
rac O O
or O O
rho O O
. O O

we O O
determined O O
retroviral-mediated O O
amino O O
acid O O
residues O O
from O O
five O O
peptides O O
from O O
the O O
homogeneous O O
monomer O O
of O O
homogentisate O O
1 O O
, O O
2-dioxygenase O O
retroviral-mediated O O
hgo O O
; O O
e O O
. O O

wt1 O O
mutations O O
have O O
also O O
been O O
reported O O
in O O
juvenile B-SD O
granulosa I-SD O
cell I-SD O
tumour I-SD B-DC
, O O
non-asbestos B-SD O
related I-SD O
mesothelioma I-SD B-SD
, O O
desmoplastic B-SD B-SD
small I-SD I-SD
round I-SD I-SD
cell I-SD I-SD
tumour I-SD I-SD
and O O
, O O
most O O
recently O O
, O O
acute B-SD O
myeloid I-SD O
leukemia I-SD B-SD
. O O

to O O
investigate O O
the O O
role O O
of O O
gene O O
dosage O O
in O O
more O O
detail O O
, O O
we O O
have O O
generated O O
yeast O O
artificial O O
chromosome O O
transgenic O O
mice O O
carrying O O
the O O
human O O
pax6 O O
locus O O
. O O

thus O O
, O O
it O O
appears O O
that O O
severe O O
g6pd B-SD B-SD
deficiency I-SD I-SD
affects O O
adversely O O
the O O
proliferation O O
or O O
the O O
survival O O
of O O
nucleated O O
blood O O
cells O O
and O O
that O O
this O O
phenotypic O O
characteristic O O
is O O
critical O O
during O O
hematopoiesis O O
. O O

strikingly O O
, O O
mice O O
carrying O O
multiple O O
copies O O
on O O
a O O
wild-type O O
background O O
show O O
specific O O
developmental B-DC B-DC
abnormalities I-DC I-DC
of I-DC I-DC
the I-DC I-DC
eye I-DC I-DC
, O O
but O O
not O O
of O O
other O O
tissues O O
expressing O O
the O O
gene O O
. O O

myotonic B-SD B-SD
dystrophy I-SD I-SD
retroviral-mediated O O
dm B-SD B-SD
retroviral-mediated O O
is O O
an O O
autosomal B-DC B-DC
dominant I-DC I-DC
disorder I-DC I-DC
resulting O O
from O O
the O O
expansion O O
of O O
a O O
retroviral-mediated O O
repeat O O
in O O
the O O
3 O O
untranslated O O
region O O
of O O
a O O
putative O O
protein O O
kinase O O
retroviral-mediated O O
dmpk O O
retroviral-mediated O O
. O O

here O O
we O O
report O O
two O O
families O O
with O O
hpt-jt B-SD B-SD
syndrome I-SD I-SD
in O O
which O B-SD
adult B-SD O
renal I-SD B-SD
hamartomas I-SD I-SD
or O O
cystic B-DC B-SD
kidney I-DC I-SD
disease I-DC I-SD
were O O
prominent O O
associated O O
features O O
, O O
possibly O O
representing O O
a O O
new O O
phenotypic O O
variant O O
of O O
the O O
hpt-jt B-SD B-SD
syndrome I-SD I-SD
. O O

these O O
defects O O
are O O
associated O O
with O O
a O O
characteristic O O
set O O
of O O
polymorphic O O
dna O O
markers O O
in O O
the O O
c6 O O
/ O O
c7 O O
region O O
, O O
forming O O
a O O
distinct O O
haplotype O O
. O O

ald B-SD B-SD
is O O
due O O
to O O
mutation O O
of O O
a O O
gene O O
located O O
in O O
xq28 O O
that O O
encodes O O
a O O
peroxisomal O O
transporter O O
protein O O
of O O
unknown O O
function O O
. O O

the O O
two O O
genes O O
are O O
believed O O
to O O
interact O O
in O O
a O O
number O O
of O O
pathways O O
, O O
including O O
regulation O O
of O O
dna O O
damage-induced O O
cell-cycle O O
checkpoints O O
, O O
apoptosis O O
and O O
radiation O O
sensitivity O O
, O O
and O O
cellular O O
proliferation O O
. O O

the O O
homozygous O O
32 O O
deltat O O
deletion O O
was O O
identified O O
in O O
the O O
only O O
known O O
patient O O
of O O
african-american O O
origin O O
with O O
canavan B-SD B-SD
disease I-SD I-SD
. O O

the O O
other O O
is O O
in O O
exon O O
retroviral-mediated O O
retroviral-mediated O O
retroviral-mediated O O
-- O O
a O O
; O O
gly444 O O
-- O O
arg O O
retroviral-mediated O O
of O O
the O O
c2q0 O O
gene O O
linked O O
to O O
the O O
mhc O O
haplotype O O
a2 O O
, O O
b5 O O
, O O
drw4 O O
, O O
bfs O O
, O O
c4a3b1 O O
. O O

retroviral-mediated O O
retroviral-mediated O O
. O O

yet O O
, O O
despite O O
a O O
large O O
international O O
effort O O
, O O
little O O
is O O
known O O
about O O
the O O
molecular O O
mechanisms O O
that O O
underlie O O
this O O
devastating O O
disease O O
. O O

nucleotide O O
sequence O O
analysis O O
of O O
a O O
composite O O
cdna O O
of O O
lpp O O
revealed O O
an O O
open O O
reading O O
frame O O
of O O
retroviral-mediated O O
nucleotides O O
encoding O O
a O O
proline-rich O O
protein O O
containing O O
a O O
leucine-zipper O O
motif O O
in O O
its O O
amino-terminal O O
region O O
and O O
three O O
lim O O
domains O O
in O O
its O O
carboxy-terminal O O
region O O
. O O

this O O
alteration O O
was O O
also O O
detected O O
in O O
eight O O
retroviral-mediated O O
four O O
females O O
and O O
four O O
males O O
retroviral-mediated O O
of O O
retroviral-mediated O O
controls O O
retroviral-mediated O O
retroviral-mediated O O
female O O
, O O
retroviral-mediated O O
males O O
retroviral-mediated O O
, O O
indicating O O
that O O
the O O
substitution O O
probably O O
represents O O
a O O
polymorphism O O
. O O

in O O
addition O O
, O O
we O O
have O O
detected O O
mutations O O
at O O
codon O O
51 O O
in O O
multiple O O
pcr O O
subclones O O
in O O
two O O
other O O
pancreatic B-SD B-DC
tumors I-SD I-DC
. O O

the O O
family O O
does O O
not O O
appear O O
to O O
be O O
remarkable O O
in O O
the O O
spectrum O O
of O O
tumours B-DC B-DC
, O O
and O O
there O O
is O O
loss O O
of O O
the O O
wild-type O O
allele O O
in O O
a O O
leiomyosarcoma B-SD O
from O O
the O O
proband O O
. O O

in O O
addition O O
to O O
an O O
involvement O O
in O O
inherited O O
susceptibility O O
to O O
cancer B-DC B-DC
, O O
these O O
tumour B-M B-M
suppressor O O
genes O O
are O O
targets O O
for O O
somatic O O
mutations O O
in O O
sporadic B-DC O
cancers I-DC B-DC
of O O
the O O
same O O
type O O
found O O
in O O
the O O
familial O O
forms O O
. O O

this O O
study O O
is O O
the O O
first O O
to O O
show O O
the O O
effect O O
of O O
a O O
modifying O O
gene O O
on O O
the O O
penetrance O O
of O O
an O O
inherited B-DC B-DC
cancer I-DC I-DC
syndrome I-DC O
a O O
novel O O
homeodomain-encoding O O
gene O O
is O O
associated O O
with O O
a O O
large O O
cpg O O
island O O
interrupted O O
by O O
the O O
myotonic B-M B-M
dystrophy I-M I-M
unstable O O
retroviral-mediated O O
retroviral-mediated O O
retroviral-mediated O O
n O O
repeat O O
. O O

the O O
upper O O
limit O O
of O O
the O O
two-sided O O
retroviral-mediated O O
% O O
confidence O O
interval O O
for O O
the O O
estimate O O
of O O
the O O
common O O
segregation O O
probability O O
for O O
the O O
three O O
donors O O
is O O
at O O
or O O
below O O
. O O

dna O O
sequencing O O
of O O
the O O
exon-intron O O
junctions O O
revealed O O
a O O
number O O
of O O
revisions O O
regarding O O
the O O
boundaries O O
between O O
exons O O
4 O O
, O O
retroviral-mediated O O
, O O
and O O
retroviral-mediated O O
as O O
well O O
as O O
between O O
exons O O
10 O O
and O O
retroviral-mediated O O
. O O

the O O
israeli O O
c7-deficient B-M O
cases O O
all O O
share O O
a O O
c7 O O
haplotype O O
and O O
are O O
homozygous O O
for O O
a O O
mis-sense O O
mutation O O
in O O
exon O O
9 O O
. O O

individuals O O
without O O
apparent O O
symptoms O O
or O O
signs O O
of O O
hd B-SD B-SD
were O O
found O O
at O O
retroviral-mediated O O
repeats O O
retroviral-mediated O O
aged O O
retroviral-mediated O O
, O O
retroviral-mediated O O
, O O
retroviral-mediated O O
, O O
and O O
retroviral-mediated O O
years O O
retroviral-mediated O O
, O O
retroviral-mediated O O
repeats O O
retroviral-mediated O O
aged O O
69 O O
years O O
retroviral-mediated O O
, O O
retroviral-mediated O O
repeats O O
retroviral-mediated O O
aged O O
69 O O
and O O
retroviral-mediated O O
years O O
retroviral-mediated O O
, O O
and O O
retroviral-mediated O O
repeats O O
retroviral-mediated O O
aged O O
retroviral-mediated O O
, O O
retroviral-mediated O O
, O O
and O O
retroviral-mediated O O
years O O
retroviral-mediated O O
. O O

the O O
equation O O
for O O
the O O
best O O
fit O O
line O O
was O O
y O O
= O O
retroviral-mediated O O
. O O

to O O
help O O
clarify O O
the O O
physiological O O
roles O O
of O O
the O O
atm O O
protein O O
, O O
we O O
disrupted O O
the O O
atm O O
gene O O
in O O
mice O O
through O O
homologous O O
recombination O O
. O O

the O O
prevalence O O
of O O
ald B-SD B-SD
among O O
adults O O
with O O
addisons B-SD B-SD
disease I-SD I-SD
remains O O
unknown O O
. O O

we O O
examined O O
galactosylceramidase O O
retroviral-mediated O O
galc O O
retroviral-mediated O O
cdna O O
in O O
four O O
japanese O O
patients O O
with O O
adult B-SD O
onset I-SD O
globoid I-SD B-SD
cell I-SD I-SD
leukodystrophy I-SD I-SD
retroviral-mediated O O
krabbe B-SD O
disease I-SD O
; O O
ao-gld B-SD O
retroviral-mediated O O
by O O
polymerase O O
chain O O
reaction O O
/ O O
single-strand O O
conformation O O
polymorphism O O
retroviral-mediated O O
pcr-sscp O O
retroviral-mediated O O
analysis O O
, O O
subsequent O O
sequence O O
determination O O
, O O
and O O
restriction O O
enzyme O O
digestion O O
of O O
pcr O O
products O O
, O O
initial O O
symptoms O O
were O O
the O O
onset O O
of O O
slowly O O
progressive O O
spastic B-DC B-SD
paraplegia I-DC I-SD
from O O
the O O
middle O O
of O O
the O O
second O O
decade O O
, O O
and O O
all O O
patients O O
had O O
diminished B-DC O
galc I-DC O
activity I-DC O
in O O
their O O
leukocytes O O
. O O

a O O
large O O
fragment O O
of O O
emerin O O
cdna O O
was O O
prepared O O
by O O
pcr O O
and O O
expressed O O
as O O
a O O
recombinant O O
protein O O
in O O
escherichia O O
coli O O
. O O

this O O
difference O O
in O O
mutation O O
sites O O
may O O
affect O O
the O O
clinical O O
features O O
of O O
gld B-SD O
. O O

mutations O O
have O O
been O O
found O O
throughout O O
the O O
gene O O
; O O
however O O
, O O
these O O
genetic O O
alterations O O
do O O
not O O
appear O O
to O O
be O O
homogeneously O O
distributed O O
. O O

analysis O O
of O O
meiotic O O
segregation O O
, O O
using O O
single-sperm O O
typing O O
: O O
meiotic O O
drive O O
at O O
the O O
myotonic B-M B-M
dystrophy I-M I-M
locus O O
. O O

retroviral-mediated O O
retroviral-mediated O O
. O O

2-4 O O
2-4 O O
. O O

germline O O
mutations O O
in O O
the O O
3 O O
' O O
part O O
of O O
apc B-M O
exon O O
15 O O
do O O
not O O
result O O
in O O
truncated O O
proteins O O
and O O
are O O
associated O O
with O O
attenuated O B-SD
adenomatous B-SD I-SD
polyposis I-SD I-SD
coli I-SD I-SD
. O O

the O O
human O O
neuronal O O
nicotinic O O
acetylcholine O O
receptor O O
alpha O O
4 O O
subunit O O
gene O O
retroviral-mediated O O
chrna4 O O
retroviral-mediated O O
is O O
located O O
in O O
the O O
candidate O O
region O O
for O O
three O O
different O O
phenotypes O O
benign B-SD O
familial I-SD B-SD
neonatal I-SD I-SD
convulsions I-SD I-SD
, O O
autosomal B-SD B-DC
dominant I-SD I-DC
nocturnal I-SD I-DC
frontal I-SD I-DC
lobe I-SD I-DC
epilepsy I-SD I-DC
, O O
and O O
low-voltage O O
eeg O O
. O O

brca2 O O
analysis O O
on O O
3 O O
, O O
retroviral-mediated O O
individuals O O
from O O
the O O
same O O
population O O
showed O O
a O O
carrier O O
frequency O O
of O O
1 O O
. O O

however O O
, O O
a O O
single O O
mutation O O
was O O
observed O O
in O O
32 O O
/ O O
33 O O
defective O O
atm O O
alleles O O
in O O
jewish O O
a-t B-M B-M
families O O
of O O
north O O
african O O
origin O O
, O O
coming O O
from O O
various O O
regions O O
of O O
morocco O O
and O O
tunisia O O
. O O

this O O
question O O
is O O
of O O
particular O O
interest O O
for O O
the O O
human O O
enzyme O O
galactose-l-phosphate O O
uridylyl-transferase O O
retroviral-mediated O O
galt O O
retroviral-mediated O O
, O O
impairment O O
of O O
which O O
results O O
in O O
the O O
inherited B-DC B-DC
metabolic I-DC I-DC
disorder I-DC I-DC
retroviral-mediated O O
retroviral-mediated O O
galactosemia O O
< O O
, O O
because O O
many O O
if O O
not O O
most O O
patients O O
studied O O
to O O
date O O
are O O
compound O O
heterozygotes O O
rather O O
than O O
true O O
molecular O O
homozygotes O O
. O O

meiosis O O
is O O
arrested O O
at O O
the O O
zygotene O O
/ O O
pachytene O O
stage O O
of O O
prophase O O
i O O
as O O
a O O
result O O
of O O
abnormal O O
chromosomal O O
synapsis O O
and O O
subsequent O O
chromosome O O
fragmentation O O
. O O

the O O
retroviral-mediated O O
retroviral-mediated O O
retroviral-mediated O O
n O O
repeat O O
is O O
polymorphic O O
and O O
varies O O
in O O
size O O
between O O
retroviral-mediated O O
and O O
retroviral-mediated O O
repeats O O
in O O
unaffected O O
individuals O O
whereas O O
in O O
affected O O
patients O O
there O O
are O O
between O O
50 O O
and O O
4 O O
, O O
retroviral-mediated O O
ctgs O O
. O O

the O O
common O O
hereditary O O
forms O O
of O O
breast B-SD B-SD
cancer I-SD I-SD
have O O
been O O
largely O O
attributed O O
to O O
the O O
inheritance O O
of O O
mutations O O
in O O
the O O
brca1 O O
or O O
brca2 O O
genes O O
. O O

in O O
the O O
four O O
polymorphic O O
variants O O
that O O
have O O
two O O
point O O
mutations O O
, O O
one O O
of O O
the O O
mutations O O
is O O
always O O
retroviral-mediated O O
a O O
-- O O
g O O
retroviral-mediated O O
retroviral-mediated O O
asn O O
-- O O
asp O O
retroviral-mediated O O
, O O
which O O
on O O
its O O
own O O
gives O O
rise O O
to O O
the O O
nondeficient O O
polymorphic O O
variant O O
, O O
g6pd O O
a O O
. O O

the O O
i66m O O
mutation O O
in O O
the O O
wild-type O O
galc O O
cdna O O
retroviral-mediated O O
retroviral-mediated O O
retroviral-mediated O O
had O O
normal O O
activity O O
, O O
but O O
when O O
this O O
mutation O O
and O O
the O O
retroviral-mediated O O
polymorphism O O
were O O
introduced O O
into O O
the O O
same O O
allele O O
, O O
it O O
had O O
decreased O O
activity O O
. O O

in O O
conclusion O O
, O O
we O O
demonstrated O O
that O O
a O O
point O O
mutation O O
in O O
a O O
lariat O O
branchpoint O O
consensus O O
sequence O O
causes O O
a O O
null O O
allele O O
in O O
a O O
patient O O
with O O
fed B-SD O
. O O

thus O O
the O O
most O O
common O O
polymorphisms O O
of O O
the O O
brca1 O O
gene O O
do O O
not O O
make O O
a O O
significant O O
contribution O O
to O O
breast B-M B-M
or I-M I-M
ovarian I-M I-M
cancer I-M I-M
risk O O
. O O

rapid O O
detection O O
of O O
regionally O O
clustered O O
germ-line O O
brca1 O O
mutations O O
by O O
multiplex O O
heteroduplex O O
analysis O O
. O O

finally-and O O
in O O
contrast O O
to O O
prior O O
predictions-atm O O
and O O
retroviral-mediated O O
do O O
not O O
appear O O
to O O
interact O O
in O O
acute B-SD O
radiation I-SD O
toxicity I-SD O
, O O
suggesting O O
a O O
separate O O
atm O O
effector O O
pathway O O
for O O
this O O
dna O O
damage O O
response O O
and O O
having O O
implications O O
for O O
the O O
prognosis O O
and O O
treatment O O
of O O
human O O
tumours B-DC B-DC
. O O

the O O
nucleotide O O
sequence O O
obtained O O
from O O
the O O
genomic O O
regions O O
adjacent O O
to O O
the O O
exon O O
boundaries O O
enabled O O
us O O
to O O
develop O O
a O O
set O O
of O O
primer O O
pairs O O
for O O
pcr O O
amplification O O
of O O
the O O
complete O O
coding O O
region O O
. O O

no O O
mobility O O
shift O O
was O O
seen O O
in O O
any O O
of O O
the O O
retroviral-mediated O O
chromophobe O O
renal B-SD B-SD
cell I-SD I-SD
carcinomas I-SD I-SD
. O O

thus O O
, O O
the O O
death O O
of O O
brca1 O O
retroviral-mediated O O
5-6 O O
retroviral-mediated O O
mutant O O
embryos O O
prior O O
to O O
gastrulation O O
may O O
be O O
due O O
to O O
a O O
failure O O
of O O
the O O
proliferative O O
burst O O
required O O
for O O
the O O
development O O
of O O
the O O
different O O
germ O O
layers O O
. O O

by O O
electrophysiological O O
tests O O
and O O
magnetic O O
resonance O O
imaging O O
it O O
was O O
determined O O
that O O
two O O
patients O O
had O O
cerebral B-SD B-SD
ald I-SD I-SD
, O O
one O O
had O O
adrenomyeloneuropathy B-SD B-SD
with O O
cerebral O B-SD
involvement O I-SD
, O O
and O O
two O O
had O O
preclinical O O
amn B-SD B-SD
. O O

we O O
report O O
about O O
retroviral-mediated O O
. O O

we O O
studied O O
a O O
previously O O
described O O
swiss O O
family O O
with O O
inherited B-SD O
c9 I-SD B-SD
deficiency I-SD I-SD
. O O

this O O
suggests O O
that O O
any O O
greater O O
amount O O
of O O
segregation O O
distortion O O
at O O
the O O
myotonic B-M B-M
dystrophy I-M I-M
locus O O
must O O
result O O
from O O
events O O
following O O
sperm O O
ejaculation O O
. O O

furthermore O O
, O O
based O O
on O O
our O O
clinical O O
experience O O
, O O
nursing O O
appears O O
to O O
be O O
safe O O
for O O
lactating O O
women O O
with O O
fmf B-SD B-SD
who O O
continue O O
to O O
take O O
colchicine O O
. O O

in O O
contrast O O
to O O
other O O
mouse O O
models O O
containing O O
cag O O
repeats O O
within O O
cdnas O O
, O O
these O O
mice O O
showed O O
both O O
intergenerational O O
and O O
somatic O O
repeat O O
instability O O
. O O

when O O
these O O
data O O
were O O
combined O O
with O O
the O O
results O O
of O O
our O O
previous O O
investigations O O
, O O
mutations O O
were O O
identified O O
in O O
a O O
total O O
of O O
99 O O
retroviral-mediated O O
retroviral-mediated O O
% O O
retroviral-mediated O O
of O O
retroviral-mediated O O
patients O O
. O O

each O O
mutant O O
c2 O O
gene O O
product O O
is O O
retained O O
early O O
in O O
the O O
secretory O O
pathway O O
. O O

no O O
recombinations O O
were O O
found O O
among O O
the O O
atm O O
, O O
npat O O
, O O
acat1 O O
, O O
and O O
d9mit6 O O
loci O O
, O O
and O O
these O O
loci O O
were O O
mapped O O
2 O O
. O O

no O O
families O O
were O O
attributed O O
to O O
brca2 O O
. O O

founding O O
brca1 O O
mutations O O
in O O
hereditary B-CM B-CM
breast I-CM I-CM
and I-CM I-CM
ovarian I-CM I-CM
cancer I-CM I-CM
in O O
southern O O
sweden O O
. O O

we O O
describe O O
herein O O
, O O
to O O
our O O
knowledge O O
, O O
for O O
the O O
first O O
time O O
, O O
the O O
cloning O O
of O O
a O O
full-length O O
cdna O O
for O O
atm O O
and O O
correction O O
of O O
multiple O O
aspects O O
of O O
the O O
radio-sensitive O O
phenotype O O
of O O
a-t B-M B-M
cells O O
by O O
transfection O O
with O O
this O O
cdna O O
. O O

retroviral-mediated O O
times O O
greater O O
for O O
brca1 O O
carriers O O
harbouring O O
one O O
or O O
two O O
rare O O
hras1 O O
alleles O O
, O O
compared O O
to O O
carriers O O
with O O
only O O
common O O
alleles O O
retroviral-mediated O O
p O O
= O O
retroviral-mediated O O
. O O

among O O
family O O
members O O
, O O
an O O
average O O
age O O
of O O
less O O
than O O
retroviral-mediated O O
years O O
at O O
the O O
diagnosis O O
of O O
breast B-SD B-SD
cancer I-SD I-SD
, O O
the O O
presence O O
of O O
ovarian B-SD B-SD
cancer I-SD I-SD
, O O
the O O
presence O O
of O O
breast B-CM B-CM
and I-CM I-CM
ovarian I-CM I-CM
cancer I-CM I-CM
in O O
the O O
same O O
woman O O
, O O
and O O
ashkenazi O O
jewish O O
ancestry O O
were O O
all O O
associated O O
with O O
an O O
increased O O
risk O O
of O O
detecting O O
a O O
brca1 O O
mutation O O
. O O

in O O
patients O O
with O O
stage B-SD O
iii I-SD O
disease I-SD O
, O O
the O O
respective O O
survival O O
rates O O
were O O
retroviral-mediated O O
. O O

wiskott-aldrich B-M B-SD
syndrome I-M I-SD
protein O O
, O O
a O O
novel O O
effector O O
for O O
the O O
gtpase O O
cdc42hs O O
, O O
is O O
implicated O O
in O O
actin O O
polymerization O O
. O O

although O O
the O O
specific O O
gene O O
inactivated O O
by O O
this O O
allelic O O
loss O O
has O O
not O O
been O O
elucidated O O
, O O
the O O
dcc O O
retroviral-mediated O O
deleted O O
in O O
colorectal B-SD B-M
cancer I-SD I-M
retroviral-mediated O O
gene O O
is O O
a O O
candidate O O
. O O

the O O
findings O O
suggest O O
that O O
both O O
hdl O O
concentration O O
and O O
the O O
dynamics O O
of O O
cholesterol O O
transport O O
through O O
hdl O O
retroviral-mediated O O
i O O
. O O

results O O
brca1 O O
mutations O O
were O O
identified O O
in O O
retroviral-mediated O O
percent O O
of O O
women O O
with O O
a O O
family O O
history O O
of O O
breast B-SD B-SD
cancer I-SD I-SD
. O O

the O O
majority O O
of O O
mutant O O
mice O O
rapidly O O
develop O O
thymic B-SD B-SD
lymphomas I-SD I-SD
and O O
die O O
before O O
4 O O
months O O
of O O
age O O
. O O

the O O
wasp O O
sequence O O
contains O O
two O O
novel O O
domains O O
that O O
are O O
homologous O O
to O O
other O O
proteins O O
involved O O
in O O
action O O
organization O O
. O O

twenty-three O O
families O O
were O O
identified O O
through O O
two O O
high-risk O O
breast B-M B-M
cancer I-M I-M
research O O
programs O O
. O O

2 O O
retroviral-mediated O O
, O O
whereas O O
linkage O O
to O O
the O O
men1 B-M O
and O O
men2 B-M O
regions O O
was O O
excluded O O
. O O

the O O
extraembryonic O O
region O O
is O O
abnormal O O
, O O
but O O
aggregation O O
with O O
wild-type O O
tetraploid O O
embryos O O
does O O
not O O
rescue O O
the O O
lethality O B-SD
. O O

these O O
mutants O O
provide O O
models O O
for O O
elucidating O O
the O O
c2 O O
secretory O O
pathway O O
. O O

no O O
region O O
of O O
the O O
rb1 O O
gene O O
was O O
preferentially O O
involved O O
in O O
single O O
base O O
substitutions O O
. O O

in O O
vitro O O
expression O O
of O O
mutant O O
cdna O O
clones O O
demonstrated O O
that O O
all O O
of O O
these O O
mutations O O
led O O
to O O
a O O
deficiency B-SD O
of I-SD O
aspa I-SD O
and O O
should O O
therefore O O
result O O
in O O
canavan B-SD B-SD
disease I-SD I-SD
. O O

in O O
retroviral-mediated O O
of O O
15 O O
uncultured O O
primary O O
human O O
breast B-SD B-SD
carcinomas I-SD I-SD
, O O
intragenic O O
deletions O O
were O O
shown O O
in O O
tsg101 O O
genomic O O
dna O O
and O O
transcripts O O
by O O
gel O O
and O O
sequence O O
analysis O O
, O O
and O O
mutations O O
affecting O O
two O O
tsg101 O O
alleles O O
were O O
identified O O
in O O
four O O
of O O
these O O
cancers B-DC B-DC
. O O

no O O
germ-line O O
brca1 O O
mutations O O
were O O
found O O
. O O

expression O O
of O O
the O O
pax3-fkhr O O
protein O O
in O O
these O O
cells O O
leads O O
to O O
transformation O O
the O O
cells O O
become O O
enlarged O O
, O O
grow O O
tightly O O
packed O O
and O O
in O O
multiple O O
layers O O
, O O
and O O
acquire O O
the O O
ability O O
for O O
anchorage-independent O O
growth O O
. O O

due O O
to O O
strong O O
linkage O O
disequilibrium O O
, O O
these O O
four O O
sites O O
generate O O
only O O
three O O
haplotypes O O
with O O
a O O
frequency O O
1 O O
. O O

mutation O O
of O O
msh3 O O
in O O
endometrial B-SD B-SD
cancer I-SD I-SD
and O O
evidence O O
for O O
its O O
functional O O
role O O
in O O
heteroduplex O O
repair O O
. O O

the O O
spectrum O O
of O O
rb1 O O
germ-line O O
mutations O O
in O O
hereditary B-SD O
retinoblastoma I-SD B-SD
. O O

in O O
addition O O
, O O
our O O
finding O O
illustrates O O
the O O
importance O O
of O O
this O O
sequence O O
for O O
normal O O
human O O
mrna O O
processing O O
. O O

microcell O O
hybrids O O
containing O O
only O O
the O O
region O O
10pter-q11 O O
were O O
suppressed O O
for O O
tumorigenicity O O
following O O
injection O O
of O O
microcell O O
hybrids O O
into O O
nude O O
mice O O
. O O

phenotypic O O
and O O
genotypic O O
overlap O O
between O O
atelosteogenesis B-SD B-SD
type I-SD I-SD
2 I-SD I-SD
and O O
diastrophic B-SD B-SD
dysplasia I-SD I-SD
. O O

the O O
tsg101 O B-M
tumor B-M I-M
susceptibility O O
gene O O
is O O
located O O
in O O
chromosome O O
retroviral-mediated O O
band O O
retroviral-mediated O O
and O O
is O O
mutated O O
in O O
human O O
breast B-SD B-SD
cancer I-SD I-SD
. O O

to O O
determine O O
the O O
mechanism O O
for O O
increased O O
activity O O
of O O
the O O
la O O
variant O O
, O O
we O O
compared O O
galt O O
mrna O O
, O O
protein O O
abundance O O
, O O
and O O
enzyme O O
thermal O O
stability O O
in O O
lymphoblast O O
cell O O
lines O O
of O O
d O O
and O O
la O O
phenotypes O O
with O O
comparable O O
genotypes O O
. O O

molecular O O
bases O O
of O O
c7 B-SD B-SD
deficiency I-SD I-SD
: O O
three O O
different O O
defects O O
. O O

in O O
all O O
three O O
cases O O
, O O
there O O
is O O
a O O
strong O O
family O O
history O O
of O O
breast B-CM B-SD
, I-CM I-SD
ovarian I-CM I-CM
, I-CM I-CM
or I-CM O
other I-CM O
cancers I-CM B-DC
possibly O O
related O O
to O O
a O O
brca1 O O
defect O O
and O O
family O O
members O O
showed O O
a O O
high O O
concordance O O
of O O
cancer B-M B-DC
incidence O O
with O O
the O O
presence O O
of O O
r841w O O
. O O

1 O O
retroviral-mediated O O
. O O

none O O
of O O
these O O
patients O O
had O O
adrenocortical O O
antibodies O O
. O O

these O O
findings O O
, O O
as O O
well O O
as O O
the O O
detection O O
of O O
identical O O
wasp O O
mutations O O
in O O
patients O O
with O O
disparate O O
phenotypes O O
, O O
reveal O O
a O O
lack O O
of O O
phenotype O O
concordance O O
with O O
genotype O O
in O O
was B-SD O
and O O
thus O O
imply O O
that O O
phenotypic O O
outcome O O
in O O
this O O
disease O O
can O O
not O O
be O O
reliably O O
predicted O O
solely O O
on O O
the O O
basis O O
of O O
wasp O O
genotypes O O
. O O

four O O
novel O O
swedish O O
founding O O
mutations O O
were O O
identified O O
the O O
nucleotide O O
retroviral-mediated O O
deletion O O
a O O
was O O
found O O
in O O
five O O
families O O
, O O
the O O
c O O
retroviral-mediated O O
t O O
nonsense O O
mutation O O
in O O
three O O
families O O
, O O
the O O
retroviral-mediated O O
insertion O O
retroviral-mediated O O
in O O
three O O
families O O
, O O
and O O
the O O
nucleotide O O
retroviral-mediated O O
deletion O O
retroviral-mediated O O
in O O
two O O
families O O
. O O

the O O
characteristic O O
duarte O O
isoform O O
is O O
also O O
associated O O
with O O
a O O
variant O O
called O O
the O O
`` O O
los O O
angeles O O
retroviral-mediated O O
la O O
retroviral-mediated O O
phenotype O O
, O O
`` O O
which O O
has O O
increased O O
galt O O
enzyme O O
activity O O
. O O

retroviral-mediated O O
% O O
retroviral-mediated O O
of O O
all O O
breast B-CM B-CM
and I-CM I-CM
ovarian I-CM I-CM
cancers I-CM I-CM
in O O
this O O
population O O
. O O

the O O
cdna O O
of O O
mouse O O
hgo O O
has O O
an O O
overall O O
identity O O
of O O
retroviral-mediated O O
% O O
to O O
the O O
corresponding O O
gene O O
hmga O O
from O O
aspergillus O O
. O O

two O O
of O O
the O O
patients O O
had O O
only O O
the O O
i66m O O
mutant O O
mrna O O
, O O
and O O
one O O
only O O
the O O
g27od O O
mutant O O
mrna O O
. O O

the O O
aim O O
of O O
the O O
present O O
study O O
was O O
to O O
determine O O
if O O
it O O
might O O
also O O
be O O
altered O O
in O O
colorectal B-SD B-SD
cancers I-SD I-SD
. O O

to O O
address O O
this O O
issue O O
we O O
characterized O O
wasp O O
mutations O O
in O O
24 O O
unrelated O O
was B-M B-M
patients O O
, O O
including O O
18 O O
boys O O
with O O
severe O O
classical O O
was B-SD O
and O O
retroviral-mediated O O
boys O O
expressing O O
mild O O
forms O O
of O O
the O O
disease O O
, O O
and O O
then O O
examined O O
the O O
degree O O
of O O
correlation O O
of O O
these O O
as O O
well O O
as O O
all O O
previously O O
published O O
wasp O O
mutations O O
with O O
disease O O
severity O O
. O O

adrenal B-DC B-DC
insufficiency I-DC I-DC
retroviral-mediated O O
addisons B-SD B-SD
disease I-SD I-SD
retroviral-mediated O O
is O O
frequently O O
associated O O
with O O
amn B-SD B-SD
or O O
cerebral B-SD B-SD
ald I-SD I-SD
and O O
may O O
remain O O
the O O
only O O
clinical O O
expression O O
of O O
ald B-SD B-SD
retroviral-mediated O O
retroviral-mediated O O
% O O
of O O
cases O O
retroviral-mediated O O
. O O

we O O
tentatively O O
isolate O O
three O O
different O O
types O O
of O O
sjs B-SD B-SD
type I-SD I-SD
1a I-SD I-SD
, O O
usually O O
recognized O O
in O O
childhood O O
, O O
with O O
moderate O B-SD
bone B-DC I-SD
dysplasia I-DC I-SD
, O O
corresponding O O
to O O
the O O
original O O
descriptions O O
of O O
schwartz O O
, O O
jampel O O
and O O
aberfeld O O
; O O
type O O
1b O O
, O O
similar O O
to O O
type O O
1a O O
but O O
recognizable O O
at O O
birth O O
, O O
with O O
more O O
pronounced O B-SD
bone B-DC I-SD
dysplasia I-DC I-SD
resembling O O
kniest B-SD B-SD
dysplasia I-SD I-SD
; O O
and O O
type O O
2 O O
, O O
manifest O O
at O O
birth O O
, O O
with O O
increased O O
mortality O O
and O O
bone B-DC B-SD
dysplasia I-DC I-SD
resembling O O
pyle B-SD B-SD
disease I-SD I-SD
. O O

the O O
ninth O O
component O O
of O O
human O O
complement O O
retroviral-mediated O O
c9 O O
retroviral-mediated O O
is O O
the O O
last O O
of O O
the O O
terminal O O
complement O O
components O O
creating O O
the O O
membrane O O
attack O O
complex O O
. O O

apopain O O
, O O
a O O
human O O
counterpart O O
of O O
the O O
nematode O O
cysteine O O
protease O O
death-gene O O
product O O
, O O
ced-3 O O
, O O
has O O
a O O
key O O
role O O
in O O
proteolytic O O
events O O
leading O O
to O O
apoptosis O O
. O O

kniest O O
, O O
who O O
first O O
described O O
the O O
condition O O
in O O
retroviral-mediated O O
, O O
and O O
his O O
patient O O
, O O
who O O
, O O
at O O
the O O
age O O
of O O
50 O O
years O O
is O O
severely B-DC O
handicapped I-DC O
with O O
short B-DC B-DC
stature I-DC I-DC
, O O
restricted B-DC O
joint I-DC O
mobility I-DC O
, O O
and O O
blindness B-DC B-DC
but O O
is O O
mentally O O
alert O O
and O O
leads O O
an O O
active O O
life O O
. O O

a O O
muscle O O
biopsy O O
from O O
an O O
emery-dreifuss B-M B-M
muscular I-M I-M
dystrophy I-M I-M
retroviral-mediated O O
emdm B-M O
retroviral-mediated O O
patient O O
showed O O
complete O O
absence O O
of O O
emerin O O
by O O
both O O
western O O
blotting O O
and O O
immunohistochemistry O O
, O O
suggesting O O
a O O
simple O O
diagnostic O O
antibody O O
test O O
for O O
edmd B-M B-M
families O O
. O O

therefore O O
, O O
disease-causing O O
mutations O O
at O O
cpgs O O
in O O
rb1 O O
appear O O
to O O
be O O
determined O O
by O O
several O O
factors O O
, O O
including O O
the O O
constitutive O O
presence O O
of O O
dna O O
methylation O O
at O O
cytosines O O
within O O
cpgs O O
, O O
the O O
specific O O
codon O O
within O O
which O O
the O O
methylated O O
cytosine O O
is O O
located O O
, O O
and O O
the O O
particular O O
region O O
of O O
the O O
gene O O
within O O
which O O
that O O
codon O O
resides O O
. O O

hprt-deficient B-M O
mice O O
generated O O
using O O
mouse O O
embryonic O O
stem O O
cells O O
exhibit O O
none O O
of O O
the O O
behavioral O O
symptoms O O
associated O O
with O O
the O O
lesch-nyhan B-SD B-SD
syndrome I-SD I-SD
. O O

these O O
findings O O
help O O
to O O
outline O O
the O O
relationship O O
and O O
evolution O O
of O O
mutations O O
in O O
the O O
human O O
g6pd O O
locus O O
. O O

retroviral-mediated O O
/ O O
- O O
fibroblasts O O
are O O
inefficient O O
in O O
g1 O O
to O O
s-phase O O
progression O O
following O O
serum O O
stimulation O O
and O O
senesce O O
after O O
only O O
a O O
few O O
passages O O
in O O
culture O O
. O O

conclusions O O
the O O
dpc4 O O
gene O O
may O O
play O O
a O O
role O O
as O O
a O O
tumor-suppressor O O
gene O O
in O O
a O O
fraction O O
of O O
colorectal B-SD B-SD
cancers I-SD I-SD
; O O
however O O
, O O
while O O
allelic O O
loss O O
at O O
18q21 O O
is O O
very O O
often O O
seen O O
in O O
colorectal B-SD B-SD
cancers I-SD I-SD
, O O
only O O
a O O
minority O O
show O O
dpc4 O O
mutations O O
, O O
suggesting O O
that O O
there O O
might O O
be O O
another O O
tumor-suppressor O O
gene O O
in O O
this O O
chromosome O O
region O O
. O O

although O O
vhl B-M O
mrna O O
was O O
expressed O O
in O O
all O O
three O O
germ O O
layers O O
, O O
strong O O
expression O O
was O O
noted O O
in O O
the O O
central O O
nervous O O
system O O
, O O
kidneys O O
, O O
testis O O
and O O
lung O O
. O O

these O O
common O O
mutations O O
have O O
an O O
etiological O O
role O O
in O O
many O O
breast B-M B-M
and I-M I-M
ovarian I-M I-M
cancer I-M I-M
cases O O
and O O
provide O O
the O O
opportunity O O
to O O
examine O O
genotype-phenotype O O
correlations O O
and O O
genotype-environment O O
interactions O O
in O O
individuals O O
with O O
the O O
identical O O
brca1 O B-DC
lesion O I-DC
. O O

myotonic B-SD B-SD
dystrophy I-SD I-SD
retroviral-mediated O O
dm B-SD B-SD
retroviral-mediated O O
is O O
associated O O
with O O
the O O
expansion O O
of O O
a O O
retroviral-mediated O O
retroviral-mediated O O
retroviral-mediated O O
n O O
trinucleotide O O
repeat O O
in O O
the O O
3 O O
untranslated O O
region O O
retroviral-mediated O O
utr O O
retroviral-mediated O O
of O O
the O O
dm B-M B-M
protein O O
kinase O O
gene O O
retroviral-mediated O O
dmpk O O
retroviral-mediated O O
. O O

mice O O
lacking O O
the O O
myotonic B-M B-M
dystrophy I-M I-M
protein O O
kinase O O
develop O O
a O O
late O O
onset O O
progressive O O
myopathy B-SD B-DC
. O O

these O O
characteristics O O
were O O
observed O O
, O O
however O O
, O O
in O O
both O O
severe O O
and O O
mild O O
cases O O
of O O
the O O
disease O O
. O O

the O O
tumor B-M B-M
suppressor O O
gene O O
brca1 O O
is O O
required O O
for O O
embryonic O O
cellular O O
proliferation O O
in O O
the O O
mouse O O
. O O

identification O O
of O O
wasp O O
mutations O O
, O O
mutation O O
hotspots O O
and O O
genotype-phenotype O O
disparities O O
in O O
24 O O
patients O O
with O O
the O O
wiskott-aldrich B-SD B-SD
syndrome I-SD I-SD
. O O

five O O
were O O
splice O O
site O O
mutations O O
retroviral-mediated O O
one O O
in O O
the O O
donor O O
site O O
of O O
intron O O
4 O O
, O O
two O O
in O O
the O O
donor O O
site O O
of O O
intron O O
retroviral-mediated O O
, O O
one O O
in O O
each O O
of O O
the O O
acceptor O O
sites O O
of O O
introns O O
retroviral-mediated O O
and O O
9 O O
retroviral-mediated O O
and O O
five O O
were O O
nonsense O O
mutations O O
in O O
exons O O
retroviral-mediated O O
, O O
9 O O
, O O
10 O O
, O O
retroviral-mediated O O
, O O
and O O
retroviral-mediated O O
. O O

despite O O
high O O
levels O O
of O O
mrna O O
expression O O
, O O
there O O
was O O
no O O
evidence O O
of O O
the O O
hd B-M B-M
gene O O
product O O
in O O
any O O
of O O
these O O
transgenic O O
mice O O
. O O

spretus O O
backcross O O
placed O O
the O O
wasp O O
locus O O
near O O
the O O
centromere O O
of O O
the O O
mouse O O
x O O
chromosome O O
, O O
inseparable O O
from O O
gata1 O O
, O O
tcfe3 O O
, O O
and O O
scurfy O O
retroviral-mediated O O
sf O O
retroviral-mediated O O
. O O

twelve O O
aniridia B-M B-M
patients O O
, O O
five O O
with O O
a O O
family O O
history O O
and O O
seven O O
presumed O O
to O O
be O O
sporadic O O
, O O
were O O
exhaustively O O
screened O O
in O O
order O O
to O O
test O O
what O O
proportion O O
of O O
people O O
with O O
aniridia B-SD B-SD
, O O
uncomplicated O O
by O O
associated O O
anomalies O O
, O O
carry O O
mutations O O
in O O
the O O
human O O
pax6 O O
gene O O
. O O

this O O
vhl-responsive O O
element O O
is O O
retroviral-mediated O O
rich O O
and O O
specifically O O
binds O O
the O O
transcription O O
factor O O
sp1 O O
in O O
crude O O
nuclear O O
extracts O O
. O O

methods O O
the O O
expression O O
of O O
dcc O O
was O O
evaluated O O
immunohistochemically O O
in O O
retroviral-mediated O O
paraffin-embedded O O
samples O O
from O O
patients O O
with O O
curatively O O
resected O O
stage B-CM O
ii I-CM O
and I-CM O
iii I-CM O
colorectal I-CM B-SD
carcinomas I-CM I-SD
. O O

with O O
respect O O
to O O
their O O
roles O O
in O O
apoptosis O O
, O O
loss O O
of O O
atm O O
rendered O O
thymocytes O O
only O O
partly O O
resistant O O
to O O
irradiation-induced O O
apoptosis O O
, O O
whereas O O
additional O O
loss O O
of O O
retroviral-mediated O O
engendered O O
complete O O
resistance O O
. O O

the O O
hereditary B-M B-M
breast I-M I-M
and I-M I-M
ovarian I-M I-M
cancer I-M I-M
gene O O
, O O
brca1 O O
, O O
encodes O O
a O O
large O O
polypeptide O O
that O O
contains O O
the O O
cysteine-rich O O
ring O O
motif O O
, O O
a O O
zinc-binding O O
domain O O
found O O
in O O
a O O
variety O O
of O O
regulatory O O
proteins O O
. O O

we O O
have O O
generated O O
a O O
mouse O O
model O O
for O O
ataxia-telangiectasia B-SD B-SD
by O O
using O O
gene O O
targeting O O
to O O
generate O O
mice O O
that O O
do O O
not O O
express O O
the O O
atm O O
protein O O
. O O

no O O
tsg101 O O
defects O O
were O O
found O O
in O O
matched O O
normal O O
breast O O
tissue O O
from O O
the O O
breast B-M B-M
cancer I-M I-M
patients O O
. O O

to O O
study O O
the O O
interactions O O
of O O
these O O
two O O
genes O O
on O O
an O O
organismal O O
level O O
, O O
we O O
bred O O
mice O O
heterozygous O O
for O O
null O O
alleles O O
of O O
both O O
atm O O
and O O
retroviral-mediated O O
to O O
produce O O
all O O
genotypic O O
combinations O O
. O O

a O O
distinct O O
feature O O
of O O
the O O
mouse O O
gene O O
is O O
an O O
expanded O O
polymorphic O O
retroviral-mediated O O
trinucleotide O O
repeat O O
that O O
codes O O
for O O
polyglycine O O
and O O
varies O O
from O O
15 O O
to O O
retroviral-mediated O O
triplets O O
in O O
different O O
mus O O
musculus O O
strains O O
. O O

in O O
pedigree O O
analyses O O
, O O
this O O
1721c O O
-- O O
t O O
transition O O
segregated O O
with O O
the O O
la O O
phenotype O O
of O O
increased O O
galt O O
activity O O
in O O
three O O
different O O
biochemical O O
phenotypes O O
retroviral-mediated O O
la O O
/ O O
n O O
, O O
la O O
/ O O
g O O
, O O
and O O
la O O
/ O O
d O O
retroviral-mediated O O
. O O

this O O
agrees O O
well O O
with O O
the O O
fact O O
that O O
cardiac O O
and O O
muscle O O
symptoms O O
are O O
characteristic O O
for O O
patients O O
with O O
vlcad B-SD B-SD
deficiency I-SD I-SD
. O O

the O O
brca2 O O
coding O O
sequence O O
is O O
huge O O
, O O
composed O O
of O O
retroviral-mediated O O
exons O O
that O O
span O O
10 O O
, O O
retroviral-mediated O O
bp O O
. O O

characterisation O O
of O O
the O O
expression O O
of O O
this O O
gene O O
in O O
patient O O
tissues O O
has O O
thus O O
far O O
generated O O
conflicting O O
data O O
on O O
alterations O O
in O O
the O O
steady O O
state O O
levels O O
of O O
dmpk O O
mrna O O
, O O
and O O
on O O
the O O
final O O
dmpk O O
protein O O
levels O O
in O O
the O O
presence O O
of O O
the O O
expansion O O
. O O

after O O
digestion O O
with O O
trypsin O O
, O O
peptides O O
were O O
separated O O
by O O
reversed O O
phase O O
chromatography O O
and O O
amino O O
acid O O
sequenced O O
. O O

fish O O
experiments O O
with O O
the O O
whole O O
murine O O
cdna O O
as O O
probe O O
clearly O O
revealed O O
signals O O
at O O
the O O
human O O
chromosomal O O
band O O
3q13 O O
. O O

type B-SD B-SD
ii I-SD I-SD
complement I-SD I-SD
protein I-SD I-SD
c2 I-SD I-SD
deficiency I-SD I-SD
is O O
characterized O O
by O O
a O O
selective O O
block O O
in O O
c2 O O
secretion O O
. O O

twenty O O
microsatellite O O
markers O O
in O O
the O O
hrpt2 O O
region O O
were O O
typed O O
, O O
in O O
addition O O
to O O
markers O O
in O O
the O O
multiple B-M O
endocrine I-M O
neoplasia I-M O
retroviral-mediated I-M O
men I-M O
retroviral-mediated I-M O
types I-M O
1 I-M O
and I-M O
2 I-M O
regions O O
at O O
11q13 O O
and O O
10q11 O O
. O O

mutation O O
analysis O O
of O O
brca1 O O
and O O
brca2 O O
in O O
a O O
male B-M O
breast I-M B-M
cancer I-M I-M
population O O
. O O

the O O
present O O
study O O
confirms O O
the O O
involvement O O
of O O
brca1 O O
in O O
disease O O
predisposition O O
for O O
a O O
subset O O
of O O
hereditary B-M B-M
breast I-M I-M
cancer I-M I-M
families O O
often O O
characterized O O
by O O
ovarian B-SD B-SD
cancers I-SD I-SD
. O O

the O O
major O O
cause O O
of O O
death O O
of O O
mutant O O
mice O O
was O O
rupture O O
of O O
the O O
major O O
blood O O
vessels O O
, O O
similar O O
to O O
patients O O
with O O
type B-SD B-SD
iv I-SD I-SD
ehlers-danlos I-SD I-SD
syndrome I-SD I-SD
. O O

two O O
alternatively O O
spliced O O
vhl B-M B-M
mrnas O O
characterized O O
by O O
inclusion O O
retroviral-mediated O O
isoform O O
i O O
retroviral-mediated O O
or O O
exclusion O O
retroviral-mediated O O
isoform O O
ii O O
retroviral-mediated O O
of O O
exon O O
2 O O
are O O
transcribed O O
in O O
adult O O
tissues O O
. O O

while O O
only O O
retroviral-mediated O O
% O O
of O O
sporadic B-SD O
wilms I-SD B-SD
tumours I-SD I-SD
have O O
intragenic O O
wt1 O O
mutations O O
, O O
retroviral-mediated O O
% O O
of O O
patients O O
with O O
the O O
denys-drash B-SD B-SD
syndrome I-SD I-SD
retroviral-mediated O O
renal B-DC B-SD
nephropathy I-DC I-SD
, O O
gonadal B-DC B-SD
anomaly I-DC I-SD
, O O
predisposition B-DC O
to I-DC O
wt I-DC B-SD
retroviral-mediated O O
carry O O
constitutional O O
intragenic O O
wt1 O O
mutations O O
. O O

over O O
retroviral-mediated O O
distinct O O
brca1 O O
mutations O O
and O O
a O O
growing O O
list O O
of O O
brca2 O O
mutations O O
have O O
been O O
identified O O
, O O
with O O
the O O
majority O O
resulting O O
in O O
protein O O
truncation O O
. O O

seven O O
hd B-M B-M
patients O O
had O O
retroviral-mediated O O
repeats O O
, O O
which O O
confirms O O
that O O
this O O
allele O O
is O O
associated O O
with O O
disease O O
. O O

in O O
contrast O O
, O O
pax7-fkhr O O
overexpression O O
results O O
from O O
fusion O O
gene O O
amplification O O
. O O

a O O
tentative O O
clinico-radiological O O
classification O O
can O O
be O O
useful O O
for O O
the O O
characterization O O
of O O
patients O O
and O O
the O O
development O O
of O O
genotype-phenotype O O
correlations O O
. O O

defective O O
dimerization O O
of O O
von B-M B-M
willebrand I-M I-M
factor O O
subunits O O
due O O
to O O
a O O
retroviral-mediated O O
arg O O
mutation O O
in O O
type B-SD O
iid I-SD O
von I-SD B-SD
willebrand I-SD I-SD
disease I-SD I-SD
. O O

genetic O O
bases O O
of O O
human O O
complement B-SD O
c7 I-SD B-SD
deficiency I-SD I-SD
. O O

mutation O O
analysis O O
in O O
the O O
brca1 O O
and O O
brca2 O O
genes O O
was O O
also O O
undertaken O O
in O O
all O O
families O O
. O O

in O O
retroviral-mediated O O
of O O
the O O
retroviral-mediated O O
non-papillary B-SD O
renal I-SD B-SD
cell I-SD I-SD
carcinomas I-SD I-SD
, O O
abnormally O O
migrating O O
dna O O
bands O O
were O O
detected O O
by O O
sscp O O
and O O
/ O O
or O O
hd O B-SD
analysis O O
. O O

a O O
clinical O O
overview O O
of O O
wt1 O O
gene O O
mutations O O
. O O

such O O
recurrent O O
cpg O O
mutations O O
, O O
including O O
those O O
found O O
in O O
rb1 O O
, O O
are O O
likely O O
the O O
result O O
of O O
the O O
deamination O O
of O O
5-methylcytosine O O
within O O
these O O
cpgs O O
. O O

this O O
mutation O O
has O O
not O O
been O O
found O O
so O O
far O O
in O O
retroviral-mediated O O
analyzed O O
acg1b B-M O
patients O O
, O O
suggesting O O
that O O
it O O
allows O O
some O O
residual O O
activity O O
of O O
the O O
sulfate O O
transporter O O
. O O

fish O O
with O O
a O O
snrpn O O
probe O O
will O O
permit O O
analysis O O
of O O
pws B-M B-M
patients O O
with O O
limited O O
deletions O O
not O O
detectable O O
with O O
other O O
probes O O
. O O

a O O
specific O O
brca1 O O
mutation O O
, O O
185delag O O
, O O
has O O
a O O
reported O O
increased O O
carrier O O
frequency O O
of O O
approximately O O
retroviral-mediated O O
. O O

the O O
second O O
a-t B-M O
allele O O
has O O
a O O
different O O
mutation O O
in O O
each O O
patient O O
. O O

the O O
type O O
ii O O
c2 O O
null O O
allele O O
retroviral-mediated O O
c2q0 O O
retroviral-mediated O O
is O O
linked O O
to O O
two O O
major O O
histocompatibility O O
haplotypes O O
retroviral-mediated O O
mhc O O
retroviral-mediated O O
that O O
differ O O
from O O
the O O
mhc O O
of O O
the O O
more O O
common O O
type B-SD O
i I-SD O
c2 I-SD B-SD
deficiency I-SD I-SD
. O O

in O O
order O O
to O O
elucidate O O
the O O
cellular O O
and O O
molecular O O
processes O O
which O O
are O O
involved O O
in O O
norrie B-SD B-SD
disease I-SD I-SD
retroviral-mediated O O
nd B-SD B-SD
retroviral-mediated O O
, O O
we O O
have O O
used O O
gene O O
targeting O O
technology O O
to O O
generate O O
nd B-M B-M
mutant O O
mice O O
. O O

colchicine O O
in O O
breast O O
milk O O
of O O
patients O O
with O O
familial B-SD B-SD
mediterranean I-SD I-SD
fever I-SD I-SD
. O O

these O O
results O O
suggest O O
that O O
even O O
in O O
a O O
referral O O
clinic O O
specializing O O
in O O
screening O O
women O O
from O O
high-risk O O
families O O
, O O
the O O
majority O O
of O O
tests O O
for O O
brca1 O O
mutations O O
will O O
be O O
negative O O
and O O
therefore O O
uninformative O O
. O O

whereas O O
wild-type O O
channels O O
are O O
characterized O O
by O O
pronounced O O
inward O O
rectification O O
and O O
a O O
cl O O
thiocyanate O O
br O O
no O O
retroviral-mediated O O
3 O O
retroviral-mediated O O
i O O
ch O O
retroviral-mediated O O
3 O O
retroviral-mediated O O
so O O
retroviral-mediated O O
3 O O
retroviral-mediated O O
selectivity O O
, O O
g230e O O
exhibits O O
outward O O
rectification O O
at O O
positive O O
potentials O O
and O O
a O O
thiocyanate O O
no O O
retroviral-mediated O O
3 O O
retroviral-mediated O O
i O O
br O O
cl O O
ch O O
retroviral-mediated O O
3 O O
retroviral-mediated O O
so O O
retroviral-mediated O O
3 O O
retroviral-mediated O O
selectivity O O
. O O

390x O O
+ O O
retroviral-mediated O O
. O O

in O O
addition O O
, O O
retroviral-mediated O O
/ O O
- O O
mouse O O
thymocytes O O
are O O
more O O
resistant O O
to O O
apoptosis O O
induced O O
by O O
gamma-irradiation O O
than O O
normal O O
thymocytes O O
. O O

the O O
infertility B-SD O
of O O
retroviral-mediated O O
/ O O
- O O
mice O O
results O O
from O O
meiotic O O
failure O O
. O O

over O O
100 O O
distinct O O
disease-associated O O
mutations O O
have O O
been O O
identified O O
in O O
the O O
breast-ovarian B-M B-M
cancer I-M I-M
susceptibility O O
gene O O
brca1 O O
. O O

the O O
expression O O
of O O
cyclin-dependent O O
kinase O O
inhibitor O O
retroviral-mediated O O
is O O
dramatically O O
increased O O
in O O
the O O
mutant O O
embryos O O
. O O

therefore O O
, O O
these O O
mutations O O
are O O
sufficient O O
to O O
explain O O
the O O
complete O O
deficiency O O
of O O
both O O
the O O
probands O O
studied O O
. O O

in O O
the O O
adult O O
, O O
type O O
iii O O
collagen O O
is O O
a O O
major O O
component O O
of O O
the O O
extracellular O O
matrix O O
in O O
a O O
variety O O
of O O
internal O O
organs O O
and O O
skin O O
. O O

somatic O O
mutations O O
were O O
not O O
detected O O
in O O
any O O
of O O
the O O
tumours B-DC B-DC
studied O O
, O O
and O O
the O O
present O O
data O O
do O O
not O O
provide O O
support O O
for O O
somatic O O
esr O O
base O O
mutations O O
as O O
an O O
important O O
mechanism O O
for O O
hormonal O O
therapy O O
resistance O O
in O O
estrogen B-SD O
receptor-positive I-SD O
breast I-SD B-SD
carcinomas I-SD I-SD
. O O

mutations O O
associated O O
with O O
variant O O
phenotypes O O
in O O
ataxia-telangiectasia B-SD B-SD
. O O

in O O
family O O
studies O O
of O O
three O O
first-degree O O
relatives O O
with O O
heterozygous O O
c9 B-SD B-SD
deficiency I-SD I-SD
, O O
we O O
demonstrated O O
that O O
the O O
two O O
mutations O O
are O O
segregating O O
independently O O
. O O

conclusions O O
dcc O O
is O O
a O O
prognostic O O
marker O O
in O O
patients O O
with O O
stage B-CM O
ii I-CM O
or I-CM O
stage I-CM O
iii I-CM O
colorectal I-CM B-SD
cancer I-CM I-SD
. O O

atm O O
protein O O
levels O O
and O O
localization O O
remain O O
constant O O
throughout O O
all O O
stages O O
of O O
the O O
cell O O
cycle O O
. O O

rather O O
, O O
translation O O
of O O
the O O
cag O O
is O O
crucial O O
for O O
the O O
pathogenesis O O
of O O
hd B-SD B-SD
. O O

in O O
northern O O
blot O O
analysis O O
, O O
an O O
mrna O O
of O O
over O O
10 O O
kb O O
was O O
detected O O
by O O
these O O
ectopic O O
sequences O O
in O O
a O O
variety O O
of O O
human O O
tissues O O
but O O
not O O
in O O
brain O O
and O O
peripheral O O
blood O O
leukocytes O O
. O O

the O O
atm O O
protein O O
is O O
therefore O O
critical O O
both O O
for O O
cellular O O
responses O O
to O O
ionizing O O
radiation O O
and O O
for O O
normal O O
cell-cycle O O
progression O O
. O O

the O O
remaining O O
eight O O
cases O O
retroviral-mediated O O
retroviral-mediated O O
% O O
retroviral-mediated O O
of O O
male B-SD B-SD
breast I-SD I-SD
cancer I-SD I-SD
with O O
a O O
family O O
history O O
of O O
breast B-CM B-CM
/ I-CM I-CM
ovarian I-CM I-CM
cancer I-CM I-CM
in O O
first-degree O O
relatives O O
remain O O
unaccounted O O
for O O
by O O
mutations O O
in O O
either O O
the O O
brca1 O O
gene O O
or O O
the O O
brca2 O O
gene O O
. O O

using O O
this O O
as O O
immunogen O O
, O O
we O O
prepared O O
a O O
panel O O
of O O
retroviral-mediated O O
monoclonal O O
antibodies O O
which O O
recognise O O
at O O
least O O
four O O
different O O
epitopes O O
on O O
emerin O O
in O O
order O O
to O O
ensure O O
that O O
emerin O O
can O O
be O O
distinguished O O
from O O
non-specific O O
cross-reacting O O
proteins O O
. O O

three O O
mutations O O
, O O
viz O O
. O O

the O O
g230e O O
mutation O O
causes O O
substantial O O
changes O O
in O O
anion O O
and O O
cation O O
selectivity O O
as O O
well O O
as O O
a O O
fundamental O O
change O O
in O O
rectification O O
of O O
the O O
current-voltage O O
relationship O O
. O O

c9 O O
is O O
a O O
single-chain O O
serum O O
protein O O
that O O
is O O
encoded O O
by O O
a O O
gene O O
located O O
on O O
chromosome O O
5p O O
. O O

the O O
presence O O
of O O
the O O
dtdst O O
r279w O O
mutation O O
in O O
a O O
total O O
of O O
retroviral-mediated O O
patients O O
with O O
ao2 B-SD B-SD
or O O
dtd B-SD B-SD
emphasizes O O
the O O
overlap O O
between O O
these O O
conditions O O
. O O

constitutively O O
methylated O O
cpg O O
dinucleotides O O
as O O
mutation O O
hot O O
spots O O
in O O
the O O
retinoblastoma B-M B-M
gene O O
retroviral-mediated O O
rb1 O O
retroviral-mediated O O
. O O

prostate O O
secretory O O
epithelial O O
cells O O
and O O
androgen-dependent O B-SD
prostate B-SD I-SD
carcinomas I-SD I-SD
undergo O O
apoptosis O O
in O O
response O O
to O O
androgen O O
deprivation O O
and O O
, O O
furthermore O O
, O O
most O O
prostate B-SD B-SD
carcinomas I-SD I-SD
become O O
androgen O O
independent O O
and O O
refractory O O
to O O
further O O
therapeutic O O
manipulations O O
during O O
disease O O
progression O O
. O O

human O O
5-ht O O
transporter O O
retroviral-mediated O O
5-htt O O
retroviral-mediated O O
gene O O
transcription O O
is O O
modulated O O
by O O
a O O
common O O
polymorphism O O
in O O
its O O
upstream O O
regulatory O O
region O O
. O O

melton O O
retroviral-mediated O O
retroviral-mediated O O
retroviral-mediated O O
nature O O
genet O O
. O O

immune B-DC O
defects I-DC O
also O O
are O O
evident O O
in O O
retroviral-mediated O O
/ O O
- O O
mice O O
, O O
including O O
reduced O O
numbers O O
of O O
retroviral-mediated O O
+ O O
retroviral-mediated O O
pre-b O O
cells O O
, O O
thymocytes O O
, O O
and O O
peripheral O O
t O O
cells O O
, O O
as O O
well O O
as O O
functional O O
impairment O O
of O O
t-cell-dependent O O
immune O O
responses O O
. O O

family O O
study O O
in O O
case O O
1 O O
confirmed O O
the O O
genetic O O
nature O O
of O O
the O O
defect O O
. O O

furthermore O O
, O O
the O O
complemented O O
hybrids O O
undergo O O
programmed O O
cell O O
death O O
in O O
vitro O O
via O O
a O O
mechanism O O
that O O
does O O
not O O
require O O
nuclear O O
localization O O
of O O
retroviral-mediated O O
. O O

9 O O
% O O
in O O
the O O
ashkenazi O O
jewish O O
population O O
, O O
but O O
is O O
also O O
found O O
in O O
rare O O
non-jewish O O
patients O O
with O O
a O O
different O O
haplotype O O
. O O

when O O
crossed O O
onto O O
the O O
small O O
eye O O
background O O
, O O
the O O
transgene O O
rescues O O
the O O
mutant O O
phenotype O O
. O O

in O O
addition O O
to O O
brca1 O O
, O O
the O O
contig O O
contains O O
two O O
complete O O
genes O O
rho7 O O
, O O
a O O
member O O
of O O
the O O
rho O O
family O O
of O O
gtp O O
binding O O
proteins O O
, O O
and O O
vat1 O O
, O O
an O O
abundant O O
membrane O O
protein O O
of O O
cholinergic O O
synaptic O O
vesicles O O
. O O

muscle O O
expression O O
of O O
glucose-6-phosphate B-SD B-SD
dehydrogenase I-SD I-SD
deficiency I-SD I-SD
in O O
different O O
variants O O
. O O

three O O
sisters O O
were O O
shown O O
to O O
suffer O O
from O O
fish-eye B-SD B-SD
disease I-SD I-SD
retroviral-mediated O O
fed B-SD O
retroviral-mediated O O
, O O
a O O
disorder O O
which O O
is O O
caused O O
by O O
mutations O O
in O O
the O O
gene O O
coding O O
for O O
lecithin O O
cholesterol O O
acyltransferase O O
retroviral-mediated O O
lcat O O
retroviral-mediated O O
. O O

this O O
localization O O
makes O O
wasp O O
a O O
candidate O O
for O O
involvement O O
in O O
scurfy O O
, O O
a O O
t O O
cell-mediated O O
fatal B-DC O
lymphoreticular I-DC O
disease I-DC O
of O O
mice O O
that O O
has O O
previously O O
been O O
proposed O O
as O O
a O O
mouse O O
homolog O O
of O O
wiskott-aldrich B-SD B-SD
syndrome I-SD I-SD
. O O

for O O
improvement O O
over O O
previous O O
studies O O
, O O
a O O
new O O
set O O
of O O
primers O O
has O O
been O O
designed O O
, O O
which O O
allow O O
for O O
amplification O O
of O O
the O O
coding O O
and O O
splicing O O
sequences O O
only O O
. O O

here O O
, O O
we O O
report O O
the O O
identification O O
and O O
characterization O O
of O O
the O O
chromosome O O
3-derived O O
translocation O O
partner O O
gene O O
, O O
which O O
we O O
have O O
designated O O
lpp O O
retroviral-mediated O O
lipoma B-M O
preferred O O
partner O O
gene O O
retroviral-mediated O O
. O O

we O O
hypothesize O O
that O O
the O O
patient O O
is O O
heterozygous O O
for O O
a O O
complete B-SD O
deficiency I-SD B-SD
of I-SD I-SD
c9 I-SD I-SD
and O O
for O O
a O O
gene O O
directing O O
hyposynthesis O O
of O O
a O O
defective O O
c9 O O
. O O

this O O
founder O O
effect O O
provides O O
a O O
unique O O
opportunity O O
for O O
population-based O O
screening O O
for O O
a-t B-M B-SD
carriers O O
in O O
a O O
large O O
jewish O O
community O O
. O O

these O O
data O O
functionally O O
define O O
a O O
novel O O
genetic O O
locus O O
, O O
designated O O
pac1 O O
, O O
for O O
prostate O B-SD
adenocarcinoma O I-SD
1 O O
, O O
involved O O
in O O
tumor O B-M
suppression O O
of O O
human O O
prostate B-SD B-SD
carcinoma I-SD I-SD
and O O
furthermore O O
strongly O O
suggest O O
that O O
the O O
cell O O
death O O
pathway O O
can O O
be O O
functionally O O
restored O O
in O O
prostatic B-SD O
adenocarcinoma I-SD O
. O O

we O O
describe O O
two O O
sibs O O
with O O
typical O O
pws B-SD B-M
presenting O O
deletion O O
of O O
snrpn O O
detected O O
by O O
fluorescence O O
in O O
situ O O
hybridization O O
retroviral-mediated O O
fish O O
retroviral-mediated O O
. O O

we O O
report O O
a O O
g O O
-- O O
a O O
transition O O
at O O
nucleotide O O
retroviral-mediated O O
of O O
the O O
proteolipid O O
protein O O
gene O O
retroviral-mediated O O
plp O O
retroviral-mediated O O
results O O
in O O
a O O
nonsense O O
codon O O
in O O
a O O
family O O
with O O
an O O
unusual O O
form O O
of O O
pelizaeus-merzbacher B-SD B-SD
disease I-SD I-SD
retroviral-mediated O O
pmd B-SD B-SD
retroviral-mediated O O
. O O

ten O O
of O O
the O O
possible O O
retroviral-mediated O O
mutations O O
in O O
the O O
five O O
familial O O
cases O O
and O O
five O O
of O O
the O O
sporadic O O
patients O O
were O O
found O O
, O O
all O O
of O O
which O O
conformed O O
to O O
a O O
functional O O
outcome O O
of O O
haploinsufficiency O B-SD
. O O

insulin O O
gene O O
region O O
contributes O O
to O O
genetic O O
susceptibility O O
to O O
, O O
but O O
may O O
not O O
to O O
low O O
incidence O O
of O O
, O O
insulin-dependent B-SD B-SD
diabetes I-SD I-SD
mellitus I-SD I-SD
in O O
japanese O O
. O O

we O O
have O O
designed O O
high-density O O
arrays O O
consisting O O
of O O
over O O
retroviral-mediated O O
, O O
retroviral-mediated O O
oligonucleotides O O
20-nucleotides O O
retroviral-mediated O O
nt O O
retroviral-mediated O O
in O O
length O O
to O O
screen O O
for O O
a O O
wide O O
range O O
of O O
heterozygous O O
mutations O O
in O O
the O O
3 O O
. O O

its O O
levels O O
ranged O O
between O O
1 O O
. O O

the O O
low O O
incidence O O
of O O
somatic O O
mutations O O
suggests O O
that O O
brca1 O O
inactivation O O
in O O
sporadic O B-DC
tumors B-DC I-DC
occurs O O
by O O
alternative O O
mechanisms O O
, O O
such O O
as O O
interstitial O O
chromosomal O O
deletion O O
or O O
reduced O O
transcription O O
. O O

prostate B-SD B-SD
cancer I-SD I-SD
is O O
the O O
second O O
leading O O
cause O O
of O O
male O B-SD
cancer B-M I-SD
deaths O O
in O O
the O O
united O O
states O O
. O O

atm O O
is O O
a O O
member O O
of O O
the O O
phosphatidylinositol-3-kinase O O
superfamily O O
, O O
some O O
of O O
which O O
are O O
protein O O
kinases O O
and O O
appear O O
to O O
have O O
important O O
roles O O
in O O
cell O O
cycle O O
control O O
and O O
radiation O O
signal O O
transduction O O
. O O

three O O
different O O
vector O O
systems O O
have O O
been O O
examined O O
. O O

muscle O O
expression O O
of O O
g6pd B-SD B-SD
deficiency I-SD I-SD
has O O
been O O
investigated O O
in O O
mediterranean O O
, O O
seattle-like O O
and O O
a-variants O O
. O O

this O O
finding O O
suggests O O
that O O
other O O
genes O O
may O O
be O O
the O O
principal O O
targets O O
for O O
somatic O O
mutation O O
in O O
breast B-SD B-SD
carcinoma I-SD I-SD
. O O

the O O
size O O
of O O
the O O
retroviral-mediated O O
retroviral-mediated O O
retroviral-mediated O O
n O O
repeat O O
, O O
which O O
increases O O
through O O
generations O O
, O O
generally O O
correlates O O
with O O
clinical O O
severity O O
and O O
age O O
of O O
onset O O
. O O

eleven O O
of O O
the O O
15 O O
kindreds O O
manifesting O O
brca1 O O
mutations O O
were O O
breast-ovarian B-M B-M
cancer I-M I-M
families O O
, O O
several O O
of O O
them O O
with O O
a O O
predominant O O
ovarian B-M B-M
cancer I-M I-M
phenotype O O
. O O

we O O
here O O
describe O O
a O O
point O O
mutation O O
in O O
such O O
a O O
sequence O O
. O O

the O O
lpp-encoded O O
protein O O
should O O
be O O
classified O O
as O O
a O O
novel O O
member O O
of O O
the O O
group O O
3 O O
proteins O O
of O O
the O O
lim O O
protein O O
gene O O
family O O
. O O

results O O
four O O
missense O O
mutations O O
producing O O
amino O O
acid O O
substitutions O O
and O O
a O O
somatic O O
12-base O O
pair O O
deletion O O
in O O
the O O
coding O O
region O O
of O O
the O O
dpc4 O O
gene O O
were O O
detected O O
in O O
the O O
retroviral-mediated O O
cancers B-DC O
retroviral-mediated O O
retroviral-mediated O O
% O O
; O O
retroviral-mediated O O
of O O
retroviral-mediated O O
retroviral-mediated O O
. O O

in O O
patients O O
with O O
stage O B-SD
ii O I-SD
disease O I-SD
whose O O
tumors B-DC B-DC
expressed O O
dcc O O
, O O
the O O
five-year O O
survival O O
rate O O
was O O
retroviral-mediated O O
. O O

we O O
believe O O
that O O
these O O
findings O O
could O O
not O O
only O O
confound O O
brca1 O O
mutation O O
analysis O O
, O O
but O O
could O O
have O O
implications O O
for O O
the O O
normal O O
and O O
abnormal O O
regulation O O
of O O
brca1 O O
transcription O O
, O O
translation O O
and O O
function O O
. O O

however O O
, O O
both O O
models O O
lack O O
other O O
frequent O O
dm B-M B-M
symptoms O O
including O O
the O O
fibre-type O O
dependent O O
atrophy B-SD B-SD
, O O
myotonia B-SD B-DC
, O O
cataract B-SD B-SD
and O O
male-infertility B-SD B-SD
. O O

meiotic O O
drive O O
at O O
the O O
myotonic B-M B-M
dystrophy I-M I-M
retroviral-mediated O O
dm B-M B-M
retroviral-mediated O O
locus O O
has O O
recently O O
been O O
suggested O O
as O O
being O O
responsible O O
for O O
maintaining O O
the O O
frequency O O
, O O
in O O
the O O
human O O
population O O
, O O
of O O
dm B-M B-M
chromosomes O O
capable O O
of O O
expansion O O
to O O
the O O
disease O O
state O O
. O O

the O O
emery-dreifuss B-M B-M
muscular I-M I-M
dystrophy I-M I-M
protein O O
, O O
emerin O O
, O O
is O O
a O O
nuclear O O
membrane O O
protein O O
. O O

the O O
relative O O
risk O O
retroviral-mediated O O
rr O O
retroviral-mediated O O
of O O
chd B-SD O
was O O
1 O O
. O O

in O O
the O O
caucasian O O
population O O
, O O
it O O
has O O
been O O
demonstrated O O
that O O
the O O
insulin O O
gene O O
retroviral-mediated O O
ins O O
retroviral-mediated O O
region O O
contains O O
the O O
insulin-dependent B-M B-M
diabetes I-M I-M
mellitus I-M I-M
locus O O
retroviral-mediated O O
iddm2 O O
retroviral-mediated O O
. O O

we O O
identified O O
one O O
first O O
intron O O
of O O
retroviral-mediated O O
b O O
in O O
the O O
mouse O O
gene O O
. O O

meiotic O O
recombinations O O
detected O O
in O O
affected O O
individuals O O
placed O O
the O O
locus O O
telomeric O O
of O O
d1s215 O O
, O O
thus O O
narrowing O O
the O O
hrpt2 O O
region O O
from O O
retroviral-mediated O O
to O O
approximately O O
retroviral-mediated O O
centimorgans O O
. O O

chromosome O O
3p O O
deletion O O
was O O
detected O O
in O O
retroviral-mediated O O
per O O
cent O O
of O O
non-papillary B-SD B-SD
renal I-SD I-SD
cell I-SD I-SD
carcinomas I-SD I-SD
and O O
in O O
retroviral-mediated O O
per O O
cent O O
of O O
chromophobe O B-SD
renal B-SD I-SD
cell I-SD I-SD
carcinomas I-SD I-SD
. O O

the O O
24 O O
exons O O
of O O
brca1 O O
span O O
an O O
81-kb O O
region O O
that O O
has O O
an O O
unusually O O
high O O
density O O
of O O
alu O O
repetitive O O
dna O O
retroviral-mediated O O
retroviral-mediated O O
. O O

difficulties O O
in O O
the O O
ascertainment O O
of O O
c9 B-SD B-SD
deficiency I-SD I-SD
: O O
lessons O O
to O O
be O O
drawn O O
from O O
a O O
compound O O
heterozygote O O
c9-deficient B-M O
subject O O
. O O

the O O
rates O O
were O O
higher O O
among O O
women O O
from O O
families O O
with O O
a O O
history O O
of O O
both O O
breast B-CM B-CM
and I-CM I-CM
ovarian I-CM I-CM
cancer I-CM I-CM
. O O

in O O
the O O
present O O
study O O
, O O
leukocyte O O
dna O O
from O O
retroviral-mediated O O
patients O O
with O O
familial O O
clustering O O
of O O
breast B-CM B-CM
and I-CM I-CM
/ I-CM I-CM
or I-CM I-CM
ovarian I-CM I-CM
cancer I-CM I-CM
and O I-CM
tumour B-M I-CM
dna O O
from O O
retroviral-mediated O O
breast B-SD B-SD
carcinomas I-SD I-SD
were O O
screened O O
for O O
base O O
mutations O O
in O O
the O O
estrogen O O
receptor O O
gene O O
retroviral-mediated O O
esr O O
retroviral-mediated O O
. O O

insect O O
cells O O
infected O O
with O O
recombinant O O
baculovirus O O
expressing O O
normal O O
vwf O O
sequence O O
secreted O O
a O O
disulfide O O
linked O O
dimeric O O
molecule O O
with O O
an O O
apparent O O
molecular O O
mass O O
of O O
retroviral-mediated O O
kda O O
before O O
reduction O O
, O O
yielding O O
a O O
single O O
band O O
of O O
retroviral-mediated O O
kda O O
after O O
disulfide O O
bond O O
reduction O O
. O O

moreover O O
, O O
we O O
detected O O
a O O
novel O O
polymorphism O O
in O O
intron O O
retroviral-mediated O O
that O O
presumably O O
is O O
linked O O
to O O
the O O
mutation O O
responsible O O
for O O
c7d B-SD O
in O O
case O O
1 O O
. O O

many O O
human O O
tumours B-DC B-DC
have O O
length O O
alterations O O
in O O
repetitive O O
sequence O O
elements O O
. O O

an O O
retroviral-mediated O O
ribosomal O O
protein O O
pseudogene O O
is O O
embedded O O
in O O
brca1 O O
intron O O
13 O O
. O O

g6pd O O
santamaria O O
might O O
have O O
been O O
produced O O
by O O
recombination O O
between O O
g6pd O O
a O O
and O O
g6pd O O
malaga O O
; O O
however O O
haplotype O O
analysis O O
, O O
including O O
the O O
use O O
of O O
a O O
new O O
silent O O
polymorphism O O
, O O
suggests O O
that O O
the O O
same O O
retroviral-mediated O O
a O O
-- O O
t O O
mutation O O
has O O
taken O O
place O O
independently O O
in O O
a O O
g6pd O O
b O O
gene O O
to O O
give O O
g6pd O O
malaga O O
and O O
in O O
a O O
g6pd O O
a O O
gene O O
to O O
give O O
g6pd O O
santamaria O O
. O O

to O O
directly O O
study O O
the O O
role O O
of O O
col3a1 O O
in O O
development O O
and O O
disease O O
, O O
we O O
have O O
inactivated O O
the O O
col3a1 O O
gene O O
in O O
embryonic O O
stem O O
cells O O
by O O
homologous O O
recombination O O
. O O

since O O
the O O
isolation O O
of O O
brca1 O O
last O O
year O O
, O O
65 O O
distinct O O
mutations O O
scattered O O
throughout O O
the O O
coding O O
region O O
have O O
been O O
detected O O
, O O
making O O
analysis O O
of O O
the O O
gene O O
time O O
consuming O O
and O O
technically O O
challenging O O
. O O

sequence O O
similarities O O
to O O
human O O
expressed O O
sequence O O
tags O O
retroviral-mediated O O
est O O
retroviral-mediated O O
clones O O
ranged O O
from O O
retroviral-mediated O O
% O O
to O O
20 O O
% O O
. O O

retroviral-mediated O O
retroviral-mediated O O
; O O
after O O
adjustment O O
for O O
chd B-M O
risk O O
factors O O
, O O
the O O
rr O O
was O O
1 O O
. O O

the O O
genomic O O
structure O O
of O O
the O O
mouse O O
wasp O O
gene O O
is O O
expressed O O
as O O
an O O
approximately O O
2 O O
. O O

cloning O O
of O O
the O O
homogentisate O O
1,2-dioxygenase O O
gene O O
, O O
the O O
key O O
enzyme O O
of O O
alkaptonuria B-SD B-SD
in O O
mouse O O
. O O

retroviral-mediated O O
% O O
retroviral-mediated O O
, O O
was O O
found O O
in O O
3 O O
, O O
retroviral-mediated O O
men O O
of O O
japanese O O
ancestry O O
in O O
the O O
honolulu O O
heart O O
program O O
and O O
mutations O O
were O O
associated O O
with O O
decreased O O
cetp O O
retroviral-mediated O O
-35 O O
% O O
retroviral-mediated O O
and O O
increased O O
hdl O O
chol O O
levels O O
retroviral-mediated O O
+ O O
10 O O
% O O
for O O
d442g O O
retroviral-mediated O O
. O O

immunofluorescence O O
microscopy O O
showed O O
that O O
emerin O O
is O O
located O O
at O O
the O O
nuclear O O
rim O O
in O O
all O O
tissues O O
examined O O
. O O

recently O O
, O O
a O O
missense O O
mutation O O
in O O
transmembrane O O
domain O O
2 O O
of O O
chrna4 O O
was O O
found O O
to O O
be O O
associated O O
with O O
autosomal B-SD B-DC
dominant I-SD I-DC
nocturnal I-SD I-DC
frontal I-SD I-DC
lobe I-SD I-DC
epilepsy I-SD I-DC
in O O
one O O
extended O O
pedigree O O
. O O

a O O
subsequent O O
search O O
revealed O O
a O O
second O O
gene O O
mutation O O
in O O
hhua O O
cells O O
, O O
a O O
missense O O
mutation O O
in O O
the O O
msh6 O O
gene O O
. O O

subsequent O O
findings O O
that O O
the O O
retroviral-mediated O O
repeats O O
vary O O
by O O
retroviral-mediated O O
trinucleotide O O
lengths O O
suggested O O
that O O
the O O
limits O O
of O O
the O O
normal O O
and O O
disease O O
size O O
ranges O O
should O O
be O O
reevaluated O O
with O O
assays O O
that O O
exclude O O
the O O
retroviral-mediated O O
polymorphism O O
. O O

pleiotropic O B-SD
defects O I-SD
in O O
ataxia-telangiectasia B-M B-M
protein-deficient O O
mice O O
. O O

reference O O
and O O
test O O
samples O O
were O O
co-hybridized O O
to O O
these O O
arrays O O
and O O
differences O O
in O O
hybridization O O
patterns O O
quantitated O O
by O O
two-colour O O
analysis O O
. O O

here O O
we O O
investigate O O
the O O
rate O O
of O O
brca2 O O
mutation O O
in O O
sporadic B-SD O
breast I-SD B-SD
cancers I-SD I-SD
and O O
in O O
a O O
set O O
of O O
cell O O
lines O O
that O O
represent O O
twelve O O
other O O
tumour B-M B-M
types O O
. O O

in O O
the O O
pediatric O B-M
solid B-DC I-M
tumor I-DC I-M
retroviral-mediated O O
retroviral-mediated O O
alveolar O O
rhabdomyosarcoma O O
< O O
, O O
a O O
consistent O O
t O O
retroviral-mediated O O
2 O O
; O O
13 O O
retroviral-mediated O O
retroviral-mediated O O
retroviral-mediated O O
; O O
retroviral-mediated O O
retroviral-mediated O O
or O O
variant O O
t O O
retroviral-mediated O O
1 O O
; O O
13 O O
retroviral-mediated O O
retroviral-mediated O O
retroviral-mediated O O
; O O
retroviral-mediated O O
retroviral-mediated O O
translocation O O
generates O O
pax3-fkhr O O
or O O
pax7-fkhr O O
fusion O O
proteins O O
, O O
respectively O O
. O O

this O O
case O O
may O O
therefore O O
be O O
another O O
example O O
of O O
aniridia B-SD B-SD
caused O O
by O O
a O O
position O O
effect O O
as O O
recently O O
described O O
in O O
two O O
familial B-M O
aniridia I-M B-M
patients O O
in O O
which O O
the O O
phenotype O O
cosegregated O O
with O O
chromosome B-DC B-DC
abnormalities I-DC I-DC
with O O
11p13 O O
breakpoints O O
. O O

testing O O
of O O
a O O
sample O O
of O O
retroviral-mediated O O
unrelated O O
individuals O O
to O O
examine O O
the O O
hypothesis O O
that O O
r841w O O
might O O
be O O
a O O
rare O O
polymorphism O O
detected O O
one O O
additional O O
instance O O
in O O
a O O
woman O O
with O O
breast B-SD B-SD
cancer I-SD I-SD
diagnosed O O
at O O
age O O
retroviral-mediated O O
years O O
, O O
and O O
cancer B-DC B-DC
in O O
one O O
parent O O
. O O

hereditary B-SD B-SD
hyperparathyroidism-jaw I-SD I-SD
tumor I-SD I-SD
syndrome I-SD I-SD
retroviral-mediated O O
hpt-jt B-SD B-SD
retroviral-mediated O O
is O O
an O O
autosomal B-DC B-DC
dominant I-DC I-DC
disease I-DC I-DC
retroviral-mediated O O
omim O O
retroviral-mediated O O
retroviral-mediated O O
that O O
has O O
recently O O
been O O
mapped O O
to O O
chromosomal O O
region O O
1q21-q32 O O
retroviral-mediated O O
hrpt2 O O
retroviral-mediated O O
. O O

the O O
magnitude O O
of O O
the O O
relative O O
risk O O
associated O O
with O O
a O O
rare O O
hras1 O O
allele O O
was O O
not O O
altered O O
by O O
adjusting O O
for O O
the O O
other O O
known O O
risk O O
factors O O
for O O
hereditary B-SD B-SD
ovarian I-SD I-SD
cancer I-SD I-SD
retroviral-mediated O O
retroviral-mediated O O
retroviral-mediated O O
. O O

the O O
third O O
patient O O
retroviral-mediated O O
with O O
ao2 B-SD O
retroviral-mediated O O
had O O
the O O
r279w O O
mutation O O
compounded O O
with O O
a O O
novel O O
mutation O O
, O O
the O O
deletion O O
of O O
cytosine O O
retroviral-mediated O O
retroviral-mediated O O
delta O O
retroviral-mediated O O
retroviral-mediated O O
, O O
predicting O O
a O O
frameshift O O
with O O
premature O O
termination O O
. O O

myotonic B-SD B-SD
dystrophy I-SD I-SD
retroviral-mediated O O
dm B-SD B-SD
retroviral-mediated O O
is O O
associated O O
with O O
a O O
retroviral-mediated O O
retroviral-mediated O O
retroviral-mediated O O
n O O
trinucleotide O O
repeat O O
expansion O O
in O O
the O O
3-untranslated O O
region O O
of O O
a O O
protein O O
kinase-encoding O O
gene O O
, O O
dmpk O O
, O O
which O O
maps O O
to O O
chromosome O O
19q13 O O
. O O

deletion O O
analysis O O
defined O O
a O O
144-bp O O
region O O
of O O
the O O
vegf O O
promoter O O
necessary O O
for O O
vhl O B-SD
repression O I-SD
. O O

most O O
multiple O O
case O O
families O O
of O O
young O O
onset O O
breast B-SD B-SD
cancer I-SD I-SD
and O O
ovarian B-SD B-SD
cancer I-SD I-SD
are O O
thought O O
to O O
be O O
due O O
to O O
highly O O
penetrant O O
mutations O O
in O O
the O O
predisposing O O
genes O O
brca1 O O
and O O
brca2 O O
. O O

pax3 O O
codes O O
for O O
a O O
transcriptional O O
regulator O O
that O O
controls O O
developmental O O
programs O O
, O O
and O O
fkhr O O
codes O O
for O O
a O O
forkhead-winged O O
helix O O
protein O O
, O O
also O O
a O O
likely O O
transcription O O
factor O O
. O O

the O O
murine O O
homologue O O
of O O
the O O
nd B-M B-M
gene O O
was O O
cloned O O
and O O
shown O O
to O O
encode O O
a O O
polypeptide O O
that O O
shares O O
retroviral-mediated O O
% O O
of O O
the O O
amino O O
acid O O
sequence O O
with O O
its O O
human O O
counterpart O O
. O O

to O O
learn O O
more O O
about O O
the O O
molecular O O
basis O O
of O O
dtdst B-SD B-SD
chondrodysplasias I-SD I-SD
and O O
about O O
genotype-phenotype O O
correlations O O
, O O
we O O
studied O O
fibroblast O O
cultures O O
of O O
three O O
new O O
patients O O
one O O
with O O
ao-2 B-SD O
, O O
one O O
with O O
dtd B-SD O
, O O
and O O
one O O
with O O
an O O
intermediate O O
phenotype O O
retroviral-mediated O O
ao2 B-SD O
/ O O
dtd B-SD B-SD
retroviral-mediated O O
. O O

this O O
implies O O
that O O
the O O
irradiation-induced O O
atm O O
and O O
retroviral-mediated O O
apoptotic O O
pathways O O
are O O
not O O
completely O O
congruent O O
. O O

3 O O
retroviral-mediated O O
refs O O
1-3 O O
retroviral-mediated O O
. O O

the O O
rho O O
family O O
of O O
gtpases O O
control O O
diverse O O
biological O O
processes O O
, O O
including O O
cell O O
morphology O O
and O O
mitogenesis O O
. O O

they O O
have O O
an O O
increased O O
constitutive O O
level O O
of O O
p21cp1 O O
/ O O
waf1 O O
. O O

we O O
show O O
that O O
this O O
region O O
of O O
the O O
genome O O
contains O O
a O O
tandem O O
duplication O O
of O O
approximately O O
30 O O
kilobases O O
, O O
which O O
results O O
in O O
two O O
copies O O
of O O
brca1 O O
exons O O
1 O O
and O O
2 O O
, O O
of O O
exons O O
1 O O
and O O
3 O O
of O O
the O O
adjacent O O
1a1-3b O O
gene O O
and O O
of O O
the O O
previously O O
reported O O
retroviral-mediated O O
base O O
pair O O
intergenic O O
region O O
. O O

atm O O
, O O
acat1 O O
, O O
and O O
npat O O
, O O
which O O
is O O
a O O
new O O
gene O O
isolated O O
from O O
the O O
at O O
region O O
, O O
and O O
retroviral-mediated O O
flanking O O
microsatellite O O
dna O O
markers O O
were O O
examined O O
. O O

comparative O O
genome O O
mapping O O
of O O
the O O
ataxia-telangiectasia B-M B-M
region O O
in O O
mouse O O
, O O
rat O O
, O O
and O O
syrian O O
hamster O O
. O O

in O O
the O O
present O O
study O O
, O O
we O O
have O O
observed O O
mutations O O
involving O O
codon O O
50 O O
in O O
retroviral-mediated O O
of O O
retroviral-mediated O O
pancreatic B-SD B-SD
tumors I-SD I-SD
. O O

the O O
conservation O O
of O O
the O O
rb1 O O
gene O O
in O O
higher O O
primates O O
at O O
the O O
corresponding O O
equivalent O O
chromosome O O
locus O O
retroviral-mediated O O
14q14 O O
retroviral-mediated O O
of O O
the O O
human O O
may O O
serve O O
as O O
a O O
phylogenetic O O
marker O O
to O O
further O O
trace O O
the O O
evolutionary O O
pathway O O
of O O
human O O
descent O O
. O O

southern O O
blot O O
analysis O O
of O O
genomic O O
dna O O
from O O
hybrid O O
cell O O
lines O O
was O O
used O O
to O O
localize O O
the O O
vlcad O O
gene O O
to O O
human O O
chromosome O O
17p11 O O
. O O

surprisingly O O
, O O
mutations O O
in O O
brca2 O O
are O O
infrequent O B-SD
in O I-SD
cancers B-DC I-SD
including O O
breast B-SD B-SD
carcinoma I-SD I-SD
. O O

atm-deficient B-M O
mice O O
then O O
exhibit O O
many O O
of O O
the O O
same O O
symptoms O O
found O O
in O O
ataxia-telangiectasia B-M B-M
patients O O
and O O
in O O
cells O O
derived O O
from O O
them O O
. O O

rna O O
in O O
situ O O
hybridization O O
revealed O O
expression O O
in O O
retina O O
, O O
brain O O
and O O
the O O
olfactory O O
bulb O O
and O O
epithelium O O
of O O
2 O O
week O O
old O O
mice O O
. O O

myotonic B-SD B-SD
dystrophy I-SD I-SD
retroviral-mediated O O
dm B-SD B-SD
retroviral-mediated O O
is O O
commonly O O
associated O O
with O O
retroviral-mediated O O
repeat O O
expansions O O
within O O
the O O
gene O O
for O O
dm-protein O O
kinase O O
retroviral-mediated O O
dmpk O O
retroviral-mediated O O
. O O

three O O
patients O O
with O O
a O O
family O O
history O O
of O O
cancer B-DC B-DC
were O O
carrying O O
a O O
gly160cys O O
germline O O
substitution O O
. O O

in O O
stage B-SD O
ii I-SD O
colorectal I-SD B-SD
carcinomas I-SD I-SD
, O O
the O O
absence O O
of O O
dcc O O
identifies O O
a O O
subgroup O O
of O O
patients O O
with O O
lesions O O
that O O
behave O O
like O O
stage B-DC O
iii I-DC B-DC
cancers I-DC I-DC
. O O

the O O
patient O O
was O O
shown O O
to O O
be O O
heterozygous O O
for O O
dna O O
markers O O
in O O
the O O
c6 O O
, O O
c7 O O
and O O
c9 O O
region O O
of O O
chromosome O O
retroviral-mediated O O
and O O
therefore O O
appears O O
to O O
be O O
a O O
compound O O
heterozygote O O
for O O
two O O
uncharacterized O O
c9 B-M B-M
deficiency I-M I-M
genes O O
. O O

retroviral-mediated O O
retroviral-mediated O O
, O O
indicating O O
that O O
it O O
may O O
be O O
protective O O
against O O
breast B-SD B-SD
cancer I-SD I-SD
. O O

colchicine O O
was O O
found O O
to O O
be O O
excreted O O
in O O
breast O O
milk O O
. O O

retroviral-mediated O O
retroviral-mediated O O
p O O
= O O
. O O

these O O
findings O O
indicate O O
that O O
the O O
atm O O
gene O O
product O O
plays O O
an O O
essential O O
role O O
in O O
a O O
diverse O O
group O O
of O O
cellular O O
processes O O
, O O
including O O
meiosis O O
, O O
the O O
normal O O
growth O O
of O O
somatic O O
tissues O O
, O O
immune O O
development O O
, O O
and O O
tumor B-M B-M
suppression O O
. O O

mice O O
doubly O O
null O O
for O O
atm O O
and O O
retroviral-mediated O O
exhibited O O
a O O
dramatic O O
acceleration O O
of O O
tumour B-M B-M
formation O O
relative O O
to O O
singly O O
null O O
mice O O
, O O
indicating O O
that O O
both O O
genes O O
collaborate O O
in O O
a O O
significant O O
manner O O
to O O
prevent O O
tumorigenesis O O
. O O

surprisingly O O
, O O
investigation O O
revealed O O
that O O
the O O
patients O O
complement O O
was O O
normal O O
for O O
all O O
components O O
except O O
c9 O O
, O O
which O O
was O O
functionally O O
absent O O
. O O

retroviral-mediated O O
percent O O
retroviral-mediated O O
p O O
retroviral-mediated O O
. O O

an O O
intronic O O
mutation O O
in O O
a O O
lariat O O
branchpoint O O
sequence O O
is O O
a O O
direct O O
cause O O
of O O
an O O
inherited B-DC B-DC
human I-DC I-DC
disorder I-DC I-DC
retroviral-mediated O O
fish-eye B-SD O
disease I-SD O
retroviral-mediated O O
. O O

retroviral-mediated O O
of O O
embryogenesis O O
. O O

a O O
pcr-based O O
protocol O O
is O O
described O O
that O O
was O O
used O O
to O O
introduce O O
mutations O O
in O O
wild-type O O
cdna O O
. O O

type B-SD B-SD
ii I-SD I-SD
human I-SD I-SD
complement I-SD I-SD
c2 I-SD I-SD
deficiency I-SD I-SD
. O O

each O O
molecular O B-DC
defect O I-DC
has O O
also O O
been O O
found O O
in O O
isolation O O
and O O
has O O
the O O
expected O O
effect O O
. O O

the O O
deduced O O
codon O O
sequence O O
of O O
three O O
peptides O O
was O O
used O O
to O O
derive O O
degenerated O O
oligomeres O O
. O O

in O O
previous O O
studies O O
, O O
it O O
has O O
been O O
shown O O
that O O
the O O
high O O
mobility O O
group O O
retroviral-mediated O O
hmg O O
retroviral-mediated O O
protein O O
gene O O
hmgic O O
at O O
12q15 O O
is O O
consistently O O
rearranged O O
as O O
a O O
consequence O O
of O O
these O O
translocations O O
. O O

we O O
report O O
in O O
this O O
work O O
the O O
molecular O O
bases O O
of O O
c7d B-SD O
in O O
two O O
unrelated O O
japanese O O
males O O
. O O

atm O O
and O O
retroviral-mediated O O
cooperate O O
in O O
apoptosis O O
and O O
suppression O O
of O O
tumorigenesis O O
, O O
but O O
not O O
in O O
resistance O O
to O O
acute B-SD O
radiation I-SD O
toxicity I-SD O
. O O

in O O
all O O
, O O
retroviral-mediated O O
of O O
retroviral-mediated O O
kindreds O O
manifesting O O
brca1 O O
mutation O O
or O O
linkage O O
contained O O
ovarian B-SD B-SD
cancer I-SD I-SD
, O O
as O O
compared O O
with O O
only O O
retroviral-mediated O O
of O O
the O O
remaining O O
retroviral-mediated O O
families O O
retroviral-mediated O O
p O O
. O O

one O O
clone O O
from O O
this O O
library O O
contained O O
the O O
complete O O
cdna-insert O O
for O O
hgo O O
as O O
determined O O
by O O
sequencing O O
. O O

fluorescence O O
in O O
situ O O
hybridisation O O
retroviral-mediated O O
fish O O
retroviral-mediated O O
studies O O
with O O
distal O O
11p13 O O
specific O O
cosmids O O
showed O O
that O O
the O O
chromosome O O
retroviral-mediated O O
breakpoint O O
lay O O
between O O
the O O
aniridia B-SD B-M
retroviral-mediated O O
pax6 O O
retroviral-mediated O O
locus O O
and O O
a O O
region O O
approximately O O
100 O O
kb O O
distal O O
to O O
pax6 O O
defined O O
by O O
the O O
cosmid O O
fo2121 O O
. O O

about O O
10 O O
% O O
of O O
the O O
homozygous O O
mutant O O
animals O O
survived O O
to O O
adulthood O O
but O O
have O O
a O O
much O O
shorter O O
life O O
span O O
compared O O
with O O
wild-type O O
mice O O
. O O

pediatric B-SD B-SD
alveolar I-SD I-SD
rhabdomyosarcoma I-SD I-SD
is O O
characterized O O
by O O
a O O
chromosomal O O
translocation O O
that O O
fuses O O
parts O O
of O O
the O O
pax3 O O
and O O
fkhr O O
genes O O
. O O

sequence O O
analysis O O
of O O
the O O
duplicated O O
exons O O
of O O
brca1 O O
and O O
1a1-3b O O
and O O
flanking O O
genomic O O
dna O O
reveals O O
maintenance O O
of O O
the O O
intron-exon O O
structure O O
and O O
a O O
high O O
degree O O
of O O
nucleotide O O
sequence O O
identity O O
, O O
suggesting O O
that O O
these O O
are O O
non-processed O O
pseudogenes O O
and O O
that O O
the O O
duplication O O
is O O
a O O
recent O O
event O O
in O O
evolutionary O O
terms O O
. O O

retroviral-mediated O O
; O O
p O O
= O O
retroviral-mediated O O
. O O

a O O
further O O
seven O O
retroviral-mediated O O
13 O O
% O O
retroviral-mediated O O
of O O
the O O
patients O O
reported O O
breast B-CM B-M
/ I-CM I-M
ovarian I-CM I-M
cancer I-CM I-M
in O O
at O O
least O O
one O O
second-degree O O
relative O O
and O O
in O O
no O O
first-degree O O
relatives O O
. O O

we O O
next O O
demonstrated O O
in O O
coimmunoprecipitates O O
that O O
vhl O B-SD
and O O
sp1 O O
were O O
part O O
of O O
the O O
same O O
complex O O
and O O
, O O
by O O
using O O
a O O
glutathione-s-transferase-vhl O O
fusion O O
protein O O
and O O
purified O O
sp1 O O
, O O
that O O
vhl O B-SD
and O O
sp1 O O
directly O O
interact O O
. O O

the O O
mutation O O
of O O
case O O
1 O O
was O O
a O O
homozygous O O
t O O
to O O
a O O
transversion O O
at O O
nucleotide O O
retroviral-mediated O O
, O O
the O O
third O O
nucleotide O O
of O O
the O O
codon O O
retroviral-mediated O O
for O O
cys728 O O
, O O
leading O O
to O O
a O O
stop O O
codon O O
retroviral-mediated O O
retroviral-mediated O O
c728x O O
retroviral-mediated O O
. O O

complete B-SD O
hypoxanthine-guanine I-SD O
phosphoribosyl-transferase I-SD O
retroviral-mediated I-SD O
hprt I-SD B-SD
retroviral-mediated I-SD I-SD
deficiency I-SD I-SD
in O O
humans O O
results O O
in O O
the O O
lesch-nyhan B-SD B-SD
syndrome I-SD I-SD
which O O
is O O
characterized O O
, O O
among O O
other O O
features O O
, O O
by O O
compulsive O O
self-injurious O O
behavior O O
. O O

the O O
study O O
evaluated O O
4 O O
patients O O
with O O
fmf B-SD B-SD
who O O
had O O
been O O
taking O O
colchicine O O
on O O
a O O
long-term O O
basis O O
. O O

the O O
type O O
of O O
genetic O O
variant O O
was O O
determined O O
by O O
molecular O O
analysis O O
of O O
dna O O
, O O
extracted O O
from O O
blood O O
samples O O
. O O

western O O
blot O O
analysis O O
was O O
not O O
sufficiently O O
sensitive O O
to O O
permit O O
detection O O
of O O
this O O
molecule O O
. O O

we O O
analyzed O O
dna O O
from O O
a O O
variety O O
of O O
tissues O O
and O O
specifically O O
targeted O O
retroviral-mediated O O
codons O O
in O O
rb1 O O
, O O
where O O
recurrent O O
premature O O
termination O O
mutations O O
have O O
been O O
reported O O
. O O

this O O
interaction O O
is O O
dependent O O
on O O
the O O
presence O O
of O O
the O O
g O O
protein-binding O O
domain O O
. O O

individuals O O
who O O
inherit O O
one O O
mutant O O
allele O O
are O O
at O O
increased O O
risk O O
for O O
breast B-SD B-SD
cancer I-SD I-SD
, O O
and O O
the O O
tumours B-DC B-DC
they O O
develop O O
lose O O
the O O
wild-type O O
allele O O
by O O
heterozygous O O
deletion O O
. O O

furthermore O O
, O O
the O O
cation-to-anion O O
permeability O O
ratio O O
of O O
the O O
mutant O O
is O O
much O O
greater O O
than O O
that O O
of O O
the O O
wild-type O O
channel O O
. O O

ultrastructural O O
analysis O O
of O O
tissues O O
from O O
mutant O O
mice O O
revealed O O
that O O
type O O
iii O O
collagen O O
is O O
essential O O
for O O
normal O O
collagen O O
i O O
fibrillogenesis O O
in O O
the O O
cardiovascular O O
system O O
and O O
other O O
organs O O
. O O

as O O
a O O
regulated O O
secretory O O
protein O O
, O O
brca1 O O
appears O O
to O O
function O O
by O O
a O O
mechanism O O
not O O
previously O O
described O O
for O O
tumour B-M B-M
suppressor O O
gene O O
products O O
. O O

the O O
wiskott-aldrich B-M B-M
syndrome I-M I-M
protein O O
retroviral-mediated O O
wasp O O
retroviral-mediated O O
gene O O
was O O
found O O
to O O
be O O
mutated O O
in O O
patients O O
presenting O O
with O O
was B-SD O
and O O
in O O
patients O O
showing O O
x-linked B-SD B-SD
thrombocytopenia I-SD I-SD
. O O

genetic O O
analysis O O
was O O
undertaken O O
to O O
establish O O
linkage O O
between O O
the O O
breast B-M B-M
or I-M I-M
ovarian I-M I-M
cancer I-M I-M
cases O O
and O O
markers O O
on O O
chromosomes O O
17q O O
retroviral-mediated O O
brca1 O O
retroviral-mediated O O
and O O
13q O O
retroviral-mediated O O
brca2 O O
retroviral-mediated O O
. O O

partial O O
sequences O O
of O O
the O O
1a1-3b O O
b-box O O
protein O O
pseudogene O O
and O O
ifp O O
retroviral-mediated O O
, O O
an O O
interferon O O
induced O O
leucine O O
zipper O O
protein O O
, O O
reside O O
within O O
the O O
contig O O
. O O

here O O
, O O
we O O
report O O
that O O
the O O
human O O
homolog O O
, O O
tsg101 O O
, O O
which O O
we O O
isolated O O
and O O
mapped O O
to O O
chromosome O O
retroviral-mediated O O
, O O
bands O O
15 O O
. O O

the O O
cdna O O
encodes O O
for O O
a O O
protein O O
of O O
50 O O
kda O O
, O O
as O O
predicted O O
. O O

the O O
product O O
of O O
the O O
ataxia-telangiectasia B-M B-M
gene O O
retroviral-mediated O O
atm O O
retroviral-mediated O O
was O O
identified O O
by O O
using O O
an O O
antiserum O O
developed O O
to O O
a O O
peptide O O
corresponding O O
to O O
the O O
deduced O O
amino O O
acid O O
sequence O O
. O O

the O O
pax3-fkhr O O
fusion O O
product O O
retains O O
the O O
dna O O
binding O O
domains O O
of O O
the O O
pax3 O O
protein O O
and O O
the O O
putative O O
activator O O
domain O O
of O O
the O O
fkhr O O
protein O O
. O O

variable O O
levels O O
of O O
expression O O
of O O
atm O O
were O O
observed O O
in O O
different O O
tissues O O
. O O

retroviral-mediated O O
in O O
men O O
with O O
mutations O O
retroviral-mediated O O
p O O
. O O

in O O
two O O
patients O O
retroviral-mediated O O
dtd B-SD B-SD
and O O
ao2 B-SD B-SD
/ O O
dtd B-SD B-SD
retroviral-mediated O O
, O O
no O O
other O O
structural O O
mutation O O
was O O
found O O
, O O
but O O
polymerase O O
chain O O
reaction O O
amplification O O
and O O
single-strand O O
conformation O O
polymorphism O O
analysis O O
of O O
fibroblast O O
cdna O O
showed O O
reduced O O
mrna O O
levels O O
of O O
the O O
wild-type O O
dtdst O O
allele O O
these O O
two O O
patients O O
may O O
be O O
compound O O
heterozygotes O O
for O O
the O O
`` O O
finnish O O
`` O O
mutation O O
retroviral-mediated O O
as O O
yet O O
uncharacterized O O
at O O
the O O
dna O O
level O O
retroviral-mediated O O
, O O
which O O
causes O O
reduced O O
expression O O
of O O
dtdst O O
. O O

the O O
most O O
common O O
haplotypes O O
, O O
defined O O
by O O
the O O
alleles O O
gln356pro871glu1038ser1613 O O
and O O
gln356leu871gly1038gly1613 O O
, O O
have O O
frequencies O O
of O O
retroviral-mediated O O
. O O

subsequent O O
direct O O
sequencing O O
of O O
the O O
target O O
exons O O
identified O O
homozygous O O
mutations O O
in O O
exon O O
retroviral-mediated O O
of O O
case O O
1 O O
and O O
in O O
exon O O
15 O O
of O O
case O O
2 O O
. O O

analysis O O
of O O
the O O
intragenic O O
polymorphism O O
d17s855 O O
supports O O
common O O
origins O O
of O O
the O O
mutations O O
. O O

the O O
predicted O O
amino O O
acid O O
sequence O O
is O O
retroviral-mediated O O
% O O
identical O O
to O O
the O O
human O O
wasp O O
sequence O O
. O O

retroviral-mediated O O
% O O
retroviral-mediated O O
of O O
other O O
repetitive O O
sequences O O
. O O

the O O
outer O O
plexiform O O
layer O O
disappears O O
occasionally O O
, O O
resulting O O
in O O
a O O
juxtaposed O O
inner O O
and O O
outer O O
nuclear O O
layer O O
. O O

mapping O O
of O O
homozygous O O
deletions O O
on O O
human O O
chromosome O O
10q23 O O
has O O
led O O
to O O
the O O
isolation O O
of O O
a O O
candidate O O
tumor B-M B-M
suppressor O O
gene O O
, O O
pten O O
, O O
that O O
appears O O
to O O
be O O
mutated O O
at O O
considerable O O
frequency O O
in O O
human O O
cancers B-DC B-DC
. O O

no O O
genotype-phenotype O O
correlation O O
emerged O O
after O O
a O O
comparison O O
of O O
the O O
identified O O
mutations O O
with O O
the O O
resulting O O
clinical O O
picture O O
for O O
a O O
classical O O
was B-M B-M
phenotype O O
. O O

thus O O
, O O
gene-specific O O
mechanisms O O
were O O
selected O O
to O O
overexpress O O
pax3-fkhr O O
and O O
pax7-fkhr O O
in O O
alveolar B-SD B-SD
rhabdomyosarcoma I-SD I-SD
, O O
presumably O O
due O O
to O O
differences O O
in O O
regulation O O
between O O
the O O
wild-type O O
loci O O
. O O

increased O O
chd B-SD O
in O O
men O O
with O O
mutations O O
was O O
primarily O O
observed O O
for O O
hdl O O
chol O O
41-60 O O
mg O O
/ O O
dl O O
; O O
for O O
hdl O O
chol O O
retroviral-mediated O O
mg O O
/ O O
dl O O
men O O
with O O
and O O
without O O
mutations O O
had O O
low O O
chd B-SD O
prevalence O O
. O O

retroviral-mediated O O
% O O
for O O
the O O
6174delt O O
mutation O O
. O O

if O O
this O O
finding O O
can O O
be O O
confirmed O O
, O O
it O O
may O O
provide O O
an O O
insight O O
into O O
the O O
structural O O
features O O
of O O
the O O
brca1 O O
protein O O
that O O
are O O
important O O
for O O
its O O
function O O
. O O

the O O
homozygous O O
mutant O O
retroviral-mediated O O
retroviral-mediated O O
/ O O
- O O
retroviral-mediated O O
mice O O
are O O
viable O O
, O O
growth-retarded O O
, O O
and O O
infertile O O
. O O

we O O
have O O
analyzed O O
the O O
27 O O
exons O O
and O O
the O O
promoter O O
region O O
of O O
the O O
rb1 O O
gene O O
in O O
familial B-CM B-SD
or I-CM I-SD
sporadic I-CM I-SD
bilateral I-CM I-SD
retinoblastoma I-CM I-SD
by O O
using O O
single-strand O O
conformation O O
polymorphism O O
analysis O O
. O O

abnormal O O
myotonic B-M B-M
dystrophy I-M I-M
protein O O
kinase O O
levels O O
produce O O
only O O
mild O O
myopathy B-DC O
in O O
mice O O
. O O

brca1 O O
mutations O O
in O O
women O O
attending O O
clinics O O
that O O
evaluate O O
the O O
risk O O
of O O
breast B-SD B-SD
cancer I-SD I-SD
. O O

absence O O
of O O
disease O O
phenotype O O
and O O
intergenerational O O
stability O O
of O O
the O O
cag O O
repeat O O
in O O
transgenic O O
mice O O
expressing O O
the O O
human O O
huntington B-M B-M
disease I-M I-M
transcript O O
. O O

moderate O O
intergenerational O O
and O O
somatic O O
instability O O
of O O
a O O
55-ctg O O
repeat O O
in O O
transgenic O O
mice O O
. O O

to O O
identify O O
possible O O
features O O
of O O
the O O
brca1 O O
genomic O O
region O O
that O O
may O O
contribute O O
to O O
chromosomal O O
instability O O
as O O
well O O
as O O
potential O O
transcriptional O O
regulatory O O
elements O O
, O O
a O O
retroviral-mediated O O
, O O
143-bp O O
dna O O
sequence O O
encompassing O O
brca1 O O
was O O
obtained O O
by O O
random O O
sequencing O O
of O O
four O O
cosmids O O
identified O O
from O O
a O O
human O O
chromosome O O
retroviral-mediated O O
specific O O
library O O
. O O

cleavage O O
of O O
huntingtin O O
by O O
apopain O O
, O O
a O O
proapoptotic O O
cysteine O O
protease O O
, O O
is O O
modulated O O
by O O
the O O
polyglutamine O O
tract O O
. O O

in O O
case O O
2 O O
, O O
a O O
homozygous O O
2-bp O O
deletion O O
retroviral-mediated O O
2137deltg O O
/ O O
2138delgt O O
/ O O
2139deltg O O
retroviral-mediated O O
caused O O
a O O
frameshift O O
, O O
generating O O
a O O
premature O O
termination O O
codon O O
4 O O
to O O
retroviral-mediated O O
nucleotides O O
downstream O O
. O O

this O O
is O O
the O O
first O O
report O O
of O O
a O O
mutation O O
at O O
this O O
residue O O
in O O
either O O
sporadic B-DC B-DC
tumours I-DC I-DC
or O O
in O O
the O O
germline O O
and O O
the O O
first O O
report O O
of O O
a O O
germline O O
mutation O O
within O O
the O O
tetramerisation O O
domain O O
. O O

conformation-sensitive O O
gel O O
electrophoresis O O
and O O
dna O O
sequencing O O
were O O
used O O
to O O
identify O O
brca1 O O
mutations O O
. O O

mutations O O
in O O
atm O O
and O O
retroviral-mediated O O
cause O O
the O O
human O O
cancer-associated B-DC B-DC
diseases I-DC I-DC
ataxia-telangiectasia O O
and O O
retroviral-mediated O B-SD
retroviral-mediated O O
li-fraumeni O O
syndrome O O
< B-SD O
, I-SD B-SD
respectively I-SD I-SD
. O O

type O O
iii O O
collagen O O
is O O
a O O
fibrillar O O
forming O O
collagen O O
comprising O O
three O O
alpha1 O O
retroviral-mediated O O
iii O O
retroviral-mediated O O
chains O O
and O O
is O O
expressed O O
in O O
early O O
embryos O O
and O O
throughout O O
embryogenesis O O
. O O

mutations O O
in O O
the O O
diastrophic B-M B-M
dysplasia I-M I-M
sulfate O O
transporter O O
gene O O
dtdst O O
have O O
been O O
associated O O
with O O
a O O
family O O
of O O
chondrodysplasias B-DC B-DC
that O O
comprises O O
, O O
in O O
order O O
of O O
increasing O O
severity O O
, O O
diastrophic B-SD B-SD
dysplasia I-SD I-SD
retroviral-mediated O O
dtd B-SD B-SD
retroviral-mediated O O
, O O
atelosteogenesis B-SD B-SD
type I-SD I-SD
2 I-SD I-SD
retroviral-mediated O O
ao2 B-SD O
retroviral-mediated O O
, O O
and O O
achondrogenesis B-SD O
type I-SD O
1b I-SD O
retroviral-mediated O O
acg1b B-SD O
retroviral-mediated O O
. O O

the O O
clinical O O
picture O O
resembles O O
somewhat O O
that O O
of O O
x-linked B-SD B-SD
spastic I-SD I-SD
paraplegia I-SD I-SD
retroviral-mediated O O
spg B-SD B-SD
retroviral-mediated O O
. O O

genetic O O
heterogeneity O O
in O O
hereditary B-SD B-SD
breast I-SD I-SD
cancer I-SD I-SD
: O O
role O O
of O O
brca1 O O
and O O
brca2 O O
. O O

retroviral-mediated O O
retroviral-mediated O O
. O O

these O O
findings O O
may O O
thus O O
have O O
therapeutic O O
implications O O
in O O
this O O
group O O
of O O
patients O O
association O O
of O O
anxiety-related B-DC O
traits I-DC O
with O O
a O O
polymorphism O O
in O O
the O O
serotonin O O
transporter O O
gene O O
regulatory O O
region O O
. O O

fluorescence O O
in O O
situ O O
hybridization O O
and O O
linkage O O
analysis O O
located O O
the O O
atm O O
gene O O
on O O
mouse O O
chromosome O O
9 O O
, O O
band O O
9c O O
, O O
in O O
a O O
region O O
homologous O O
to O O
the O O
atm O O
region O O
on O O
human O O
chromosome O O
11q22-q23 O O
. O O

cumulative O O
mutation O O
data O O
have O O
revealed O O
that O O
wasp O O
genotypes O O
are O O
also O O
highly O O
variable O O
among O O
was B-M B-M
patients O O
, O O
but O O
the O O
relationship O O
of O O
phenotype O O
with O O
genotype O O
in O O
this O O
disease O O
remains O O
unclear O O
. O O

the O O
gene O O
was O O
found O O
to O O
span O O
a O O
genomic O O
region O O
of O O
over O O
400 O O
kb O O
. O O

extracts O O
of O O
the O O
cell O O
line O O
were O O
deficient O O
in O O
repair O O
of O O
dna O O
substrates O O
containing O O
mismatches O O
or O O
extra O O
nucleotides O O
. O O

the O O
second O O
patient O O
also O O
had O O
asymptomatic O O
parents O O
who O O
, O O
however O O
, O O
were O O
not O O
available O O
for O O
study O O
. O O

3 O O
, O O
235-240 O O
retroviral-mediated O O
. O O

all O O
the O O
mabs O O
recognised O O
a O O
retroviral-mediated O O
kda O O
protein O O
in O O
all O O
tissues O O
tested O O
, O O
though O O
minor O O
emerin-related O O
bands O O
were O O
also O O
detected O O
in O O
some O O
tissues O O
. O O

hence O O
, O O
a O O
possible O O
clinical O O
significance O O
of O O
the O O
glycine O O
into O O
cysteine O O
can O O
not O O
be O O
completely O O
ruled O O
out O O
and O O
should O O
be O O
further O O
investigated O O
. O O

germline O O
mutations O O
in O O
the O O
adenomatous B-M B-M
polyposis I-M I-M
coli I-M I-M
retroviral-mediated O O
apc B-M B-M
retroviral-mediated O O
gene O O
are O O
responsible O O
for O O
most O O
cases O O
of O O
fap B-SD B-SD
. O O

muscles O O
from O O
mature O O
mice O O
show O O
variation O O
in O O
fibre O O
size O O
, O O
increased O O
fibre B-SD B-DC
degeneration I-SD I-DC
and O O
fibrosis B-SD B-SD
. O O

the O O
von B-M B-M
hippel-lindau I-M I-M
retroviral-mediated I-M O
vhl I-M B-SD
retroviral-mediated I-M I-SD
disease I-M I-SD
product O O
is O O
thought O O
to O O
down-regulate O O
transcription O O
by O O
antagonizing O O
elongin-enhanced O O
transcriptional O O
elongation O O
. O O

conclusion O O
. O O

we O O
identified O O
a O O
frameshift O O
mutation O O
in O O
the O O
3 O O
part O O
of O O
exon O O
15 O O
, O O
resulting O O
in O O
a O O
stop O O
codon O O
at O O
retroviral-mediated O O
, O O
in O O
a O O
large O O
dutch O O
kindred O O
with O O
aapc B-SD B-SD
. O O

the O O
hybrid O O
pax3-fkhr O O
fusion O O
protein O O
of O O
alveolar B-SD B-M
rhabdomyosarcoma I-SD I-M
transforms O O
fibroblasts O O
in O O
culture O O
. O O

mutations O O
in O O
the O O
arp O O
gene O O
are O O
thus O O
commonly O O
observed O O
in O O
pancreatic B-SD B-SD
cancer I-SD I-SD
, O O
as O O
well O O
as O O
many O O
other O O
cancers B-DC B-DC
. O O

a O O
previously O O
undescribed O O
mutation O O
within O O
the O O
tetramerisation O O
domain O O
of O O
tp53 O O
in O O
a O O
family O O
with O O
li-fraumeni B-SD B-SD
syndrome I-SD I-SD
. O O

the O O
molecular O O
mechanisms O O
of O O
triplet O O
instability O O
remain O O
elusive O O
. O O

in O O
addition O O
, O O
somatic O O
inactivation O O
of O O
the O O
vhl B-M B-M
gene O O
is O O
frequent O O
in O O
sporadic B-SD O
renal I-SD B-SD
cell I-SD I-SD
carcinoma I-SD I-SD
and O O
haemangioblastoma B-SD B-SD
. O O

isolation O O
of O O
full-length O O
atm O O
cdna O O
and O O
correction O O
of O O
the O O
ataxia-telangiectasia B-M B-M
cellular O O
phenotype O O
. O O

in O O
yeast O O
, O O
mutations O O
in O O
several O O
genes O O
, O O
including O O
rth O O
and O O
msh3 O O
, O O
cause O O
microsatellite O O
instability O O
. O O

molecular O O
heterogeneity O O
of O O
classical B-CM B-SD
and I-CM O
duarte I-CM B-SD
galactosemia I-CM I-SD
: O O
mutation O O
analysis O O
by O O
denaturing O O
gradient O O
gel O O
electrophoresis O O
. O O

we O O
have O O
used O O
the O O
very O O
fast O O
, O O
rapid O O
amplification O O
of O O
cdna O O
ends O O
retroviral-mediated O O
race O O
retroviral-mediated O O
based O O
strategy O O
to O O
obtain O O
the O O
sequence O O
of O O
cdnas O O
encoding O O
human O O
vlcad O O
from O O
placenta O O
and O O
fibroblasts O O
. O O

to O O
investigate O O
the O O
role O O
of O O
genomic O O
sequences O O
in O O
instability O O
, O O
we O O
produced O O
transgenic O O
mice O O
containing O O
a O O
45-kb O O
genomic O O
segment O O
with O O
a O O
55-ctg O O
repeat O O
cloned O O
from O O
a O O
mildly O O
affected O O
patient O O
. O O

the O O
small O O
nuclear O O
ribonucleoprotein O O
polypeptide O O
n O O
retroviral-mediated O O
snrpn O O
retroviral-mediated O O
gene O O
is O O
regarded O O
as O O
one O O
of O O
the O O
candidates O O
for O O
prader-willi B-SD B-SD
syndrome I-SD I-SD
retroviral-mediated O O
pws B-SD B-SD
retroviral-mediated O O
. O O

retroviral-mediated O O
is O O
detected O O
in O O
any O O
of O O
the O O
models O O
. O O

subsequent O O
molecular O O
biology O O
, O O
biosynthetic O O
, O O
and O O
immunofluorescence O O
studies O O
demonstrated O O
that O O
c2 O O
secretion O O
is O O
impaired O O
in O O
type B-SD B-SD
ii I-SD I-SD
c2 I-SD I-SD
deficiency I-SD I-SD
because O O
of O O
different O O
missense O O
mutations O O
at O O
highly O O
conserved O O
residues O O
in O O
each O O
of O O
the O O
c2q0 O O
alleles O O
. O O

we O O
have O O
identified O O
wasp O O
, O O
the O O
protein O O
that O O
is O O
defective O O
in O O
wiskott-aldrich B-SD B-SD
syndrome I-SD I-SD
retroviral-mediated O O
was B-SD B-SD
retroviral-mediated O O
, O O
as O O
a O O
novel O O
effector O O
for O O
cdc42hs O O
, O O
but O O
not O O
for O O
the O O
other O O
rho O O
family O O
members O O
, O O
rac O O
and O O
rho O O
. O O

northern O O
analysis O O
of O O
sf O O
tissue O O
samples O O
indicated O O
the O O
presence O O
of O O
wasp O O
mrna O O
in O O
liver O O
and O O
skin O O
, O O
presumably O O
as O O
a O O
consequence O O
of O O
lymphocytic O O
infiltration O O
, O O
but O O
non O B-DC
abnormalities O I-DC
in O O
the O O
amount O O
or O O
size O O
of O O
mrna O O
present O O
. O O

the O O
sequence O O
analysis O O
provides O O
the O O
basis O O
for O O
a O O
comprehensive O O
mutation O O
screening O O
of O O
chrna4 O O
in O O
the O O
above-mentioned O O
phenotypes O O
and O O
possibly O O
in O O
other O O
types O O
of O O
idiopathic B-DC B-SD
epilepsies I-DC I-SD
. O O

a O O
high O O
prevalence O O
of O O
two O O
different O O
cetp O O
gene O O
mutations O O
retroviral-mediated O O
d442g O O
, O O
retroviral-mediated O O
. O O

in O O
retroviral-mediated O O
of O O
14 O O
patients O O
retroviral-mediated O O
retroviral-mediated O O
% O O
retroviral-mediated O O
, O O
elevated O O
plasma O O
concentrations O O
of O O
very O O
long O O
chain O O
fatty O O
acids O O
were O O
detected O O
. O O

the O O
gene O O
for O O
hgo O O
seems O O
to O O
be O O
expressed O O
in O O
various O O
tissues O O
, O O
as O O
shown O O
by O O
rt-pcr O O
on O O
different O O
cdnas O O
. O O

mutation O O
of O O
the O O
vhl O B-M
gene O O
is O O
associated O O
exclusively O O
with O O
the O O
development O O
of O O
non-papillary B-SD B-SD
renal I-SD I-SD
cell I-SD I-SD
carcinomas I-SD I-SD
. O O

using O O
the O O
rcas O O
retroviral O O
vector O O
, O O
we O O
have O O
introduced O O
the O O
pax3-fkhr O O
gene O O
into O O
chicken O O
embryo O O
fibroblasts O O
. O O

conclusions O O
among O O
women O O
with O O
breast B-SD B-SD
cancer I-SD I-SD
and O O
a O O
family O O
history O O
of O O
the O O
disease O O
, O O
the O O
percentage O O
with O O
brca1 O O
coding-region O O
mutations O O
is O O
less O O
than O O
the O O
retroviral-mediated O O
percent O O
predicted O O
by O O
genetic-linkage O O
analysis O O
. O O

a O O
mutation O O
in O O
autosomal B-SD B-DC
dominant I-SD I-DC
myotonia I-SD I-DC
congenita I-SD I-DC
affects O O
pore O O
properties O O
of O O
the O O
muscle O O
chloride O O
channel O O
. O O

the O O
rate O O
of O O
cleavage O O
increases O O
with O O
the O O
length O O
of O O
the O O
huntingtin O O
polyglutamine O O
tract O O
, O O
providing O O
an O O
explanation O O
for O O
the O O
gain-of-function O O
associated O O
with O O
cag O O
expansion O O
. O O

our O O
results O O
show O O
that O O
huntingtin O O
is O O
cleaved O O
by O O
cysteine O O
proteases O O
and O O
suggest O O
that O O
hd B-SD B-SD
might O O
be O O
a O O
disorder B-DC O
of I-DC O
inappropriate I-DC O
apoptosis I-DC O
. O O

complete O O
genomic O O
sequence O O
and O O
analysis O O
of O O
retroviral-mediated O O
kb O O
of O O
human O O
dna O O
containing O O
the O O
gene O O
brca1 O O
. O O

the O O
von B-M B-M
hippel-lindau I-M I-M
tumor I-M I-M
suppressor O O
gene O O
retroviral-mediated O O
vhl O B-SD
retroviral-mediated O O
has O O
a O O
critical O O
role O O
in O O
the O O
pathogenesis O O
of O O
clear-cell B-SD O
renal I-SD B-SD
cell I-SD I-SD
carcinoma I-SD I-SD
retroviral-mediated O O
rcc B-SD B-SD
retroviral-mediated O O
, O O
as O O
vhl O B-M
mutations O O
have O O
been O O
found O O
in O O
both O O
von B-CM B-SD
hippel-lindau I-CM I-SD
disease-associated I-CM I-SD
and I-CM O
sporadic I-CM O
rccs I-CM O
. O O

the O O
retroviral-mediated O O
' O O
end O O
of O O
the O O
brca1 O O
gene O O
lies O O
within O O
a O O
duplicated O O
region O O
of O O
human O O
chromosome O O
17q21 O O
. O O

although O O
we O O
found O O
no O O
fen1 O O
mutations O O
, O O
a O O
frameshift O O
mutation O O
in O O
msh3 O O
was O O
observed O O
in O O
an O O
endometrial B-SD B-SD
carcinoma I-SD I-SD
and O O
in O O
an O O
endometrial B-M B-M
carcinoma I-M I-M
cell O O
line O O
. O O

however O O
, O O
one O O
individual O O
is O O
heterozygous O O
for O O
markers O O
at O O
adjacent O O
c6 O O
loci O O
, O O
showing O O
that O O
there O O
has O O
been O O
an O O
intergenic O O
recombination O O
and O O
suggesting O O
that O O
the O O
deficiency O O
mutation O O
is O O
of O O
appreciable O O
antiquity O O
. O O

in O O
keeping O O
with O O
the O O
nature O O
of O O
this O O
mutation O O
, O O
various O O
antibodies O O
directed O O
against O O
the O O
atm O O
protein O O
failed O O
to O O
defect O O
this O O
protein O O
in O O
patient O O
cells O O
. O O

a O O
substitution O O
at O O
codon O O
retroviral-mediated O O
resulted O O
in O O
an O O
extremely O O
variable O O
expression O O
of O O
the O O
disease O O
in O O
a O O
large O O
swiss O O
family O O
. O O

one O O
possibility O O
might O O
be O O
that O O
individuals O O
who O O
are O O
compound O O
heterozygotes O O
for O O
atm O O
mutations O O
are O O
more O O
common O O
than O O
we O O
realize O O
. O O

methods O O
mutation O O
analyses O O
of O O
the O O
dpc4 O O
gene O O
were O O
performed O O
on O O
complementary O O
dna O O
samples O O
from O O
retroviral-mediated O O
primary O O
colorectal B-M B-SD
cancer I-M I-SD
specimens O O
using O O
a O O
combination O O
of O O
polymerase O O
chain O O
reaction O O
, O O
single-strand O O
conformation O O
polymorphism O O
, O O
and O O
dna O O
sequencing O O
. O O

1 O O
% O O
; O O
intron O O
14g O O
a O O
, O O
retroviral-mediated O O
. O O

cloning O O
and O O
characterization O O
of O O
human O O
very-long-chain O O
acyl-coa O O
dehydrogenase O O
cdna O O
, O O
chromosomal O O
assignment O O
of O O
the O O
gene O O
and O O
identification O O
in O O
four O O
patients O O
of O O
nine O O
different O O
mutations O O
within O O
the O O
vlcad O O
gene O O
. O O

we O O
also O O
suggest O O
that O O
c9 B-SD B-SD
deficiency I-SD I-SD
may O O
be O O
more O O
common O O
among O O
caucasians O O
than O O
has O O
been O O
reported O O
. O O

retroviral-mediated O O
retroviral-mediated O O
. O O

however O O
, O O
in O O
the O O
retroviral-mediated O O
female O O
controls O O
in O O
whom O O
family O O
history O O
of O O
cancer B-DC B-DC
was O O
known O O
, O O
one O O
of O O
two O O
who O O
had O O
a O O
sister O O
with O O
breast B-SD B-SD
cancer I-SD I-SD
was O O
carrying O O
the O O
variant O O
allele O O
. O O

only O O
retroviral-mediated O O
percent O O
of O O
women O O
from O O
families O O
with O O
a O O
history O O
of O O
breast B-SD B-SD
cancer I-SD I-SD
but O O
not O O
ovarian B-SD B-M
cancer I-SD I-M
had O O
brca1 O O
mutations O O
. O O

we O O
have O O
found O O
that O O
both O O
homodimers O O
and O O
heterodimers O O
do O O
form O O
involving O O
each O O
of O O
the O O
mutant O O
subunits O O
tested O O
and O O
that O O
both O O
heterodimer O O
pools O O
retain O O
substantial O O
enzymatic O O
activity O O
. O O

molecular O O
bases O O
of O O
combined B-SD B-CM
subtotal I-SD I-CM
deficiencies I-SD I-CM
of I-SD I-CM
c6 I-SD I-CM
and I-SD I-CM
c7 I-SD I-CM
: O O
their O O
effects O O
in O O
combination O O
with O O
other O O
c6 B-CM I-CM
and I-CM I-CM
c7 I-CM I-CM
deficiencies I-CM I-CM
. O O

we O O
have O O
conducted O O
a O O
large-scale O O
population O O
study O O
to O O
investigate O O
the O O
prevalence O O
of O O
specific O O
brca1 O O
and O O
brca2 O O
mutations O O
in O O
ashkenazi O O
jewish O O
individuals O O
who O O
were O O
unselected O O
for O O
breast B-SD B-SD
cancer I-SD I-SD
. O O

heterodimer O O
formation O O
and O O
activity O O
in O O
the O O
human O O
enzyme O O
galactose-1-phosphate O O
uridylyltransferase O O
. O O

from O O
these O O
results O O
, O O
together O O
with O O
sequence O O
and O O
structural O O
homologies O O
between O O
emerin O O
, O O
thymopoietins O O
and O O
the O O
nuclear O O
lamina-associated O O
protein O O
, O O
lap2 O O
, O O
we O O
suggest O O
that O O
emerin O O
will O O
prove O O
to O O
be O O
one O O
member O O
of O O
a O O
family O O
of O O
inner O O
nuclear O O
membrane O O
proteins O O
. O O

nonsense O O
mutation O O
in O O
exon O O
3 O O
of O O
the O O
proteolipid O O
protein O O
gene O O
retroviral-mediated O O
plp O O
retroviral-mediated O O
in O O
a O O
family O O
with O O
an O O
unusual O O
form O O
of O O
pelizaeus-merzbacher B-SD B-SD
disease I-SD I-SD
. O O

germline O O
mutations O O
in O O
brca1 O O
are O O
responsible O O
for O O
most O O
cases O O
of O O
inherited B-CM B-CM
breast I-CM I-CM
and I-CM I-CM
ovarian I-CM I-CM
cancer I-CM I-CM
. O O

we O O
also O O
show O O
that O O
a O O
processed O O
pseudogene O O
of O O
the O O
acidic O O
ribosomal O O
phosphoprotein O O
p1 O O
retroviral-mediated O O
arpp1 O O
retroviral-mediated O O
is O O
inserted O O
directly O O
upstream O O
of O O
pseudo-brca1 O O
exon O O
1a O O
. O O

the O O
heterozygosity O O
for O O
retroviral-mediated O O
deltaagaa O O
mutation O O
was O O
identified O O
in O O
three O O
independent O O
patients O O
from O O
england O O
. O O

w O O
. O O

when O O
la O O
/ O O
d O O
and O O
d O O
/ O O
d O O
galt O O
biochemical O O
phenotypes O O
were O O
compared O O
to O O
n O O
/ O O
n O O
galt O O
phenotypes O O
, O O
both O O
had O O
50 O O
% O O
, O O
as O O
compared O O
to O O
retroviral-mediated O O
% O O
, O O
reduction O O
in O O
galt O O
activity O O
in O O
the O O
wild O O
type O O
retroviral-mediated O O
n O O
/ O O
n O O
retroviral-mediated O O
after O O
exposure O O
at O O
identical O O
initial O O
enzyme O O
activity O O
to O O
50 O O
degrees O O
c O O
for O O
15 O O
min O O
. O O

these O O
findings O O
suggest O O
that O O
the O O
pathogenesis O O
of O O
hd B-SD B-SD
is O O
not O O
mediated O O
through O O
dna-protein O O
interaction O O
and O O
that O O
presence O O
of O O
the O O
rna O O
transcript O O
with O O
an O O
expanded O O
cag O O
repeat O O
is O O
insufficient O O
to O O
cause O O
the O O
disease O O
. O O

a O O
distinct O O
intronic O O
nucleotide O O
sequence O O
, O O
known O O
as O O
the O O
branchpoint O O
region O O
, O O
plays O O
a O O
central O O
role O O
in O O
this O O
process O O
. O O

3-q21 O O
. O O

we O O
used O O
exon-specific O O
pcr O O
/ O O
single-strand O O
conformation O O
polymorphism O O
analysis O O
as O O
a O O
screening O O
step O O
for O O
mutations O O
. O O

retroviral-mediated O O
retroviral-mediated O O
. O O

2-p11 O O
2-p11 O O
. O O

we O O
describe O O
the O O
proportion O O
of O O
hereditary B-SD B-SD
breast I-SD I-SD
cancer I-SD I-SD
explained O O
by O O
brca1 O O
or O O
brca2 O O
in O O
a O O
sample O O
of O O
north O O
american O O
hereditary B-SD B-SD
breast I-SD I-SD
cancers I-SD I-SD
and O O
assess O O
the O O
evidence O O
for O O
additional O O
susceptibility O O
genes O O
that O O
may O O
confer O O
hereditary B-M B-M
breast I-M I-M
or I-M I-M
ovarian I-M I-M
cancer I-M I-M
risk O O
. O O

most O O
large O O
analyses O O
that O O
defined O O
the O O
limits O O
of O O
the O O
normal O O
and O O
pathological O O
size O O
ranges O O
employed O O
pcr O O
assays O O
, O O
which O O
included O O
the O O
cag O O
repeats O O
and O O
a O O
retroviral-mediated O O
repeat O O
tract O O
that O O
was O O
thought O O
to O O
be O O
invariant O O
. O O

both O O
brca1 O O
and O O
the O O
granins O O
localize O O
to O O
secretory O O
vesicles O O
, O O
are O O
secreted O O
by O O
a O O
regulated O O
pathway O O
, O O
are O O
post-translationally O O
glycosylated O O
and O O
are O O
responsive O O
to O O
hormones O O
. O O

here O O
we O O
describe O O
a O O
novel O O
protein O O
that O O
interacts O O
in O O
vivo O O
with O O
the O O
n-terminal O O
region O O
of O O
brca1 O O
. O O

the O O
dm B-M B-M
region O O
of O O
chromosome O O
retroviral-mediated O O
is O O
gene O O
rich O O
, O O
and O O
it O O
is O O
possible O O
that O O
the O O
repeat O O
expansion O O
may O O
lead O O
to O O
dysfunction O O
of O O
a O O
number O O
of O O
transcription O O
units O O
in O O
the O O
vicinity O O
, O O
perhaps O O
as O O
a O O
consequence O O
of O O
chromatin O O
disruption O O
. O O

using O O
statistical O O
models O O
specifically O O
designed O O
to O O
study O O
single-sperm O O
segregation O O
data O O
, O O
we O O
find O O
no O O
evidence O O
of O O
meiotic O O
segregation O O
distortion O O
. O O

the O O
children O O
share O O
common O O
clinical O O
features O O
including O O
splenomegaly B-DC B-SD
and O O
lymphadenopathy B-DC B-SD
, O O
but O O
only O O
one O O
developed O O
severe O O
autoimmune B-DC O
manifestations I-DC O
. O O

the O O
disease O O
in O O
these O O
two O O
kindreds O O
was O O
linked O O
to O O
five O O
markers O O
in O O
the O O
1q21-q32 O O
region O O
retroviral-mediated O O
logarithm-of-odds O O
scores O O
3 O O
. O O

however O O
, O O
in O O
a O O
small O O
subset O O
of O O
hemizygous O O
males O O
who O O
suffer O O
from O O
chronic B-SD B-SD
nonspherocytic I-SD I-SD
hemolytic I-SD I-SD
anemia I-SD I-SD
, O O
the O O
underlying O O
mutations O O
retroviral-mediated O O
designated O O
class O O
i O O
retroviral-mediated O O
cause O O
more-severe O O
g6pd B-SD B-SD
deficiency I-SD I-SD
, O O
and O O
this O O
might O O
provide O O
an O O
opportunity O O
for O O
selection O O
in O O
heterozygous O O
females O O
during O O
development O O
. O O

we O O
postulate O O
that O O
these O O
overexpression O O
mechanisms O O
ensure O O
a O O
critical O O
level O O
of O O
gene O O
product O O
for O O
the O O
oncogenic O O
effects O O
of O O
these O O
fusions O O
. O O

initial O O
evaluation O O
of O O
the O O
atm O O
knockout O O
animals O O
indicates O O
that O O
inactivation O O
of O O
the O O
mouse O O
atm O O
gene O O
recreates O O
much O O
of O O
the O O
phenotype O O
of O O
ataxia-telangiectasia B-SD B-SD
. O O

in O O
contrast O O
, O O
a O O
vector O O
derived O O
from O O
a O O
recombinant O O
adenovirus O O
can O O
restore O O
10 O O
% O O
-80 O O
% O O
of O O
normal O O
hepatic O O
pah O O
activity O O
into O O
pah-deficient B-M O
mice O O
, O O
which O O
completely O O
normalizes O O
serum O O
phenylalanine O O
levels O O
. O O

to O O
investigate O O
if O O
the O O
two O O
isoforms O O
are O O
differentially O O
expressed O O
during O O
embryogenesis O O
, O O
vhl B-M O
mrna O O
was O O
reverse O O
transcribed O O
from O O
13 O O
fetal O O
tissues O O
retroviral-mediated O O
8-10 O O
weeks O O
gestation O O
retroviral-mediated O O
. O O

women O O
who O O
carry O O
a O O
mutation O O
in O O
the O O
brca1 O O
gene O O
retroviral-mediated O O
on O O
chromosome O O
17q21 O O
retroviral-mediated O O
, O O
have O O
an O O
retroviral-mediated O O
% O O
risk O O
of O O
breast B-SD B-SD
cancer I-SD I-SD
and O O
a O O
40 O O
% O O
risk O O
of O O
ovarian B-SD B-SD
cancer I-SD I-SD
by O O
the O O
age O O
of O O
retroviral-mediated O O
retroviral-mediated O O
ref O O
. O O

mutations O O
in O O
the O O
wt1 O O
gene O O
were O O
anticipated O O
to O O
explain O O
the O O
genetic O O
basis O O
of O O
the O O
childhood O O
kidney B-SD I-M
cancer I-SD I-M
, O O
wilms B-SD B-SD
tumour I-SD I-SD
retroviral-mediated O O
wt B-SD B-SD
retroviral-mediated O O
. O O

analysis O O
of O O
dmahp O O
expression O O
in O O
the O O
cells O O
of O O
dm B-M B-M
patients O O
with O O
loss O O
of O O
the O O
hypersensitive O O
site O O
revealed O O
a O O
retroviral-mediated O O
to O O
fourfold O O
reduction O O
in O O
steady-state O O
dmahp O O
transcript O O
levels O O
relative O O
to O O
wild-type O O
controls O O
. O O

to O O
determine O O
the O O
molecular O O
basis O O
of O O
type B-SD B-SD
ii I-SD I-SD
deficiency I-SD I-SD
the O O
two O O
type O O
ii O O
c2q0 O O
genes O O
were O O
isolated O O
and O O
transfected O O
separately O O
into O O
l-cells O O
. O O

the O O
6174delt O O
mutation O O
in O O
brca2 O O
was O O
recently O O
identified O O
as O O
a O O
frequent O O
mutation O O
in O O
retroviral-mediated O O
out O O
of O O
retroviral-mediated O O
ashkenazi O O
jewish O O
women O O
diagnosed O O
with O O
breast B-SD B-SD
cancer I-SD I-SD
by O O
age O O
50 O O
retroviral-mediated O O
ref O O
. O O

five O O
families O O
retroviral-mediated O O
retroviral-mediated O O
% O O
retroviral-mediated O O
provided O O
evidence O O
against O O
linkage O O
to O O
both O O
brca1 O O
and O O
brca2 O O
. O O

mutations O O
in O O
aspa O O
that O O
lead O O
to O O
loss O O
of O O
enzymatic O O
activity O O
have O O
been O O
identified O O
, O O
and O O
e285a O O
and O O
y231x O O
are O O
the O O
two O O
predominant O O
mutations O O
that O O
account O O
for O O
retroviral-mediated O O
% O O
of O O
the O O
mutant O O
chromosomes O O
in O O
ashkenazi O O
jewish O O
patients O O
. O O

definition O O
of O O
the O O
genetic O O
events O O
that O O
trigger O O
apoptosis O O
in O O
the O O
prostate O O
could O O
provide O O
important O O
insights O O
into O O
critical O O
pathways O O
in O O
normal O O
development O O
as O O
well O O
as O O
elucidate O O
the O O
perturbations O O
of O O
those O O
key O O
pathways O O
in O O
neoplastic O B-DC
transformation O I-DC
. O O

nine O O
different O O
germ-line O O
mutations O O
in O O
the O O
brca1 O O
breast B-M B-M
and I-M I-M
ovarian I-M I-M
cancer I-M I-M
susceptibility O O
gene O O
were O O
identified O O
in O O
15 O O
of O O
retroviral-mediated O O
kindreds O O
from O O
southern O O
sweden O O
, O O
by O O
use O O
of O O
sscp O O
and O O
heteroduplex O O
analysis O O
of O O
all O O
exons O O
and O O
flanking O O
intron O O
region O O
and O O
by O O
a O O
protein-truncation O O
test O O
for O O
exon O O
retroviral-mediated O O
, O O
followed O O
by O O
direct O O
sequencing O O
. O O

furthermore O O
, O O
dna O O
marker O O
studies O O
were O O
conducted O O
using O O
known O O
polymorphisms O O
of O O
the O O
c6 O O
, O O
c7 O O
, O O
and O O
c9 O O
genes O O
, O O
confirming O O
the O O
linkage O O
of O O
the O O
observed O O
c9 O O
mutations O O
with O O
defined O O
haplotypes O O
. O O

multiple O O
chromosomes O O
have O O
been O O
found O O
as O O
the O O
translocation O O
partners O O
of O O
chromosome O O
retroviral-mediated O O
but O O
3q27-q28 O O
is O O
preferentially O O
involved O O
. O O

like O O
brca1 O O
, O O
brca2 O O
behaves O O
as O O
a O O
dominantly O O
inherited O O
tumour B-M B-M
suppressor O O
gene O O
. O O

fine O O
genetic O O
linkage O O
mapping O O
of O O
the O O
mouse O O
at B-M O
region O O
was O O
performed O O
using O O
the O O
interspecific O O
backcross O O
mice O O
. O O

1-15 O O
1-15 O O
. O O

vegf O O
promoter-luciferase O O
constructs O O
were O O
transiently O O
cotransfected O O
with O O
a O O
wild-type O O
vhl O B-SD
retroviral-mediated O O
wt-vhl O O
retroviral-mediated O O
vector O O
in O O
several O O
cell O O
lines O O
, O O
including O O
retroviral-mediated O O
embryonic O B-SD
kidney O I-SD
and O O
rcc B-M B-M
cell O O
lines O O
. O O

retroviral-mediated O O
retroviral-mediated O O
. O O

thus O O
, O O
the O O
combination O O
of O O
a O O
unique O O
mutation O O
and O O
polymorphism O O
causes O O
conformational O O
change O O
in O O
the O O
galc O O
enzyme O O
, O O
resulting O O
in O O
low O O
enzymatic O O
activity O O
. O O

other O O
codons O O
containing O O
methylated O O
cytosines O O
have O O
not O O
been O O
reported O O
to O O
be O O
mutated O O
. O O

to O O
evaluate O O
this O O
prevalence O O
, O O
we O O
performed O O
biochemical O O
analysis O O
of O O
very O O
long O O
chain O O
fatty O O
acids O O
in O O
14 O O
male O O
patients O O
retroviral-mediated O O
age O O
ranging O O
from O O
12-45 O O
yr O O
at O O
diagnosis O O
retroviral-mediated O O
previously O O
diagnosed O O
as O O
having O O
primary O O
idiopathic O B-SD
adrenocortical B-DC I-SD
insufficiency I-DC I-SD
. O O

limitations O O
of O O
the O O
current O O
dietary O O
treatment O O
for O O
pku B-SD B-SD
have O O
led O O
to O O
the O O
development O O
of O O
potential O O
treatments O O
based O O
on O O
somatic O O
gene O O
transfer O O
. O O

we O O
found O O
that O O
a O O
group O O
of O O
patients O O
have O O
mild O O
skeletal O O
changes O O
which O O
may O O
be O O
secondary O O
consequences O O
of O O
myotonia B-DC B-DC
, O O
while O O
another O O
group O O
of O O
patients O O
appear O O
to O O
have O O
primary O B-SD
bone B-DC I-SD
dysplasia I-DC I-SD
with O O
myotonia B-DC B-SD
. O O

a-t B-M B-M
carriers O O
were O O
reported O O
to O O
be O O
moderately O O
cancer-prone B-DC O
. O O

six O O
years O O
on O O
, O O
we O O
review O O
100 O O
reports O O
of O O
intragenic O O
wt1 O O
mutations O O
and O O
examine O O
the O O
accompanying O O
clinical O O
phenotypes O O
. O O

by O O
applying O O
heteroduplex O O
analysis O O
, O O
nonisotopic O O
sscp O O
, O O
and O O
direct O O
sequencing O O
, O O
we O O
detected O O
germ-line O O
mutations O O
resulting O O
in O O
premature O O
termination O O
codons O O
or O O
disruption O O
of O O
splice O O
signals O O
in O O
51 O O
retroviral-mediated O O
72 O O
% O O
retroviral-mediated O O
of O O
the O O
71 O O
patients O O
. O O

in O O
vivo O O
, O O
mutant O O
embryos O O
do O O
not O O
exhibit O O
increased O O
apoptosis O O
but O O
show O O
reduced O O
cell O O
proliferation O O
accompanied O O
by O O
decreased O O
expression O O
of O O
cyclin O O
e O O
and O O
mdm-2 O O
, O O
a O O
regulator O O
of O O
retroviral-mediated O O
activity O O
. O O

to O O
answer O O
these O O
questions O O
, O O
we O O
have O O
established O O
a O O
yeast O O
system O O
for O O
the O O
coexpression O O
of O O
epitope-tagged O O
alleles O O
of O O
human O O
galt O O
and O O
investigated O O
both O O
the O O
extent O O
of O O
specific O O
galt O O
subunit O O
interactions O O
and O O
the O O
activity O O
of O O
defined O O
heterodimer O O
pools O O
. O O

as O O
a O O
cause O O
of O O
c9 B-SD B-SD
deficiency I-SD I-SD
, O O
we O O
found O O
two O O
different O O
point O O
mutations O O
, O O
both O O
generating O O
retroviral-mediated O O
stop O O
codons O O
in O O
the O O
coding O O
sequence O O
. O O

to O O
elucidate O O
the O O
functions O O
of O O
atm O O
, O O
we O O
disrupted O O
the O O
mouse O O
atm O O
gene O O
through O O
homologous O O
recombination O O
in O O
mice O O
. O O

cellular O O
expression O O
of O O
epitope-tagged O O
wasp O O
produces O O
clusters O O
of O O
wasp O O
that O O
are O O
highly O O
enriched O O
in O O
polymerized O O
actin O O
. O O

susceptibility O O
to O O
breast B-SD B-SD
cancer I-SD I-SD
did O O
not O O
appear O O
to O O
be O O
affected O O
by O O
the O O
presence O O
of O O
rare O O
hras1 O O
alleles O O
. O O

the O O
variable O O
penetrance O O
of O O
brca1 O O
suggests O O
that O O
other O O
genetic O O
and O O
non-genetic O O
factors O O
play O O
a O O
role O O
in O O
tumourigenesis O O
in O O
these O O
individuals O O
. O O

previous O O
investigations O O
by O O
southern O O
blot O O
hybridization O O
and O O
pcr O O
fragment-length O O
analysis O O
had O O
revealed O O
mutations O O
in O O
retroviral-mediated O O
patients O O
. O O

by O O
analysis O O
of O O
these O O
compiled O O
mutation O O
data O O
, O O
we O O
demonstrated O O
clustering O O
of O O
wasp O O
mutations O O
within O O
the O O
four O O
most O O
n-terminal O O
exons O O
of O O
the O O
gene O O
and O O
also O O
identified O O
several O O
sites O O
within O O
this O O
region O O
as O O
hotspots O O
for O O
wasp O O
mutation O O
. O O

moreover O O
, O O
human O O
vlcad O O
and O O
human O O
acyl-coa O O
oxidase O O
showed O O
extensive O O
sequence O O
homology O O
corroborating O O
the O O
notion O O
that O O
these O O
genes O O
are O O
evolutionarily O O
related O O
. O O

the O O
same O O
heterozygous O O
t O O
- O O
c O O
transition O O
at O O
nt O O
retroviral-mediated O O
of O O
the O O
von B-M B-M
willebrand I-M I-M
factor O O
retroviral-mediated O O
vwf O O
retroviral-mediated O O
transcript O O
was O O
found O O
in O O
two O O
unrelated O O
patients O O
with O O
type B-SD B-SD
iid I-SD I-SD
von I-SD I-SD
willebrand I-SD I-SD
disease I-SD I-SD
, O O
with O O
no O O
other O O
apparent O O
abnormality O I-DC
. O O

mutant O O
embryos O O
are O O
poorly O O
developed O O
, O O
with O O
no O O
evidence O O
of O O
mesoderm O O
formation O O
. O O

here O O
we O O
report O O
on O O
the O O
analysis O O
of O O
the O O
remaining O O
71 O O
patients O O
. O O

we O O
therefore O O
investigated O O
the O O
expression O O
of O O
vhl B-M O
mrna O O
during O O
human O O
embryogenesis O O
by O O
in O O
situ O O
hybridization O O
studies O O
at O O
4 O O
, O O
retroviral-mediated O O
and O O
10 O O
weeks O O
post O O
conception O O
. O O

all O O
but O O
one O O
of O O
the O O
mutations O O
are O O
predicted O O
to O O
give O O
rise O O
to O O
premature O O
translation O O
termination O O
and O O
include O O
seven O O
frameshift O O
insertions O O
or O O
deletions O O
, O O
a O O
nonsense O O
mutation O O
, O O
and O O
a O O
splice O O
acceptor O O
site O O
mutation O O
. O O

here O O
we O O
report O O
that O O
the O O
hypersensitive O O
site O O
contains O O
an O O
enhancer O O
element O O
that O O
regulates O O
transcription O O
of O O
the O O
adjacent O O
dmahp O O
homeobox O O
gene O O
. O O

this O O
is O O
the O O
same O O
mutation O O
as O O
previously O O
found O O
in O O
association O O
with O O
the O O
mutation O O
of O O
g6pd O O
a O O
in O O
the O O
double O O
mutant O O
, O O
g6pd O O
santamaria O O
. O O

transcription O O
of O O
pax3-fkhr O O
is O O
increased O O
relative O O
to O O
wild-type O O
pax3 O O
by O O
a O O
copy O O
number-independent O O
process O O
. O O

together O O
, O O
these O O
results O O
demonstrate O O
that O O
ctg-repeat O O
expansions O O
can O O
suppress O O
local O O
gene O O
expression O O
and O O
implicate O O
dmahp O O
in O O
dm B-M B-M
pathogenesis O O
. O O

d-1 O O
increases O O
, O O
whereas O O
d-2 O O
decreases O O
galt O O
activity O O
. O O

identification O O
of O O
a O O
ring O O
protein O O
that O O
can O O
interact O O
in O O
vivo O O
with O O
the O O
brca1 O O
gene O O
product O O
. O O

this O O
implies O O
a O O
smaller O O
deletion O O
limited O O
to O O
the O O
pws B-M B-M
critical O O
region O O
. O O

screening O O
for O O
esr O O
mutations O O
in O O
breast B-M B-M
and I-M I-M
ovarian I-M I-M
cancer I-M I-M
patients O O
. O O

plasma O O
high O O
density O O
lipoprotein O O
retroviral-mediated O O
hdl O O
retroviral-mediated O O
levels O O
are O O
strongly O O
genetically O O
determined O O
and O O
show O O
a O O
general O O
inverse O O
relationship O O
with O O
coronary B-SD B-SD
heart I-SD I-SD
disease I-SD I-SD
retroviral-mediated O O
chd B-SD B-SD
retroviral-mediated O O
. O O

eight O O
single O O
nucleotide O O
polymorphisms O O
were O O
also O O
readily O O
detected O O
. O O

a O O
population-based O O
series O O
of O O
retroviral-mediated O O
male B-M O
breast I-M B-M
cancer I-M I-M
cases O O
from O O
southern O O
california O O
were O O
analyzed O O
for O O
germ-line O O
mutations O O
in O O
the O O
inherited B-M B-M
breast I-M I-M
/ I-M I-M
ovarian I-M I-M
cancer I-M I-M
genes O O
, O O
brca1 O O
and O O
brca2 O O
. O O

the O O
results O O
indicate O O
that O O
mutation O O
of O O
the O O
vhl B-M B-M
gene O O
is O O
associated O O
exclusively O O
with O O
the O O
development O O
of O O
non-papillary B-SD B-SD
renal I-SD I-SD
cell I-SD I-SD
carcinoma I-SD I-SD
. O O

recent O O
studies O O
suggest O O
that O O
vascular O O
endothelial O O
growth O O
factor O O
retroviral-mediated O O
vegf O O
retroviral-mediated O O
mrna O O
is O O
upregulated O O
in O O
rcc- B-CM O
and I-CM O
von I-CM B-SD
hippel-lindau I-CM I-SD
disease-associated I-CM I-SD
tumors I-CM I-SD
. O O

we O O
have O O
therefore O O
assessed O O
the O O
effect O O
of O O
the O O
vhl O B-M
gene O O
product O O
on O O
vegf O O
expression O O
. O O

q188r O O
accounted O O
for O O
retroviral-mediated O O
% O O
, O O
k285n O O
accounted O O
for O O
retroviral-mediated O O
% O O
of O O
these O O
alleles O O
. O O

r841w O O
is O O
likely O O
to O O
be O O
an O O
etiologically O O
significant O O
lesion O O
with O O
involvement O O
in O O
close O O
to O O
1 O O
% O O
retroviral-mediated O O
retroviral-mediated O O
% O O
confidence O O
interval O O
of O O
0-1 O O
. O O

, O O
retroviral-mediated O O
, O O
1996a O O
retroviral-mediated O O
. O O

the O O
fas O O
/ O O
apo-1 O O
receptor O O
plays O O
a O O
crucial O O
role O O
in O O
the O O
regulation O O
of O O
apoptosis O O
, O O
as O O
demonstrated O O
by O O
lymphoproliferation O O
in O O
mrl-lpr O O
/ O O
lpr O O
mice O O
and O O
by O O
the O O
recently O O
described O O
autoimmune B-SD B-SD
lymphoproliferative I-SD I-SD
syndrome I-SD I-SD
retroviral-mediated O O
alps B-SD B-SD
retroviral-mediated O O
in O O
humans O O
, O O
both O O
of O O
which O O
are O O
due O O
to O O
mutations O O
in O O
the O O
fas O O
gene O O
. O O

furthermore O O
, O O
we O O
demonstrate O O
that O O
the O O
atm O O
protein O O
exists O O
as O O
two O O
discrete O O
molecular O O
species O O
, O O
and O O
that O O
loss O O
of O O
one O O
or O O
of O O
both O O
of O O
these O O
can O O
lead O O
to O O
the O O
development O O
of O O
the O O
disease O O
. O O

many O O
of O O
these O O
experiments O O
found O O
an O O
overlap O O
between O O
the O O
normal O O
and O O
disease O O
size O O
ranges O O
. O O

however O O
, O O
our O O
data O O
suggest O O
that O O
the O O
arg356 O O
allele O O
may O O
have O O
a O O
different O O
genotype O O
distribution O O
in O O
breast B-M B-M
cancer I-M I-M
patients O O
from O O
that O O
in O O
controls O O
retroviral-mediated O O
arg356 O O
homozygotes O O
are O O
more O O
frequent O O
in O O
the O O
control O O
groups O O
, O O
p O O
= O O
retroviral-mediated O O
. O O

objective O O
. O O

all O O
variants O O
showed O O
the O O
enzyme O O
defect O O
in O O
muscle O O
. O O

common O O
brca1 O O
variants O O
and O O
susceptibility O O
to O O
breast B-CM B-CM
and I-CM I-CM
ovarian I-CM I-CM
cancer I-CM I-CM
in O O
the O O
general O O
population O O
. O O

the O O
protein O O
truncation O O
test O O
retroviral-mediated O O
ptt O O
retroviral-mediated O O
was O O
used O O
on O O
rt-pcr O O
products O O
, O O
sscp O O
on O O
genomic O O
pcr O O
amplifications O O
, O O
and O O
chemical O O
cleavage O O
of O O
mismatch O O
on O O
both O O
rt-pcr O O
and O O
genomic O O
amplifications O O
. O O

autosomal B-SD B-DC
dominant I-SD I-DC
primary I-SD I-DC
hyperparathyroidism I-SD I-DC
and I-SD O
jaw I-SD B-SD
tumor I-SD I-SD
syndrome I-SD I-SD
associated O O
with O O
renal B-SD B-SD
hamartomas I-SD I-SD
and O O
cystic B-DC B-SD
kidney I-DC I-SD
disease I-DC I-SD
: O O
linkage O O
to O O
1q21-q32 O O
and O O
loss O O
of O O
the O O
wild O O
type O O
allele O O
in O O
renal B-SD B-SD
hamartomas I-SD I-SD
. O O

however O O
, O O
it O O
is O O
not O O
yet O O
clear O O
what O O
proportion O O
of O O
hereditary B-SD B-SD
breast I-SD I-SD
cancer I-SD I-SD
is O O
explained O O
by O O
brca1 O O
and O O
brca2 O O
or O O
by O O
some O O
other O O
unidentified O O
susceptibility O O
gene O O
retroviral-mediated O O
s O O
retroviral-mediated O O
. O O

the O O
ability O O
to O O
scan O O
a O O
large O O
gene O O
rapidly O O
and O O
accurately O O
for O O
all O O
possible O O
heterozygous O O
mutations O O
in O O
large O O
numbers O O
of O O
patient O O
samples O O
will O O
be O O
critical O O
for O O
the O O
future O O
of O O
medicine O O
. O O

x-linked B-SD B-SD
adrenoleukodystrophy I-SD I-SD
is O O
a O O
frequent O O
cause O O
of O O
idiopathic O B-SD
addison B-SD B-SD
's I-SD I-SD
disease I-SD I-SD
in O O
young O O
adult O O
male O O
patients O O
. O O

truncated O O
atm O O
protein O O
was O O
not O O
detected O O
in O O
lymphoblasts O O
from O O
ataxia-telangiectasia B-M B-M
patients O O
homozygous O O
for O O
mutations O O
leading O O
to O O
premature O O
protein O O
termination O O
. O O

the O O
hras1 O O
variable O O
number O O
of O O
tandem O O
repeats O O
retroviral-mediated O O
vntr O O
retroviral-mediated O O
polymorphism O O
, O O
located O O
1 O O
kilobase O O
retroviral-mediated O O
kb O O
retroviral-mediated O O
downstream O O
of O O
the O O
hras1 O O
proto-oncogene O O
retroviral-mediated O O
chromosome O O
11p15 O O
. O O

we O O
conclude O O
that O O
the O O
codon O O
change O O
n314d O O
in O O
cis O O
with O O
the O O
base-pair O O
transition O O
1721c O O
-- O O
t O O
produces O O
the O O
la B-SD O
variant I-SD O
of I-SD O
galactosemia I-SD B-SD
and O O
that O O
this O O
nucleotide O O
change O O
increases O O
galt O O
activity O O
by O O
increasing O O
galt O O
protein O O
abundance O O
without O O
increasing O O
transcription O O
or O O
decreasing O O
thermal O O
lability O O
. O O

in O O
most O O
people O O
with O O
red-blood-cell O O
glucose-6-phosphate B-SD O
dehydrogenase I-SD I-SD
retroviral-mediated I-SD I-SD
g6pd I-SD I-SD
retroviral-mediated I-SD I-SD
deficiency I-SD I-SD
, O O
the O O
enzyme-deficient O O
phenotype O O
is O O
only O O
moderately O O
expressed O O
in O O
nucleated O O
cells O O
. O O

the O O
1721c O O
-- O O
t O O
transition O O
is O O
a O O
neutral O O
polymorphism O O
for O O
leucine O O
at O O
amino O O
acid O O
retroviral-mediated O O
retroviral-mediated O O
l218l O O
retroviral-mediated O O
. O O

four O O
patients O O
also O O
showed O O
rare O O
sequence O O
variants O O
. O O

many O O
different O O
mutations O O
occur O O
in O O
brca1 O O
, O O
including O O
several O O
examples O O
of O O
recurrent O O
mutations O O
, O O
each O O
of O O
which O O
accounts O O
for O O
a O O
significant O O
number O O
of O O
families O O
with O O
heritable O O
cancer B-M B-M
predisposition O O
. O O

classical O B-SD
phenylketonuria B-SD I-SD
retroviral-mediated O O
pku B-SD B-SD
retroviral-mediated O O
is O O
an O O
autosomal B-DC B-DC
recessive I-DC I-DC
disorder I-DC I-DC
caused O O
by O O
a O O
deficiency B-SD B-SD
of I-SD I-SD
hepatic I-SD I-SD
phenylalanine I-SD I-SD
hydroxylase I-SD I-SD
retroviral-mediated O O
pah O O
retroviral-mediated O O
. O O

retroviral-mediated O O
retroviral-mediated O O
. O O

inherited O O
mutant O O
alleles O O
of O O
familial O B-M
tumour B-M I-M
suppressor O O
genes O O
predispose O O
individuals O O
to O O
particular O O
types O O
of O O
cancer B-DC B-DC
. O O

these O O
ocular O O
findings O O
are O O
consistent O O
with O O
observations O O
in O O
nd B-M B-M
patients O O
and O O
the O O
generated O O
mouse O O
line O O
provides O O
a O O
faithful O O
model O O
for O O
study O O
of O O
early O O
pathogenic O O
events O O
in O O
this O O
severe O O
x-linked B-DC B-DC
recessive I-DC I-DC
neurological I-DC I-DC
disorder I-DC I-DC
. O O

retroviral-mediated O O
and O O
retroviral-mediated O O
. O O

the O O
effect O O
of O O
altered O O
expression O O
levels O O
of O O
dmpk O O
, O O
which O O
is O O
ubiquitously O O
expressed O O
in O O
all O O
muscle O O
cell O O
lineages O O
during O O
development O O
, O O
was O O
examined O O
by O O
disrupting O O
the O O
endogenous O O
dmpk O O
gene O O
and O O
overexpressing O O
a O O
normal O O
human O O
dmpk O O
transgene O O
in O O
mice O O
. O O

kniest B-SD B-SD
dysplasia I-SD I-SD
is O O
a O O
severe O O
chondrodysplasia B-DC B-DC
caused O O
by O O
the O O
defective B-DC O
formation I-DC O
of I-DC O
type I-DC O
ii I-DC O
collagen I-DC O
. O O

these O O
findings O O
strongly O O
implicate O O
tsg101 O O
mutations O O
in O O
human O O
breast B-SD B-SD
cancer I-SD I-SD
. O O

fusion O O
genes O O
resulting O O
from O O
alternative O O
chromosomal O O
translocations O O
are O O
overexpressed O O
by O O
gene-specific O O
mechanisms O O
in O O
alveolar B-SD B-SD
rhabdomyosarcoma I-SD I-SD
. O O

we O O
have O O
identified O O
14 O O
families O O
with O O
ataxia-telangiectasia B-SD B-SD
retroviral-mediated O O
a-t B-SD B-SD
retroviral-mediated O O
in O O
which O O
mutation O O
of O O
the O O
atm O O
gene O O
is O O
associated O O
with O O
a O O
less O O
severe O O
clinical O O
and O O
cellular O O
phenotype O O
retroviral-mediated O O
approximately O O
10 O O
% O O
-15 O O
% O O
of O O
a-t B-M B-M
families O O
identified O O
in O O
the O O
united O O
kingdom O O
retroviral-mediated O O
. O O

ukcccr O O
familial O B-M
ovarian B-M I-M
cancer I-M I-M
study O O
group O O
. O O

a O O
2 O O
year O O
old O O
female O O
presenting O O
with O O
bilateral B-SD O
sporadic I-SD O
aniridia I-SD B-SD
was O O
found O O
to O O
have O O
an O O
apparently O O
balanced O O
reciprocal O O
translocation O O
with O O
a O O
chromosome O O
retroviral-mediated O O
breakpoint O O
within O O
band O O
retroviral-mediated O O
. O O

introducing O O
chromosome O O
retroviral-mediated O O
, O O
encoding O O
the O O
msh3 O O
gene O O
, O O
into O O
the O O
mutant O O
cell O O
line O O
increased O O
the O O
stability O O
of O O
some O O
but O O
not O O
all O O
microsatellites O O
. O O

targeted O O
disruption O O
of O O
atm O O
leads O O
to O O
growth B-DC B-DC
retardation I-DC I-DC
, O O
chromosomal B-SD O
fragmentation I-SD O
during I-SD O
meiosis I-SD O
, O O
immune B-DC O
defects I-DC O
, O O
and O O
thymic B-SD B-SD
lymphoma I-SD I-SD
. O O

these O O
results O O
strengthen O O
the O O
contention O O
that O O
simple O O
retroviral-mediated O O
or O O
gain-of-expression O O
of O O
dmpk O O
is O O
not O O
the O O
only O O
crucial O O
requirement O O
for O O
development O O
of O O
the O O
disease O O
. O O

it O O
differs O O
from O O
this O O
and O O
both O O
the O O
classical O O
and O O
connatal O O
forms O O
of O O
pmd B-SD B-SD
in O O
that O O
it O O
is O O
relatively O O
mild O O
in O O
form O O
, O O
onset O O
is O O
delayed O O
beyond O O
age O O
2 O O
years O O
, O O
nystagmus B-DC O
is O O
absent O O
, O O
tremors B-DC O
are O O
prominent O O
, O O
mental B-DC B-DC
retardation I-DC I-DC
is O O
not O O
severe O O
, O O
some O O
patients O O
show O O
dementia B-DC O
or O O
personality B-DC B-DC
disorders I-DC I-DC
, O O
the O O
disease O O
is O O
progressive O O
rather O O
than O O
static O O
in O O
some O O
, O O
and O O
several O O
females O O
show O O
signs O O
of O O
disease O O
. O O

where O O
it O O
is O O
combined O O
with O O
a O O
c6-deficient B-M B-M
gene O O
, O O
the O O
serum O O
c7 O O
levels O O
can O O
be O O
surprisingly O O
high O O
, O O
possibly O O
because O O
there O O
is O O
no O O
c6 O O
generating O O
retroviral-mediated O O
to O O
consume O O
the O O
c7 O O
. O O

4-kb O O
mrna O O
in O O
thymus O O
and O O
spleen O O
. O O

similar O O
rr O O
values O O
were O O
obtained O O
for O O
the O O
d442g O O
mutation O O
alone O O
. O O

abnormal O O
cag O O
expansions O O
in O O
the O O
it-15 O O
gene O O
are O O
associated O O
with O O
huntington B-SD B-SD
disease I-SD I-SD
retroviral-mediated O O
hd B-SD B-SD
retroviral-mediated O O
. O O

there O O
are O O
several O O
common O O
polymorphisms O O
in O O
the O O
brca1 O O
gene O O
which O O
generate O O
amino O O
acid O O
substitutions O O
. O O

brca1 O O
mutation O O
screening O O
on O O
approximately O O
3 O O
, O O
retroviral-mediated O O
ashkenazi O O
jewish O O
samples O O
determined O O
a O O
carrier O O
frequency O O
of O O
1 O O
. O O

although O O
the O O
dm B-M B-M
mutation O O
was O O
identified O O
more O O
than O O
five O O
years O O
ago O O
, O O
the O O
pathogenic O O
mechanisms O O
underlying O O
this O O
most O O
prevalent O O
form O O
of O O
hereditary O B-SD
adult O I-SD
neuromuscular B-DC I-SD
disease I-DC I-SD
remain O O
elusive O O
. O O

in O O
the O O
diagnostic O O
setting O O
it O O
is O O
necessary O O
to O O
define O O
the O O
limits O O
of O O
the O O
cag O O
size O O
ranges O O
on O O
normal O O
and O O
hd B-M B-M
retroviral-mediated O O
chromosomes O O
. O O

the O O
molecular O O
basis O O
of O O
c7 B-SD B-SD
deficiency I-SD I-SD
has O O
been O O
investigated O O
in O O
two O O
irish O O
families O O
and O O
a O O
number O O
of O O
israeli O O
families O O
of O O
moroccan O O
sephardic O O
jewish O O
origin O O
. O O

by O O
combining O O
these O O
oligos O O
, O O
we O O
were O O
able O O
to O O
amplify O O
fragments O O
from O O
100 O O
to O O
300 O O
bases O O
retroviral-mediated O O
b O O
retroviral-mediated O O
from O O
mouse O O
liver O O
cdna O O
by O O
polymerase O O
chain O O
reaction O O
after O O
reverse O O
transcription O O
retroviral-mediated O O
rt-pcr O O
retroviral-mediated O O
. O O

these O O
findings O O
suggest O O
that O O
gly O O
retroviral-mediated O O
is O O
critical O O
for O O
normal O O
ion O O
conductance O O
in O O
hclc-1 O O
and O O
that O O
this O O
residue O O
resides O O
within O O
the O O
channel O O
pore O O
. O O

very-long-chain O O
acyl-coa O O
dehydrogenase O O
retroviral-mediated O O
vlcad O O
retroviral-mediated O O
is O O
one O O
of O O
four O O
straight-chain O O
acyl-coa O O
dehydrogenase O O
retroviral-mediated O O
acd O O
retroviral-mediated O O
enzymes O O
, O O
which O O
are O O
all O O
nuclear O O
encoded O O
mitochondrial O O
flavoproteins O O
catalyzing O O
the O O
initial O O
step O O
in O O
fatty O O
acid O O
beta-oxidation O O
. O O

retroviral-mediated O O
retroviral-mediated O O
, O O
as O O
well O O
as O O
in O O
three O O
ashkenazi O O
male B-M O
breast I-M B-M
cancer I-M I-M
patients O O
. O O

missense O O
mutations O O
in O O
the O O
fas O O
gene O O
resulting O O
in O O
autoimmune B-SD B-SD
lymphoproliferative I-SD I-SD
syndrome I-SD I-SD
: O O
a O O
molecular O O
and O O
immunological O O
analysis O O
. O O

retroviral-mediated O O
. O O

dna O O
chip-based O O
assays O O
may O O
provide O O
a O O
valuable O O
new O O
technology O O
for O O
high-throughput O O
cost-efficient O O
detection O O
of O O
genetic O O
alterations O O
. O O

retroviral-mediated O O
% O O
retroviral-mediated O O
, O O
but O O
relatively O O
low O O
density O O
retroviral-mediated O O
4 O O
. O O

in O O
contrast O O
, O O
cells O O
expressing O O
the O O
mutant O O
fragment O O
secreted O O
a O O
monomeric O O
molecule O O
of O O
apparent O O
molecular O O
mass O O
of O O
retroviral-mediated O O
kda O O
, O O
which O O
remained O O
unchanged O O
after O O
reduction O O
. O O

retroviral-mediated O O
kb O O
and O O
is O O
interrupted O O
by O O
the O O
retroviral-mediated O O
retroviral-mediated O O
retroviral-mediated O O
n O O
repeat O O
. O O

background O O
allelic O O
loss O O
of O O
chromosome O O
18q O O
predicts O O
a O O
poor O O
outcome O O
in O O
patients O O
with O O
stage B-SD O
ii I-SD O
colorectal I-SD B-SD
cancer I-SD I-SD
. O O

fourteen O O
of O O
fifteen O O
patient O O
samples O O
with O O
known O O
mutations O O
were O O
accurately O O
diagnosed O O
, O O
and O O
no O O
false O O
positive O O
mutations O O
were O O
identified O O
in O O
20 O O
control O O
samples O O
. O O

in O O
10 O O
of O O
these O O
families O O
, O O
all O O
the O O
homozygotes O O
have O O
a O O
137-bp O O
insertion O O
in O O
their O O
cdna O O
caused O O
by O O
a O O
point O O
mutation O O
in O O
a O O
sequence O O
resembling O O
a O O
splice-donor O O
site O O
. O O

the O O
entire O O
coding O O
sequence O O
of O O
the O O
atm O O
transcript O O
was O O
cloned O O
and O O
found O O
to O O
contain O O
an O O
open O O
reading O O
frame O O
encoding O O
a O O
protein O O
of O O
retroviral-mediated O O
amino O O
acids O O
with O O
retroviral-mediated O O
% O O
overall O O
identity O O
and O O
retroviral-mediated O O
% O O
similarity O O
to O O
the O O
human O O
atm O O
protein O O
. O O

atm O O
+ O O
/ O O
- O O
fibroblasts O O
and O O
thymocytes O O
showed O O
intermediately O O
defective O O
responses O O
to O O
irradiation O O
but O O
no O O
growth O O
defect O O
, O O
suggesting O O
that O O
the O O
increased O O
cancer B-M O
risk O O
of O O
at B-M B-M
heterozygotes O O
could O O
be O O
attributable O O
to O O
poor O O
checkpoint O O
function O O
. O O

these O O
correspond O O
to O O
exons O O
of O O
a O O
gene O O
predicted O O
to O O
encode O O
a O O
homeodomain O O
protein O O
. O O

identification O O
and O O
expression O O
of O O
eight O O
novel O O
mutations O O
among O O
non-jewish O O
patients O O
with O O
canavan B-SD B-SD
disease I-SD I-SD
. O O

a O O
statistically O O
significant O O
relationship O O
was O O
found O O
in O O
the O O
activity O O
of O O
g6pd O O
between O O
erythrocytes O O
and O O
muscle O O
of O O
the O O
male O O
subjects O O
retroviral-mediated O O
r O O
= O O
retroviral-mediated O O
. O O

phenotypic O O
characterization O O
of O O
individuals O O
with O O
30-40 O O
cag O O
repeats O O
in O O
the O O
huntington B-M B-M
disease I-M I-M
retroviral-mediated O O
hd B-M B-M
retroviral-mediated O O
gene O O
reveals O O
hd B-M B-M
cases O O
with O O
retroviral-mediated O O
repeats O O
and O O
apparently O O
normal O O
elderly O O
individuals O O
with O O
36-39 O O
repeats O O
. O O

although O O
the O O
genes O O
regulated O O
by O O
the O O
vhl B-M B-M
gene O O
product O O
have O O
not O O
yet O O
been O O
identified O O
, O O
our O O
findings O O
are O O
compatible O O
with O O
the O O
hypothesis O O
that O O
vhl B-M B-SD
retroviral-mediated O O
control O O
of O O
transcriptional O O
elongation O O
may O O
have O O
a O O
role O O
in O O
normal O O
human O O
development O O
. O O

the O O
pattern O O
of O O
hereditary B-DC B-SD
cancer I-DC I-SD
in O O
14 O O
retroviral-mediated O O
retroviral-mediated O O
% O O
retroviral-mediated O O
of O O
the O O
retroviral-mediated O O
families O O
studied O O
was O O
attributed O O
to O O
brca1 O O
by O O
a O O
combination O O
of O O
linkage O O
and O O
mutation O O
analyses O O
. O O

we O O
identified O O
three O O
missense O O
mutations O O
retroviral-mediated O O
i66m O O
, O O
g270d O O
, O O
l618s O O
retroviral-mediated O O
and O O
one O O
exon-6 O O
skipping O O
retroviral-mediated O O
535-573del O O
retroviral-mediated O O
. O O

atm O O
, O O
the O O
mouse O O
homolog O O
of O O
the O O
human O O
atm O O
gene O O
defective O O
in O O
ataxia-telangiectasia B-SD B-SD
retroviral-mediated O O
a-t B-SD B-SD
retroviral-mediated O O
, O O
has O O
been O O
identified O O
. O O

results O O
the O O
expression O O
of O O
dcc O O
was O O
a O O
strong O O
positive O O
predictive O O
factor O O
for O O
survival O O
in O O
both O O
stage B-CM O
ii I-CM O
and I-CM O
stage I-CM O
iii I-CM O
colorectal I-CM B-SD
carcinomas I-CM I-SD
. O O

to O O
investigate O O
whether O O
the O O
presence O O
of O O
rare O O
hras1 O O
alleles O O
increases O O
susceptibility O O
to O O
hereditary B-CM B-CM
breast I-CM I-CM
and I-CM I-CM
ovarian I-CM I-CM
cancer I-CM I-CM
, O O
we O O
have O O
typed O O
a O O
panel O O
of O O
retroviral-mediated O O
female O O
brca1 O O
carriers O O
at O O
this O O
locus O O
using O O
a O O
pcr-based O O
technique O O
. O O

heterogeneity O O
in O O
schwartz-jampel B-SD O
chondrodystrophic I-SD B-SD
myotonia I-SD I-SD
. O O

hprt-aprt-deficient B-M O
mice O O
are O O
not O O
a O O
model O O
for O O
lesch-nyhan B-SD B-SD
syndrome I-SD I-SD
. O O

allele-specific O O
amino O O
acid O O
substitutions O O
retroviral-mediated O O
ser189 O O
-- O O
phe O O
; O O
gly444 O O
-- O O
arg O O
retroviral-mediated O O
cause O O
impaired O O
c2 O O
secretion O O
. O O

germline O O
mutations O O
in O O
the O O
rb1 O O
gene O O
in O O
patients O O
with O O
hereditary B-SD B-SD
retinoblastoma I-SD I-SD
. O O

we O O
have O O
developed O O
a O O
multiplex O O
heteroduplex O O
analysis O O
that O O
is O O
designed O O
to O O
analyze O O
one-quarter O O
of O O
the O O
coding O O
sequence O O
in O O
a O O
single-step O O
screening O O
procedure O O
and O O
that O O
will O O
detect O O
approximately O O
50 O O
% O O
of O O
all O O
brca1 O O
mutations O O
so O O
far O O
reported O O
in O O
breast B-M B-M
/ I-M I-M
ovarian I-M I-M
cancer I-M I-M
families O O
. O O

in O O
drosophila O O
cells O O
, O O
cotransfected O O
vhl O B-M
represses O O
sp1-mediated O O
activation O O
but O O
not O O
basal O O
activity O O
of O O
the O O
vegf O O
promoter O O
. O O

northern O O
blot O O
analysis O O
and O O
sequencing O O
of O O
cloned O O
pcr O O
amplified O O
vlcad O O
cdna O O
from O O
four O O
unrelated O O
patients O O
with O O
vlcad B-SD B-SD
deficiency I-SD I-SD
showed O O
that O O
vlcad O O
mrna O O
was O O
undetectable O O
in O O
one O O
patient O O
and O O
that O O
the O O
other O O
three O O
have O O
mutations O O
in O O
both O O
vlcad O O
alleles O O
. O O

the O O
a305e O O
missense O O
mutation O O
accounted O O
for O O
retroviral-mediated O O
% O O
retroviral-mediated O O
24 O O
/ O O
50 O O
retroviral-mediated O O
of O O
mutant O O
chromosomes O O
in O O
patients O O
of O O
western O O
european O O
descent O O
, O O
while O O
the O O
two O O
predominant O O
jewish O O
mutations O O
each O O
accounted O O
for O O
a O O
single O O
mutant O O
chromosome O O
. O O

other O O
tumor B-M B-M
types O O
found O O
in O O
brca1 O O
mutation O O
/ O O
haplotype O O
carriers O O
included O O
prostatic B-CM O
, I-CM O
pancreas I-CM O
, I-CM O
skin I-CM O
, I-CM O
and I-CM O
lung I-CM B-SD
cancer I-CM I-SD
, O O
a O O
malignant B-SD B-SD
melanoma I-SD I-SD
, O O
an O O
oligodendroglioma B-SD O
, O O
and O O
a O O
carcinosarcoma B-SD O
. O O

using O O
northern O O
and O O
western O O
blot O O
analysis O O
to O O
investigate O O
the O O
tissue O O
specific O O
distribution O O
of O O
vlcad O O
mrna O O
and O O
protein O O
in O O
several O O
human O O
tissues O O
we O O
showed O O
that O O
vlcad O O
is O O
most O O
abundant O O
in O O
heart O O
and O O
skeletal O O
muscle O O
. O O

methods O O
. O O

in O O
contrast O O
to O O
that O O
seen O O
in O O
humans O O
, O O
the O O
cag O O
repeat O O
in O O
these O O
mice O O
was O O
remarkably O O
stable O O
in O O
retroviral-mediated O O
meioses O O
. O O

by O O
using O O
this O O
approach O O
, O O
we O O
were O O
able O O
to O O
identify O O
mutation O O
in O O
retroviral-mediated O O
new O O
patients O O
, O O
but O O
the O O
overall O O
efficiency O O
of O O
the O O
procedure O O
when O O
we O O
used O O
a O O
single-pass O O
regimen O O
was O O
only O O
retroviral-mediated O O
% O O
. O O

the O O
predicted O O
pten O O
product O O
has O O
a O O
protein O O
tyrosine O O
phosphatase O O
domain O O
and O O
extensive O O
homology O O
to O O
tensin O O
, O O
a O O
protein O O
that O O
interacts O O
with O O
actin O O
filaments O O
at O O
focal O O
adhesions O O
. O O

the O O
dpc4 O O
gene O O
, O O
which O O
is O O
located O O
at O O
18q21 O O
, O O
has O O
been O O
identified O O
as O O
a O O
tumor-suppressor O O
gene O O
from O O
examination O O
of O O
pancreatic B-SD B-SD
cancers I-SD I-SD
. O O

however O O
, O O
these O O
findings O O
suggest O O
that O O
pku B-SD B-SD
can O O
be O O
completely O O
corrected O O
by O O
somatic O O
gene O O
therapy O O
, O O
and O O
provide O O
some O O
direction O O
for O O
the O O
future O O
development O O
of O O
adenoviral O O
vectors O O
. O O

the O O
mutation O O
underlying O O
huntington B-SD B-SD
disease I-SD I-SD
retroviral-mediated O O
hd B-SD B-SD
retroviral-mediated O O
is O O
cag O O
expansion O O
in O O
the O O
first O O
exon O O
of O O
the O O
hd B-M B-M
gene O O
. O O

this O O
is O O
in O O
accordance O O
with O O
molecular O O
findings O O
in O O
other O O
patients O O
with O O
kniest B-SD B-SD
dysplasia I-SD I-SD
and O O
confirms O O
, O O
in O O
the O O
original O O
patient O O
, O O
that O O
the O O
disorder O O
is O O
caused O O
by O O
small O O
inframe O O
deletions O O
often O O
due O O
to O O
exon O O
skipping O O
as O O
a O O
result O O
of O O
col2a1 O O
splice O O
site O O
mutations O O
. O O

a O O
much O O
larger O O
fraction O O
of O O
breast B-SD B-SD
cancer I-SD I-SD
might O O
, O O
in O O
principle O O
, O O
be O O
due O O
to O O
common O O
variants O O
which O O
confer O O
more O O
modest O O
individual O O
risks O O
. O O

dual O O
roles O O
of O O
atm O O
in O O
the O O
cellular O O
response O O
to O O
radiation O O
and O O
in O O
cell O O
growth O O
control O O
. O O

nullizygous O O
retroviral-mediated O O
- O O
/ O O
- O O
retroviral-mediated O O
mice O O
showed O O
only O O
inconsistent O O
and O O
minor O O
size O O
changes O O
in O O
head O O
and O O
neck O O
muscle O O
fibres O O
at O O
older O O
age O O
, O O
animals O O
with O O
the O O
highest O O
dmpk O O
transgene O O
expression O O
showed O O
hypertrophic B-SD O
cardiomyopathy I-SD B-SD
and O O
enhanced O B-SD
neonatal O I-SD
mortality O I-SD
. O O

the O O
ataxia-telangiectasia B-M B-M
gene O O
product O O
, O O
a O O
constitutively O O
expressed O O
nuclear O O
protein O O
that O O
is O O
not O O
up-regulated O O
following O O
genome O O
damage O O
. O O

, O O
g270d O O
, O O
l618s O O
, O O
and O O
exon-6 O O
skipping O O
retroviral-mediated O O
535-573del O O
retroviral-mediated O O
, O O
produced O O
diminished B-DC O
galc I-DC O
activity I-DC O
as O O
expected O O
. O O

the O O
mouse O O
homolog O O
of O O
the O O
wiskott-aldrich B-M B-M
syndrome I-M I-M
protein O O
retroviral-mediated O O
wasp O O
retroviral-mediated O O
gene O O
is O O
highly O O
conserved O O
and O O
maps O O
near O O
the O O
scurfy O O
retroviral-mediated O O
sf O O
retroviral-mediated O O
mutation O O
on O O
the O O
x O O
chromosome O O
. O O

since O O
patients O O
with O O
between O O
30 O O
and O O
40 O O
repeats O O
are O O
rare O O
, O O
a O O
consortium O O
was O O
assembled O O
to O O
collect O O
such O O
individuals O O
. O O

this O O
type O O
of O O
inversion O O
appeared O O
to O O
be O O
conserved O O
in O O
the O O
three O O
rodent O O
species O O
, O O
mouse O O
, O O
rat O O
, O O
and O O
syrian O O
hamster O O
, O O
using O O
additional O O
comparative O O
mapping O O
data O O
with O O
the O O
rck O O
gene O O
an O O
animal O O
model O O
for O O
norrie B-SD B-SD
disease I-SD I-SD
retroviral-mediated O O
nd B-SD B-SD
retroviral-mediated O O
: O O
gene O O
targeting O O
of O O
the O O
mouse O O
nd B-M O
gene O O
. O O

all O O
renal B-SD O
hamartomas I-SD O
showed O O
loss O O
of O O
heterozygosity O O
at O O
the O O
1q21-q32 O O
region O O
. O O

independent O O
origin O O
of O O
single O O
and O O
double O O
mutations O O
in O O
the O O
human O O
glucose O O
6-phosphate O O
dehydrogenase O O
gene O O
. O O

both O O
binding O O
sites O O
are O O
preserved O O
in O O
the O O
mutant O O
but O O
have O O
decreased O O
affinities O O
for O O
iodide O O
. O O

g6pd O O
malaga O O
is O O
associated O O
with O O
enzyme B-DC B-DC
deficiency I-DC I-DC
retroviral-mediated O O
class O O
iii O O
retroviral-mediated O O
, O O
and O O
the O O
enzymic O O
properties O O
of O O
g6pd O O
malaga O O
and O O
g6pd O O
santamaria O O
are O O
quite O O
similar O O
, O O
indicating O O
that O O
in O O
this O O
case O O
the O O
effects O O
of O O
the O O
two O O
mutations O O
are O O
additive O O
rather O O
than O O
synergistic O O
. O O

however O O
, O O
the O O
overall O O
prevalence O O
of O O
definite O O
chd B-SD O
was O O
retroviral-mediated O O
% O O
in O O
men O O
with O O
mutations O O
and O O
retroviral-mediated O O
% O O
in O O
men O O
without O O
mutations O O
. O O

the O O
extensive O O
peripheral O O
tissue O O
binding O O
and O O
relatively O O
low O O
concentration O O
of O O
colchicine O O
in O O
breast O O
milk O O
suggests O O
that O O
the O O
amount O O
ingested O O
by O O
the O O
infant O O
is O O
small O O
. O O

detection O O
of O O
heterozygous O O
mutations O O
in O O
brca1 O O
using O O
high O O
density O O
oligonucleotide O O
arrays O O
and O O
two-colour O O
fluorescence O O
analysis O O
. O O

retroviral-mediated O O
retroviral-mediated O O
. O O

within O O
this O O
latter O O
group O O
, O O
there O O
are O O
differences O O
in O O
age O O
of O O
manifestation O O
, O O
clinical O O
course O O
and O O
pattern O O
of O O
bone O O
changes O O
. O O

2 O O
, O O
a O O
region O O
proposed O O
to O O
contain O O
tumor B-M B-M
suppressor O O
gene O O
retroviral-mediated O O
s O O
retroviral-mediated O O
, O O
is O O
mutated O O
at O O
high O O
frequency O O
in O O
human O O
breast B-SD B-SD
cancer I-SD I-SD
. O O

we O O
have O O
reported O O
the O O
presence O O
of O O
a O O
specific O O
mutation O O
retroviral-mediated O O
atg50 O O
-- O O
retroviral-mediated O O
retroviral-mediated O O
or O O
deletion O O
of O O
codon O O
50 O O
of O O
the O O
arp O O
gene O O
in O O
different O O
tumor B-DC B-M
types I-DC O
retroviral-mediated O O
shridhar O O
et O O
retroviral-mediated O O
. O O

retroviral-mediated O O
retroviral-mediated O O
; O O
after O O
additional O O
adjustment O O
for O O
hdl O O
levels O O
, O O
the O O
rr O O
was O O
1 O O
. O O

2 O O
percent O O
retroviral-mediated O O
p O O
= O O
retroviral-mediated O O
. O O

9 O O
and O O
retroviral-mediated O O
. O O

we O O
conclude O O
that O O
the O O
mutations O O
causing O O
galactosemia B-SD B-SD
are O O
highly O O
heterogeneous O O
and O O
that O O
k285n O O
is O O
a O O
second O O
common O O
galactosemia B-M B-M
mutation O O
in O O
our O O
population O O
. O O

the O O
most O O
common O O
variant O O
of O O
galt O O
, O O
the O O
duarte O O
variant O O
, O O
occurs O O
as O O
two O O
types O O
, O O
duarte-1 O O
retroviral-mediated O O
d-1 O O
retroviral-mediated O O
and O O
duarte-2 O O
retroviral-mediated O O
d-2 O O
retroviral-mediated O O
, O O
both O O
of O O
which O O
carry O O
the O O
sequence O O
change O O
n314d O O
. O O

moreover O O
, O O
mitotic O O
instability O O
analysis O O
of O O
different O O
human O O
dm B-M B-M
tissues O O
shows O O
length O O
mosaicism O O
between O O
different O O
cell O O
lineages O O
. O O

15 O O
retroviral-mediated O O
of O O
mouse O O
liver O O
. O O

at O O
the O O
cytogenetic O O
level O O
this O O
region O O
is O O
frequently O O
deleted O O
in O O
a O O
variety O O
of O O
different O O
solid B-DC B-DC
tumors I-DC I-DC
, O O
although O O
not O O
in O O
pancreatic B-SD B-SD
cancer I-SD I-SD
. O O

adult B-SD O
onset I-SD O
globoid I-SD O
cell I-SD O
leukodystrophy I-SD B-SD
retroviral-mediated O O
krabbe B-SD O
disease I-SD O
retroviral-mediated O O
: O O
analysis O O
of O O
galactosylceramidase O O
cdna O O
from O O
four O O
japanese O O
patients O O
. O O

2 O O
kb O O
and O O
contain O O
the O O
intragenic O O
microsatellite O O
markers O O
d17s1323 O O
, O O
d17s1322 O O
, O O
and O O
d17s855 O O
, O O
which O O
localize O O
to O O
introns O O
retroviral-mediated O O
, O O
retroviral-mediated O O
, O O
and O O
20 O O
, O O
respectively O O
. O O

germ-line O O
mutations O O
of O O
the O O
brca1 O O
gene O O
are O O
responsible O O
for O O
a O O
substantial O O
proportion O O
of O O
families O O
with O O
multiple O O
cases O O
of O O
early-onset O O
breast B-CM B-CM
and I-CM I-CM
/ I-CM I-CM
or I-CM I-CM
ovarian I-CM I-CM
cancer I-CM I-CM
. O O

all O O
retroviral-mediated O O
samples O O
were O O
reanalyzed O O
in O O
cambridge O O
by O O
using O O
assays O O
specific O O
for O O
the O O
cag O O
repeats O O
. O O

the O O
duarte O O
biochemical O O
phenotype O O
has O O
a O O
molecular O O
genotype O O
of O O
n314d O O
/ O O
n314d O O
. O O

a O O
sex-dependent O O
penetrance O O
of O O
primary B-SD O
hpt I-SD O
, O O
resulting O O
in O O
predominantly O O
male-affected O O
cases O O
was O O
evident O O
in O O
the O O
two O O
families O O
. O O

the O O
causes O O
of O O
heterogeneity O O
are O O
not O O
known O O
yet O O
but O O
are O O
likely O O
to O O
include O O
both O O
different O O
mutations O O
at O O
the O O
sjs B-M O
locus O O
on O O
chromosome O O
1 O O
and O O
the O O
presence O O
of O O
a O O
second O O
sjs B-M O
locus O O
. O O

thus O O
, O O
wasp O O
provides O O
a O O
novel O O
link O O
between O O
cdc42hs O O
and O O
the O O
actin O O
cytoskeleton O O
, O O
which O O
suggests O O
a O O
molecular O O
mechanism O O
for O O
many O O
of O O
the O O
cellular B-DC B-DC
abnormalities I-DC I-DC
in O O
was B-SD B-SD
. O O

autosomal B-SD B-DC
dominant I-SD I-DC
myotonia I-SD I-DC
congenita I-SD I-DC
is O O
an O O
inherited B-DC B-DC
disorder I-DC I-DC
of I-DC O
skeletal I-DC O
muscle I-DC O
caused O O
by O O
mutations O O
in O O
a O O
voltage-gated O O
retroviral-mediated O O
channel O O
gene O O
retroviral-mediated O O
clcn1 O O
, O O
7q35 O O
retroviral-mediated O O
. O O

however O O
, O O
these O O
mutations O O
are O O
uncommon O O
in O O
the O O
population O O
and O O
they O O
probably O O
account O O
for O O
only O O
a O O
few O O
percent O O
of O O
all O O
breast B-M B-M
cancer I-M I-M
incidence O O
. O O

in O O
contrast O O
, O O
where O O
the O O
c7 O O
genes O O
are O O
both O O
defective O O
retroviral-mediated O O
but O O
still O O
partially O O
functional O O
retroviral-mediated O O
, O O
there O O
may O O
be O O
a O O
profound O O
deficit O B-DC
of O O
circulating O O
c7 O O
because O O
there O O
is O O
ample O O
c6 O O
to O O
produce O O
retroviral-mediated O O
and O O
consume O O
the O O
already O O
small O O
amount O O
of O O
c7 O O
. O O

finally O O
, O O
this O O
report O O
provides O O
a O O
widely O O
applicable O O
strategy O O
which O O
ensures O O
fast O O
and O O
effective O O
screening O O
for O O
intronic O O
defects O O
that O O
underlie O O
differential O O
gene O O
expression O O
. O O

these O O
findings O O
are O O
consistent O O
with O O
a O O
role O O
for O O
the O O
atm O O
protein O O
in O O
ensuring O O
the O O
fidelity O O
of O O
dna O O
repair O O
and O O
cell O O
cycle O O
regulation O O
following O O
genome O O
damage O O
. O O

buttressing O O
these O O
in O O
vivo O O
observations O O
is O O
the O O
fact O O
that O O
mutant O O
blastocyst O O
growth O O
is O O
grossly O O
impaired O O
in O O
vitro O O
. O O

in O O
this O O
report O O
, O O
we O O
demonstrate O O
that O O
in O O
addition O O
to O O
functional O O
alterations O O
these O O
translocations O O
are O O
associated O O
with O O
fusion O O
product O O
overexpression O O
. O O

e. O O
, O O
reverse O O
cholesterol O O
transport O O
retroviral-mediated O O
determine O O
the O O
anti-atherogenicity O O
of O O
the O O
hdl O O
fraction O O
. O O

we O O
report O O
a O O
novel O O
missense O O
change O O
in O O
brca1 O O
, O O
retroviral-mediated O O
c O O
-- O O
t O O
retroviral-mediated O O
r841w O O
retroviral-mediated O O
, O O
found O O
in O O
3 O O
cases O O
from O O
a O O
subject O O
group O O
of O O
305 O O
breast B-M B-M
and I-M I-M
retroviral-mediated I-M I-M
ovarian I-M I-M
cancer I-M I-M
cases O O
from O O
orange O O
county O O
, O O
retroviral-mediated O O
. O O

the O O
cholesteryl O O
ester O O
transfer O O
protein O O
retroviral-mediated O O
cetp O O
retroviral-mediated O O
mediates O O
the O O
transfer O O
of O O
cholesteryl O O
esters O O
from O O
hdl O O
to O O
other O O
lipoproteins O O
and O O
is O O
a O O
key O O
participant O O
in O O
the O O
reverse O O
transport O O
of O O
cholesterol O O
from O O
the O O
periphery O O
to O O
the O O
liver O O
. O O

in O O
one O O
family O O
, O O
both O O
alleles O O
were O O
normal O O
in O O
the O O
parents O O
and O O
one O O
sister O O
; O O
thus O O
, O O
the O O
mutation O O
originated O O
de O O
novo O O
in O O
the O O
proposita O O
. O O

this O O
correction O O
of O O
the O O
defects O O
in O O
a-t B-M B-M
cells O O
provides O O
further O O
evidence O O
of O O
the O O
multiplicity O O
of O O
effector O O
functions O O
of O O
the O O
atm O O
protein O O
and O O
suggests O O
possible O O
approaches O O
to O O
gene O O
therapy O O
. O O

on O O
genomic O O
products O O
exons O O
1 O O
to O O
13 O O
retroviral-mediated O O
including O O
retroviral-mediated O O
bp O O
of O O
the O O
3 O O
untranslated O O
sequence O O
and O O
all O O
intron O O
/ O O
exon O O
boundaries O O
retroviral-mediated O O
were O O
screened O O
, O O
as O O
was O O
a O O
neuroretina O O
specific O O
enhancer O O
in O O
intron O O
4 O O
. O O

molecular O O
basis O O
for O O
duarte B-CM O
and I-CM O
los I-CM O
angeles I-CM O
variant I-CM O
galactosemia I-CM B-SD
. O O

neither O O
a O O
cytogenetically O O
detectable O O
15q12 O O
deletion O O
nor O O
a O O
deletion O O
for O O
the O O
d15s11 O O
, O O
d15s10 O O
, O O
and O O
gabrb3 O O
cosmid O O
probes O O
were O O
found O O
in O O
either O O
patient O O
. O O

we O O
investigated O O
whether O O
the O O
expression O O
of O O
the O O
dcc O O
protein O O
in O O
tumor B-M B-M
cells O O
is O O
a O O
prognostic O O
marker O O
in O O
colorectal B-SD B-SD
carcinoma I-SD I-SD
. O O

mutations O O
in O O
brca1 O O
account O O
for O O
approximately O O
retroviral-mediated O O
% O O
of O O
familial B-SD B-SD
breast I-SD I-SD
cancer I-SD I-SD
and O O
retroviral-mediated O O
% O O
of O O
inherited B-CM B-CM
breast I-CM I-CM
/ I-CM I-CM
ovarian I-CM I-CM
cancer I-CM I-CM
, O O
whereas O O
mutations O O
in O O
brca2 O O
account O O
for O O
a O O
comparable O O
percentage O O
of O O
inherited B-M B-M
breast I-M I-M
cancer I-M I-M
cases O O
. O O

ovarian B-M B-M
cancer I-M I-M
risk O O
in O O
brca1 O O
carriers O O
is O O
modified O O
by O O
the O O
hras1 O O
variable O O
number O O
of O O
tandem O O
repeat O O
retroviral-mediated O O
vntr O O
retroviral-mediated O O
locus O O
. O O

the O O
short O O
variant O O
of O O
the O O
polymorphism O O
reduces O O
the O O
transcriptional O O
efficiency O O
of O O
the O O
5-htt O O
gene O O
promoter O O
, O O
resulting O O
in O O
decreased O O
5-htt O O
expression O O
and O O
5-ht O O
uptake O O
in O O
lymphoblasts O O
. O O

we O O
have O O
used O O
this O O
technique O O
to O O
analyze O O
brca1 O O
in O O
retroviral-mediated O O
families O O
with O O
a O O
history O O
of O O
breast B-CM B-CM
and I-CM I-CM
/ I-CM I-CM
or I-CM I-CM
ovarian I-CM I-CM
cancer I-CM I-CM
and O O
identified O O
retroviral-mediated O O
distinct O O
mutations O O
in O O
retroviral-mediated O O
families O O
. O O

the O O
order O O
of O O
genes O O
on O O
the O O
chromosome O O
is O O
centromere-1fp O O
35-vat1-rho7-brca1-1a1-3b-telomere O O
. O O

six O O
single-base O O
changes O O
leading O O
to O O
missense O O
mutations O O
were O O
identified O O
in O O
patients O O
from O O
turkey O O
retroviral-mediated O O
d114e O O
, O O
r168c O O
retroviral-mediated O O
, O O
the O O
netherlands O O
retroviral-mediated O O
i16t O O
retroviral-mediated O O
, O O
germany O O
retroviral-mediated O O
g27r O O
retroviral-mediated O O
, O O
ireland O O
retroviral-mediated O O
c152y O O
retroviral-mediated O O
, O O
and O O
canada O O
retroviral-mediated O O
g123e O O
retroviral-mediated O O
. O O

these O O
results O O
are O O
significant O O
not O O
only O O
in O O
terms O O
of O O
their O O
implications O O
for O O
furthering O O
our O O
understanding O O
of O O
galactosemia B-SD B-SD
and O O
galt O O
holoenzyme O O
structure-function O O
relationships O O
but O O
also O O
because O O
the O O
system O O
described O O
may O O
serve O O
as O O
a O O
model O O
for O O
similar O O
studies O O
of O O
other O O
complexes O O
composed O O
of O O
multiple O O
subunits O O
. O O

brca1 O O
r841w O O
: O O
a O O
strong O O
candidate O O
for O O
a O O
common O O
mutation O O
with O O
moderate O O
phenotype O O
. O O

individuals O O
who O O
have O O
rare O O
alleles O O
of O O
the O O
vntr O O
have O O
an O O
increased O O
risk O O
of O O
certain O O
types O O
of O O
cancers B-DC B-DC
, O O
including O O
breast B-SD B-SD
cancer I-SD I-SD
retroviral-mediated O O
2-4 O O
retroviral-mediated O O
. O O

atm-deficient B-M O
fibroblasts O O
grow O O
poorly O O
in O O
culture O O
and O O
display O O
a O O
high O O
level O O
of O O
double-stranded O O
chromosome O O
breaks O O
. O O

this O O
expanded O O
population-based O O
study O O
confirms O O
that O O
the O O
brca1 O O
185delag O O
mutation O O
and O O
the O O
brca2 O O
6174delt O O
mutation O O
constitute O O
the O O
two O O
most O O
frequent O O
mutation O O
alleles O O
predisposing O O
to O O
hereditary B-SD B-SD
breast I-SD I-SD
cancer I-SD I-SD
among O O
the O O
ashkenazim O O
, O O
and O O
suggests O O
a O O
relatively O O
lower O O
penetrance O O
for O O
the O O
6174delt O O
mutation O O
in O O
brca2 O O
. O O

to O O
begin O O
to O O
address O O
the O O
hypothesis O O
that O O
abnormal O O
regulation O O
of O O
the O O
breast B-M B-M
/ I-M I-M
ovarian I-M I-M
cancer I-M I-M
susceptibility O O
gene O O
brca1 O O
is O O
a O O
critical O O
step O O
in O O
sporadic O O
breast O O
/ O O
ovarian O O
tumorigenesis O O
, O O
we O O
have O O
determined O O
the O O
detailed O O
structure O O
of O O
the O O
brca1 O O
genomic O O
region O O
. O O

we O O
found O O
that O O
in O O
fractionated O O
blood O O
cell O O
types O O
retroviral-mediated O O
including O O
erythroid O O
, O O
myeloid O O
, O O
and O O
lymphoid O O
cell O O
lineages O O
retroviral-mediated O O
there O O
was O O
a O O
significant O O
excess O O
of O O
g6pd-normal O O
cells O O
. O O

ataxia-telangiectasia B-SD B-SD
: O O
founder O O
effect O O
among O O
north O O
african O O
jews O O
. O O

in O O
the O O
first O O
family O O
, O O
renal B-DC B-SD
lesions I-DC I-SD
were O O
present O O
in O O
five O O
out O O
of O O
six O O
affected O O
individuals O O
, O O
whereas O O
hpt B-SD O
and O O
jt B-SD O
were O O
seen O O
in O O
four O O
and O O
two O O
cases O O
, O O
respectively O O
. O O

recent O O
work O O
has O O
identified O O
a O O
mouse O O
gene O O
retroviral-mediated O O
tsg101 O O
retroviral-mediated O O
whose O O
inactivation O O
in O O
fibroblasts O O
results O O
in O O
cellular O O
transformation O O
and O O
the O O
ability O O
to O O
produce O O
metastatic B-DC B-SD
tumors I-DC I-SD
in O O
nude O O
mice O O
. O O

on O O
all O O
d-2 O O
alleles O O
n314d O O
occurred O O
in O O
cis O O
with O O
two O O
intronic O O
sequence O O
changes O O
, O O
on O O
the O O
d-1 O O
alleles O O
in O O
cis O O
with O O
a O O
neutral O O
mutation O O
in O O
exon O O
retroviral-mediated O O
. O O

one O O
of O O
the O O
fundamental O O
questions O O
concerning O O
expression O O
and O O
function O O
of O O
dimeric O O
enzymes O O
involves O O
the O O
impact O O
of O O
naturally O O
occurring O O
mutations O O
on O O
subunit O O
assembly O O
and O O
heterodimer O O
activity O O
. O O

the O O
mutations O O
were O O
small O O
insertions O O
and O O
deletions O O
and O O
point O O
mutations O O
in O O
roughly O O
equal O O
proportions O O
. O O

influence O O
of O O
pax6 O O
gene O O
dosage O O
on O O
development O O
: O O
overexpression O O
causes O O
severe O O
eye B-DC B-DC
abnormalities I-DC I-DC
. O O

exon O O
pcr O O
and O O
sequencing O O
revealed O O
a O O
heterozygous O O
point O O
mutation O O
at O O
the O O
3 O O
splice O O
acceptor O O
site O O
of O O
intron O O
1 O O
in O O
one O O
irish O O
family O O
. O O

atm-null O O
mice O O
, O O
as O O
well O O
as O O
those O O
null O O
for O O
retroviral-mediated O O
, O O
develop O O
mainly O O
t-cell B-SD B-SD
lymphomas I-SD I-SD
, O O
supporting O O
the O O
view O O
that O O
these O O
genes O O
have O O
similar O O
roles O O
in O O
thymocyte O O
development O O
. O O

1 O O
1 O O
. O O

adult O O
retroviral-mediated O O
/ O O
retroviral-mediated O O
show O O
ultrastructural O O
changes O O
in O O
muscle O O
and O O
a O O
50 O O
% O O
decrease O O
in O O
force O O
generation O O
compared O O
to O O
young O O
mice O O
. O O

an O O
arg O O
ser O O
codon O O
substitution O O
in O O
exon O O
retroviral-mediated O O
is O O
the O O
only O O
molecular O O
alteration O O
within O O
the O O
mature O O
c7 O O
protein O O
. O O

we O O
have O O
optimized O O
methods O O
for O O
reliable O O
sizing O O
of O O
cag O O
repeats O O
and O O
show O O
cases O O
that O O
demonstrate O O
the O O
dangers O O
of O O
using O O
pcr O O
assays O O
that O O
include O O
both O O
the O O
cag O O
and O O
retroviral-mediated O O
polymorphisms O O
. O O

we O O
report O O
the O O
functional O O
definition O O
of O O
a O O
novel O O
genetic O O
locus O O
within O O
human O O
chromosome O O
10pter-q11 O O
that O O
mediates O O
both O O
in O O
vivo O O
tumor O B-M
suppression O O
and O O
in O O
vitro O O
apoptosis O O
of O O
prostatic B-M O
adenocarcinoma I-M O
cells O O
. O O

pten O O
, O O
a O O
putative O O
protein O O
tyrosine O O
phosphatase O O
gene O O
mutated O O
in O O
human O O
brain B-CM O
, I-CM O
breast I-CM O
, I-CM O
and I-CM O
prostate I-CM B-SD
cancer I-CM I-SD
. O O

galt O O
protein O O
abundance O O
was O O
increased O O
in O O
la O O
compared O O
to O O
d O O
alleles O O
, O O
but O O
mrna O O
was O O
similar O O
among O O
all O O
genotypes O O
. O O

in O O
preliminary O O
screens O O
, O O
mutations O O
of O O
pten O O
were O O
detected O O
in O O
retroviral-mediated O O
% O O
retroviral-mediated O O
13 O O
/ O O
42 O O
retroviral-mediated O O
of O O
glioblastoma B-M O
cell O O
lines O O
and O O
xenografts O O
, O O
100 O O
% O O
retroviral-mediated O O
4 O O
/ O O
4 O O
retroviral-mediated O O
of O O
prostate B-M B-M
cancer I-M I-M
cell O O
lines O O
, O O
retroviral-mediated O O
% O O
retroviral-mediated O O
4 O O
/ O O
65 O O
retroviral-mediated O O
of O O
breast B-M B-M
cancer I-M I-M
cell O O
lines O O
and O O
xenografts O O
, O O
and O O
retroviral-mediated O O
% O O
retroviral-mediated O O
3 O O
/ O O
18 O O
retroviral-mediated O O
of O O
primary B-SD O
glioblastomas I-SD B-SD
. O O

it O O
is O O
therefore O O
of O O
interest O O
to O O
identify O O
other O O
genes O O
that O O
contribute O O
to O O
this O O
instability O O
. O O

the O O
structural O O
consequences O O
of O O
the O O
identified O O
mutation O O
, O O
resulting O O
in O O
the O O
cys2010 O O
- O O
arg O O
substitution O O
, O O
were O O
evaluated O O
by O O
expression O O
of O O
the O O
vwf O O
carboxyl-terminal O O
domain O O
containing O O
residues O O
1366-2050 O O
. O O

9 O O
retroviral-mediated O O
in O O
the O O
japanese O O
general O O
population O O
. O O

the O O
age O O
of O O
cancer B-M B-DC
onset O O
was O O
not O O
always O O
distinct O O
from O O
typical O O
sporadic O O
cases O O
. O O

wiskott-aldrich B-SD B-SD
syndrome I-SD I-SD
: O O
no O O
strict O O
genotype-phenotype O O
correlations O O
but O O
clustering O O
of O O
missense O O
mutations O O
in O O
the O O
amino-terminal O O
part O O
of O O
the O O
wasp O O
gene O O
product O O
. O O

the O O
losses O O
invariably O O
involved O O
the O O
wild O O
type O O
allele O O
derived O O
from O O
the O O
unaffected O O
parent O O
, O O
suggesting O O
the O O
inactivation O O
of O O
a O O
tumor B-M B-M
suppressor O O
gene O O
in O O
this O O
region O O
. O O

however O O
, O O
a O O
probable O O
germline O O
mutation O O
in O O
a O O
pancreatic B-M B-M
tumour I-M I-M
cell O O
line O O
suggests O O
a O O
role O O
for O O
brca2 O O
in O O
susceptibility O O
to O O
pancreatic B-SD B-SD
cancer I-SD I-SD
. O O

we O O
show O O
here O O
that O O
brca1 O O
+ O O
/ O O
- O O
mice O O
are O O
normal O O
and O O
fertile O O
and O O
lack O B-DC
tumors B-DC I-DC
by O O
age O O
eleven O O
months O O
. O O

brca1 O O
and O O
brca2 O O
probably O O
explain O O
the O O
majority O O
of O O
hereditary B-SD B-SD
breast I-SD I-SD
cancer I-SD I-SD
that O O
exists O O
in O O
the O O
north O O
american O O
population O O
. O O

to O O
elucidate O O
the O O
role O O
of O O
dmpk O O
in O O
dm B-M B-M
pathogenesis O O
we O O
have O O
developed O O
dmpk O O
deficient O O
retroviral-mediated O O
retroviral-mediated O O
/ O O
- O O
retroviral-mediated O O
mice O O
. O O

we O O
found O O
that O O
dna O O
methylation O O
within O O
rb1 O O
exons O O
retroviral-mediated O O
, O O
14 O O
, O O
retroviral-mediated O O
, O O
and O O
27 O O
appeared O O
to O O
be O O
restricted O O
to O O
cpgs O O
, O O
including O O
six O O
retroviral-mediated O O
codons O O
. O O

the O O
brca1 O O
or O O
brca2 O O
status O O
of O O
four O O
families O O
retroviral-mediated O O
retroviral-mediated O O
% O O
retroviral-mediated O O
could O O
not O O
be O O
determined O O
. O O

this O O
corresponds O O
well O O
to O O
the O O
previous O O
assignment O O
of O O
the O O
locus O O
for O O
the O O
human O O
alkaptonuria B-M B-M
gene O O
retroviral-mediated O O
aku O B-SD
retroviral-mediated O O
to O O
the O O
same O O
chromosomal O O
region O O
by O O
multipoint O O
linkage O O
analysis O O
. O O

in O O
a O O
study O O
of O O
g6pd B-M B-M
deficient I-M I-M
patients O O
who O O
presented O O
with O O
clinical O O
favism B-SD B-SD
in O O
spain O O
, O O
we O O
have O O
found O O
a O O
new O O
polymorphic O O
variant O O
that O O
we O O
have O O
called O O
g6pd O O
malaga O O
, O O
whose O O
only O O
abnormality O O
is O O
a O O
retroviral-mediated O O
a O O
-- O O
t O O
retroviral-mediated O O
181 O O
asp O O
-- O O
val O O
retroviral-mediated O O
mutation O O
. O O

3 O O
percent O O
and O O
33 O O
. O O

the O O
cox O O
proportional-hazards O O
model O O
was O O
used O O
to O O
adjust O O
for O O
covariates O O
including O O
age O O
, O O
sex O O
, O O
tumor B-M B-M
site O O
, O O
degree O O
of O O
tumor B-M B-M
differentiation O O
, O O
and O O
use O O
of O O
adjuvant O O
therapy O O
. O O

the O O
eight O O
novel O O
mutations O O
identified O O
included O O
retroviral-mediated O O
and O O
4-bp O O
deletions O O
retroviral-mediated O O
32 O O
deltat O O
and O O
retroviral-mediated O O
deltaagaa O O
, O O
respectively O O
retroviral-mediated O O
and O O
i16t O O
, O O
g27r O O
, O O
d114e O O
, O O
g123e O O
, O O
c152y O O
, O O
and O O
r168c O O
missense O O
mutations O O
. O O

the O O
spectrum O O
comprises O O
15 O O
% O O
large O O
deletions O O
, O O
retroviral-mediated O O
% O O
small O O
length O O
alterations O O
, O O
and O O
42 O O
% O O
base O O
substitutions O O
. O O

comparison O O
of O O
genomic O O
sequences O O
downstream O O
retroviral-mediated O O
centromeric O O
retroviral-mediated O O
of O O
the O O
repeat O O
in O O
human O O
and O O
mouse O O
identified O O
regions O O
of O O
significant O O
homology O O
. O O

in O O
the O O
work O O
described O O
herein O O
, O O
we O O
have O O
selected O O
two O O
distinct O O
naturally O O
occurring O O
null O O
mutations O O
of O O
galt O O
, O O
q188r O O
and O O
r333w O O
, O O
and O O
asked O O
the O O
questions O O
retroviral-mediated O O
i O O
retroviral-mediated O O
what O O
are O O
the O O
impacts O O
of O O
these O O
mutations O O
on O O
subunit O O
assembly O O
, O O
and O O
retroviral-mediated O O
ii O O
retroviral-mediated O O
if O O
heterodimers O O
do O O
form O O
, O O
are O O
they O O
active O O
? O O

the O O
results O O
suggest O O
that O O
, O O
for O O
a O O
given O O
variant O O
, O O
the O O
extent O O
of O O
the O O
enzyme O B-DC
defect O I-DC
in O O
muscle O O
may O O
be O O
determined O O
, O O
using O O
this O O
equation O O
, O O
from O O
the O O
g6pd O O
activity O O
of O O
erythrocytes O O
gene O O
therapy O O
for O O
phenylketonuria B-SD B-SD
. O O

wu O O
and O O
d O O
. O O

a O O
defined O O
fragment O O
of O O
human O O
chromosome O O
10 O O
was O O
transferred O O
via O O
microcell O O
fusion O O
into O O
a O O
prostate B-M O
adenocarcinoma I-M O
cell O O
line O O
. O O

background O O
to O O
define O O
the O O
incidence O O
of O O
brca1 O O
mutations O O
among O O
patients O O
seen O O
in O O
clinics O O
that O O
evaluate O O
the O O
risk O O
of O O
breast B-SD B-SD
cancer I-SD I-SD
, O O
we O O
analyzed O O
dna O O
samples O O
from O O
women O O
seen O O
in O O
this O O
setting O O
and O O
constructed O O
probability O O
tables O O
to O O
provide O O
estimates O O
of O O
the O O
likelihood O O
of O O
finding O O
a O O
brca1 O O
mutation O O
in O O
individual O O
families O O
. O O

complement B-SD B-SD
c7 I-SD I-SD
deficiency I-SD I-SD
retroviral-mediated O O
c7d B-SD O
retroviral-mediated O O
is O O
associated O O
frequently O O
with O O
recurrent O O
bacterial B-DC B-SD
infections I-DC I-SD
, O I-SD
especially O I-SD
meningitis B-DC I-SD
caused O O
by O O
neisseria B-SD O
meningitidis I-SD O
. O O

nine O O
retroviral-mediated O O
retroviral-mediated O O
% O O
retroviral-mediated O O
of O O
the O O
patients O O
had O O
a O O
family O O
history O O
of O O
breast B-CM B-CM
and I-CM I-CM
/ I-CM I-CM
or I-CM I-CM
ovarian I-CM I-CM
cancer I-CM I-CM
in O O
at O O
least O O
one O O
first-degree O O
relative O O
. O O

overexpression O O
of O O
atm O O
cdna O O
in O O
a-t B-M B-M
cells O O
enhanced O O
the O O
survival O O
of O O
these O O
cells O O
in O O
response O O
to O O
radiation O O
exposure O O
, O O
decreased O O
radiation-induced O O
chromosome O O
aberrations O O
, O O
reduced O O
radio-resistant O O
dna O O
synthesis O O
, O O
and O O
partially O O
corrected O O
defective O O
cell O O
cycle O O
checkpoints O O
and O O
induction O O
of O O
stress-activated O O
protein O O
kinase O O
. O O

mapping O O
the O O
homolog O O
of O O
the O O
human O O
rb1 O O
gene O O
to O O
chromosome O O
14 O O
of O O
higher O O
primates O O
. O O

we O O
have O O
examined O O
the O O
frequency O O
of O O
four O O
of O O
these O O
polymorphisms O O
gln356arg O O
, O O
pro871leu O O
, O O
glu1038gly O O
and O O
ser1613gly O O
in O O
large O O
series O O
of O O
breast B-CM B-M
and I-CM I-M
ovarian I-CM I-M
cancer I-CM I-M
cases O O
and O O
matched O O
controls O O
. O O

recurrent O O
transitions O O
were O O
observed O O
at O O
most O O
of O O
the O O
14 O O
codons O O
within O O
the O O
rb1 O O
. O O

in O O
addition O O
, O O
we O O
tested O O
genetic O O
linkage O O
to O O
the O O
sjs B-M O
locus O O
on O O
chromosome O O
1 O O
in O O
one O O
family O O
with O O
two O O
affected O O
sibs O O
. O O

in O O
the O O
other O O
irish O O
family O O
, O O
exons O O
retroviral-mediated O O
and O O
retroviral-mediated O O
failed O O
to O O
amplify O O
and O O
they O O
were O O
shown O O
to O O
be O O
deleted O O
. O O

thus O O
, O O
aprt-hprt-deficient B-M O
mice O O
, O O
which O O
are O O
devoid O O
of O O
any O O
purine O O
salvage O O
pathways O O
, O O
show O O
no O O
novel O O
phenotype O O
and O O
are O O
not O O
a O O
model O O
for O O
the O O
behavioral B-DC B-DC
abnormalities I-DC I-DC
associated O O
with O O
the O O
lesch-nyhan B-SD B-SD
syndrome I-SD I-SD
as O O
previously O O
suggested O O
somatic O O
alterations O O
of O O
the O O
dpc4 O O
gene O O
in O O
human O O
colorectal B-SD B-SD
cancers I-SD I-SD
in O O
vivo O O
. O O

to O O
clarify O O
whether O O
colchicine O O
is O O
excreted O O
in O O
breast O O
milk O O
, O O
and O O
to O O
compare O O
its O O
concentrations O O
in O O
the O O
serum O O
and O O
breast O O
milk O O
of O O
lactating O O
women O O
who O O
have O O
familial B-SD B-SD
mediterranean I-SD I-SD
fever I-SD I-SD
retroviral-mediated O O
fmf B-SD B-SD
retroviral-mediated O O
. O O

brca1 O O
intron O O
lengths O O
range O O
in O O
size O O
from O O
retroviral-mediated O O
bp O O
to O O
9 O O
. O O

x-chromosome O O
inactivation O O
in O O
mammals O O
is O O
regarded O O
as O O
an O O
essentially O O
random O O
process O O
, O O
but O O
the O O
resulting O O
somatic-cell O O
mosaicism O O
creates O O
the O O
opportunity O O
for O O
cell O O
selection O O
. O O

retroviral-mediated O O
retroviral-mediated O O
is O O
one O O
possible O O
genetic O O
modifier O O
of O O
cancer B-M B-DC
penetrance O O
. O O

chromosomal O O
translocations O O
identified O O
in O O
hematopoietic B-CM O
and I-CM O
solid I-CM B-DC
tumors I-CM I-DC
result O O
in O O
deregulated O O
expression O O
of O O
protooncogenes O O
or O O
creation O O
of O O
chimeric O O
proteins O O
with O O
tumorigenic O O
potential O O
. O O

the O O
dcc O O
protein O O
and O O
prognosis O O
in O O
colorectal B-SD B-SD
cancer I-SD I-SD
. O O

sequencing O O
of O O
the O O
lcat O O
gene O O
of O O
all O O
three O O
probands O O
revealed O O
compound O O
heterozygosity O O
for O O
a O O
missense O O
mutation O O
in O O
exon O O
4 O O
which O O
is O O
reported O O
to O O
underlie O O
the O O
fed B-M O
phenotype O O
, O O
and O O
a O O
point O O
mutation O O
located O O
in O O
intron O O
4 O O
retroviral-mediated O O
ivs4 O O
t-22c O O
retroviral-mediated O O
. O O

the O O
arp O O
gene O O
encodes O O
a O O
highly O O
conserved O O
arginine-rich O O
protein O O
from O O
chromosomal O O
band O O
3p21 O O
. O O

our O O
data O O
support O O
the O O
hypothesis O O
that O O
ald B-SD B-SD
is O O
a O O
frequent O O
cause O O
of O O
idiopathic O B-SD
addisons B-SD I-SD
disease I-SD I-SD
in O O
children O O
and O O
adults O O
. O O

hemizygous O O
mice O O
carrying O O
a O O
replacement O O
mutation O O
in O O
exon O O
2 O O
of O O
the O O
nd B-M B-M
gene O O
developed O O
retrolental O O
structures O O
in O O
the O O
vitreous O O
body O O
and O O
showed O O
an O O
overall O O
disorganization O O
of O O
the O O
retinal O O
ganglion O O
cell O O
layer O O
. O O

deficiency B-SD B-SD
of I-SD I-SD
terminal I-SD I-SD
complement I-SD I-SD
components I-SD I-SD
is O O
generally O O
associated O O
with O O
recurrent O O
neisseria B-SD B-DC
infections I-SD I-DC
. O O

the O O
demonstration O O
of O O
mutations O O
giving O O
rise O O
to O O
a O O
slightly O O
milder O O
phenotype O O
in O O
a-t B-SD B-SD
raises O O
the O O
interesting O O
question O O
of O O
what O O
range O O
of O O
phenotypes O O
might O O
occur O O
in O O
individuals O O
in O O
whom O O
both O O
mutations O O
are O O
milder O O
. O O

using O O
reverse O O
transcriptase O O
combined O O
with O O
polymerase O O
chain O O
reactions O O
in O O
the O O
analysis O O
of O O
a O O
number O O
of O O
lipoma B-M B-M
cell O O
lines O O
and O O
primary B-DC O
lipomas I-DC B-DC
, O O
it O O
appeared O O
that O O
lpp O O
is O O
frequently O O
rearranged O O
also O O
in O O
cases O O
without O O
a O O
cytogenetically O O
detectable O O
involvement O O
of O O
3q27-q28 O O
. O O

although O O
this O O
patient O O
did O O
not O O
have O O
a O O
detectable O O
deletion O O
within O O
pax6 O O
, O O
her O O
aniridia B-SD B-SD
may O O
have O O
resulted O O
from O O
a O O
disruption O O
of O O
the O O
distal O O
chromatin O O
domain O O
containing O O
either O O
enhancers O O
or O O
regulators O O
for O O
pax6 O O
. O O

the O O
atm O O
gene O O
is O O
responsible O O
for O O
the O O
autosomal B-DC B-DC
recessive I-DC I-DC
disorder I-DC I-DC
ataxia-telangiectasia O O
retroviral-mediated O O
retroviral-mediated O O
a-t O O
retroviral-mediated O O
, O O
characterized B-SD O
by O O
cerebellar O B-SD
degeneration O I-SD
, O O
immunodeficiency B-DC B-DC
and I-DC O
retroviral-mediated O O
cancer B-DC O
predisposition O O
< B-DC O
. I-DC B-SD

we O O
evaluated O O
galt O O
enzyme O O
activity O O
and O O
screened O O
the O O
galt O O
genes O O
of O O
retroviral-mediated O O
patients O O
with O O
one O O
or O O
more O O
n314d-containing O O
alleles O O
. O O

increased O O
coronary B-SD B-SD
heart I-SD I-SD
disease I-SD I-SD
in O O
japanese-american O O
men O O
with O O
mutation O O
in O O
the O O
cholesteryl O O
ester O O
transfer O O
protein O O
gene O O
despite O O
increased O O
hdl O O
levels O O
. O O

eight O O
novel O O
and O O
three O O
previously O O
characterized O O
mutations O O
accounted O O
for O O
retroviral-mediated O O
% O O
retroviral-mediated O O
40 O O
/ O O
50 O O
retroviral-mediated O O
of O O
mutant O O
chromosomes O O
. O O

background O O
& O O
aims O O
the O O
chromosome O O
region O O
18q21 O O
has O O
been O O
shown O O
to O O
be O O
frequently O O
deleted O O
in O O
colorectal B-SD B-SD
cancers I-SD I-SD
, O O
and O O
such O O
frequent O O
allelic O O
loss O O
is O O
a O O
hallmark O O
of O O
the O O
presence O O
of O O
a O O
tumor-suppressor O O
gene O O
. O O

the O O
schwartz-jampel B-SD B-SD
syndrome I-SD I-SD
retroviral-mediated O O
sjs B-SD B-SD
; O O
chondrodystrophic B-SD B-SD
myotonia I-SD I-SD
; O O
mck O O
retroviral-mediated O O
, O O
retroviral-mediated O O
retroviral-mediated O O
is O O
a O O
recessively B-DC B-DC
inherited I-DC I-DC
condition I-DC I-DC
defined O O
by O O
myotonia B-DC B-DC
, O O
short B-DC B-DC
stature I-DC I-DC
, O O
and O O
bone B-DC B-SD
dysplasia I-DC I-SD
. O O

brca1 O O
is O O
secreted O O
and O O
exhibits O O
properties O O
of O O
a O O
granin O O
. O O

we O O
now O O
show O O
that O O
brca1 O O
encodes O O
a O O
190-kd O O
protein O O
with O O
sequence O O
homology O O
and O O
biochemical O O
analogy O O
to O O
the O O
granin O O
protein O O
family O O
. O O

this O O
suggests O O
that O O
genomic O O
sequences O O
may O O
play O O
a O O
critical O O
role O O
in O O
influencing O O
repeat O O
instability O O
. O O

western O O
blot O O
analysis O O
of O O
lymphoblastoid O O
cell O O
lines O O
derived O O
from O O
affected O O
family O O
members O O
from O O
this O O
kindred O O
, O O
as O O
well O O
as O O
from O O
a O O
previously O O
reported O O
swiss O O
family O O
carrying O O
a O O
frameshift O O
mutation O O
at O O
codon O O
retroviral-mediated O O
and O O
displaying O O
a O O
similar O O
attenuated O O
phenotype O O
, O O
showed O O
only O O
the O O
wild-type O O
apc B-M B-M
protein O O
. O O

the O O
most O O
common O O
phenotype O O
of O O
ald B-SD B-SD
is O O
the O O
cerebral O O
form O O
retroviral-mediated O O
retroviral-mediated O O
% O O
retroviral-mediated O O
that O O
develops O O
in O O
boys O O
between O O
5-12 O O
yr O O
. O O

sscp O O
analysis O O
of O O
individually O O
amplified O O
exons O O
, O O
with O O
which O O
nine O O
of O O
the O O
10 O O
mutations O O
were O O
seen O O
, O O
was O O
the O O
most O O
useful O O
detection O O
method O O
for O O
pax6 O O
. O O

thus O O
, O O
we O O
screened O O
retroviral-mediated O O
endometrial B-SD B-SD
carcinomas I-SD I-SD
with O O
microsatellite O O
instability O O
for O O
alterations O O
in O O
fen1 O O
retroviral-mediated O O
the O O
human O O
homolog O O
of O O
rth O O
retroviral-mediated O O
and O O
in O O
msh3 O O
retroviral-mediated O O
refs O O
12-14 O O
retroviral-mediated O O
. O O

aniridia B-SD B-SD
in O O
man O O
and O O
small O O
eye O O
in O O
mice O O
are O O
semidominant B-DC B-DC
developmental I-DC I-DC
disorders I-DC I-DC
caused O O
by O O
mutations O O
within O O
the O O
paired O O
box O O
gene O O
pax6 O O
. O O

the O O
cerebella O O
of O O
retroviral-mediated O O
/ O O
- O O
mice O O
appear O O
normal O O
by O O
histologic O O
examination O O
at O O
3 O O
to O O
4 O O
months O O
and O O
the O O
mice O O
have O O
no O O
gross O O
behavioral B-DC B-DC
abnormalities I-DC I-DC
. O O

familial B-SD B-SD
adenomatous I-SD I-SD
polyposis I-SD I-SD
retroviral-mediated O O
fap B-SD B-SD
retroviral-mediated O O
is O O
an O O
inherited O O
predisposition O O
to O O
colorectal B-SD B-SD
cancer I-SD I-SD
characterized O O
by O O
the O O
development O O
of O O
numerous O O
adenomatous B-DC B-SD
polyps I-DC I-SD
predominantly O O
in O O
the O O
colorectal O O
region O O
. O O

our O O
results O O
indicate O O
that O O
the O O
pathogenesis O O
of O O
c7d B-SD O
is O O
heterogeneous O O
like O O
most O O
of O O
the O O
other O O
deficiencies B-DC O
of I-DC O
complement I-DC O
components I-DC O
. O O

a O O
striking O O
clustering O O
of O O
missense O O
mutations O O
in O O
the O O
first O O
four O O
exons O O
contrasted O O
with O O
a O O
random O O
distribution O O
of O O
nonsense O O
mutations O O
. O O

we O O
found O O
seven O O
with O O
the O O
la O O
biochemical O O
phenotype O O
, O O
and O O
all O O
had O O
a O O
1721c O O
-- O O
t O O
transition O O
in O O
exon O O
retroviral-mediated O O
in O O
cis O O
with O O
the O O
n314d O O
missense O O
mutation O O
. O O

each O O
of O O
the O O
three O O
patients O O
was O O
found O O
to O O
be O O
heterozygous O O
for O O
a O O
c862t O O
transition O O
predicting O O
a O O
r279w O O
substitution O O
in O O
the O O
third O O
extracellular O O
loop O O
of O O
dtdst O O
. O O

identification O O
and O O
chromosomal O O
localization O O
of O O
atm O O
, O O
the O O
mouse O O
homolog O O
of O O
the O O
ataxia-telangiectasia B-M B-M
gene O O
. O O

two O O
alternative O O
hmgic O O
/ O O
lpp O O
hybrid O O
transcripts O O
have O O
been O O
detected O O
; O O
the O O
difference O O
between O O
them O O
is O O
mainly O O
the O O
presence O O
of O O
either O O
two O O
or O O
three O O
lim O O
domains O O
in O O
the O O
predicted O O
hmgi-c O O
/ O O
lpp O O
fusion O O
proteins O O
. O O

the O O
c7 O B-SD
defect O I-SD
is O O
more O O
enigmatic O O
the O O
protein O O
is O O
of O O
normal O O
molecular O O
weight O O
, O O
low O O
circulating O O
concentration O O
, O O
and O O
altered O O
isoelectric O O
point O O
. O O

one O O
is O O
in O O
exon O O
retroviral-mediated O O
retroviral-mediated O O
nucleotide O O
retroviral-mediated O O
-- O O
t O O
; O O
ser189 O O
-- O O
phe O O
retroviral-mediated O O
of O O
the O O
c2q0 O O
gene O O
linked O O
to O O
the O O
mhc O O
haplotype O O
retroviral-mediated O O
, O O
retroviral-mediated O O
, O O
drw1 O O
, O O
bfs O O
, O O
c4a0b1 O O
. O O

biochemical O O
fractionation O O
of O O
brain O O
and O O
liver O O
tissues O O
showed O O
that O O
emerin O O
was O O
present O O
in O O
nuclei O O
purified O O
by O O
centrifugation O O
through O O
65 O O
% O O
sucrose O O
and O O
was O O
absent O O
from O O
soluble O O
fractions O O
retroviral-mediated O O
post-100 O O
, O O
retroviral-mediated O O
g O O
retroviral-mediated O O
. O O

comparison O O
of O O
the O O
linkage O O
map O O
of O O
mouse O O
chromosome O O
9 O O
retroviral-mediated O O
mmu9 O O
retroviral-mediated O O
and O O
that O O
of O O
human O O
chromosome O O
retroviral-mediated O O
retroviral-mediated O O
hsa11 O O
retroviral-mediated O O
indicates O O
that O O
there O O
is O O
a O O
chromosomal O O
rearrangement O O
due O O
to O O
an O O
inversion O O
between O O
ets1 O O
and O O
atm-npat-acat1 O O
and O O
that O O
the O O
inversion O O
of O O
mmu9 O O
originated O O
from O O
the O O
chromosomal O O
breakage O O
at O O
the O O
boundary O O
between O O
gria4 O O
and O O
atm-npat-acat1 O O
on O O
hsa11 O O
. O O

the O O
vast O O
majority O O
of O O
both O O
polymorphic O O
and O O
sporadic O O
g6pd O O
variants O O
are O O
due O O
to O O
single O O
missense O O
mutations O O
. O O

wt-vhl O O
protein O O
inhibited O O
vegf O O
promoter O O
activity O O
in O O
a O O
dose-dependent O O
manner O O
up O O
to O O
retroviral-mediated O O
to O O
10-fold O O
. O O

rt-pcr O O
analysis O O
shows O O
that O O
this O O
gene O O
, O O
which O O
we O O
have O O
called O O
dm B-M B-M
locus-associated O O
homeodomain O O
protein O O
retroviral-mediated O O
dmahp O O
retroviral-mediated O O
, O O
is O O
expressed O O
in O O
a O O
number O O
of O O
human O O
tissues O O
, O O
including O O
skeletal O O
muscle O O
, O O
heart O O
and O O
brain O O
. O O

codon O O
retroviral-mediated O O
is O O
a O O
key O O
residue O O
within O O
the O O
tetramerisation O O
domain O O
, O O
and O O
the O O
amino O O
acid O O
substitution O O
of O O
a O O
proline O O
for O O
a O O
leucine O O
is O O
predicted O O
to O O
have O O
profound O O
implications O O
for O O
tetramerisation O O
and O O
potentially O O
dna O O
binding O O
. O O

expression O O
of O O
the O O
von B-M B-M
hippel-lindau I-M I-M
disease I-M I-M
tumour I-M I-M
suppressor O O
gene O O
during O O
human O O
embryogenesis O O
. O O

2 O O
2 O O
. O O

the O O
majority O O
of O O
patients O O
with O O
canavan B-SD B-SD
disease I-SD I-SD
are O O
from O O
an O O
ashkenazi O O
jewish O O
background O O
. O O

a O O
group O O
of O O
patients O O
with O O
long-surviving O B-SD
mismatched O I-SD
kidney O I-SD
allografts O I-SD
were O O
investigated O O
for O O
complement O O
function O O
using O O
haemolytic O O
assays O O
in O O
agarose O O
gels O O
. O O

the O O
first O O
step O O
in O O
the O O
splicing O O
of O O
an O O
intron O O
from O O
nuclear O O
precursors O O
of O O
mrna O O
results O O
in O O
the O O
formation O O
of O O
a O O
lariat O O
structure O O
. O O

thus O O
, O O
genetic O O
cetp B-SD B-SD
deficiency I-SD I-SD
appears O O
to O O
be O O
an O O
independent O O
risk O O
factor O O
for O O
chd B-SD O
, O O
primarily O O
due O O
to O O
increased O O
chd B-M O
prevalence O O
in O O
men O O
with O O
the O O
d442g O O
mutation O O
and O O
hdl O O
cholesterol O O
between O O
retroviral-mediated O O
and O O
retroviral-mediated O O
mg O O
/ O O
dl O O
. O O

the O O
apparently O O
healthy O O
survival O O
into O O
old O O
age O O
of O O
some O O
individuals O O
with O O
36-39 O O
repeats O O
suggests O O
that O O
the O O
hd B-M B-M
mutation O O
may O O
not O O
always O O
be O O
fully O O
penetrant O O
. O O

we O O
provide O O
evidence O O
that O O
not O O
only O O
reduced O O
, O O
but O O
also O O
increased O O
levels O O
of O O
transcriptional O O
regulators O O
can O O
cause O O
developmental B-DC B-DC
defects I-DC I-DC
. O O

molecular O O
analysis O O
of O O
the O O
patients O O
dna O O
showed O O
a O O
single O O
base O O
retroviral-mediated O O
g O O
retroviral-mediated O O
deletion O O
involving O O
the O O
gt O O
dinucleotide O O
at O O
the O O
start O O
of O O
intron O O
18 O O
destroying O O
a O O
splice O O
site O O
of O O
the O O
col2a1 O O
gene O O
. O O

this O O
brca1-associated O O
ring O O
domain O O
retroviral-mediated O O
bard1 O O
retroviral-mediated O O
protein O O
contains O O
an O O
n-terminal O O
ring O O
motif O O
, O O
three O O
tandem O O
ankyrin O O
repeats O O
, O O
and O O
a O O
c-terminal O O
sequence O O
with O O
significant O O
homology O O
to O O
the O O
phylogenetically O O
conserved O O
brct O O
domains O O
that O O
lie O O
near O O
the O O
c O O
terminus O O
of O O
brca1 O O
. O O

only O O
one O O
of O O
the O O
two O O
male B-M O
breast I-M B-M
cancer I-M I-M
patients O O
carrying O O
a O O
brca2 O O
mutation O O
had O O
a O O
family O O
history O O
of O O
cancer B-DC B-DC
, O O
with O O
one O O
case O O
of O O
ovarian B-SD B-SD
cancer I-SD I-SD
in O O
a O O
first-degree O O
relative O O
. O O

one O O
mutation O O
, O O
a O O
c O O
to O O
a O O
exchange O O
, O O
was O O
detected O O
in O O
exon O O
2 O O
at O O
cdna O O
position O O
retroviral-mediated O O
, O O
the O O
other O O
, O O
a O O
c O O
to O O
t O O
exchange O O
, O O
was O O
located O O
in O O
exon O O
4 O O
retroviral-mediated O O
cdna O O
position O O
retroviral-mediated O O
retroviral-mediated O O
. O O

mutations O O
in O O
the O O
arginine-rich O O
protein O O
gene O O
retroviral-mediated O O
arp O O
retroviral-mediated O O
in O O
pancreatic B-SD B-SD
cancer I-SD I-SD
. O O

mutations O O
detected O O
in O O
two O O
of O O
four O O
of O O
these O O
are O O
missense O O
mutations O O
, O O
normally O O
rare O O
in O O
a-t B-M B-M
patients O O
. O O

allele-specific O O
analysis O O
of O O
dmahp O O
expression O O
showed O O
that O O
steady-state O O
transcript O O
levels O O
from O O
the O O
expanded O O
allele O O
were O O
greatly O O
reduced O O
in O O
comparison O O
to O O
those O O
from O O
the O O
wild-type O O
allele O O
. O O

furthermore O O
, O O
the O O
broad O O
range O O
of O O
phenotypic O O
severity O O
observed O O
in O O
these O O
patients O O
raises O O
the O O
possibility O O
that O O
allelic O O
combination O O
, O O
not O O
just O O
allelic O O
constitution O O
, O O
may O O
play O O
some O O
role O O
in O O
determining O O
outcome O O
. O O

a O O
second O O
, O O
recently O O
identified O O
familial B-M B-M
breast I-M I-M
cancer I-M I-M
gene O O
, O O
brca2 O O
retroviral-mediated O O
refs O O
5-8 O O
retroviral-mediated O O
, O O
accounts O O
for O O
a O O
proportion O O
of O O
breast B-SD B-M
cancer I-SD I-M
roughly O O
equal O O
to O O
brca1 O O
. O O

a O O
rapid O O
carrier O O
detection O O
assay O O
detected O O
this O O
mutation O O
in O O
three O O
out O O
of O O
retroviral-mediated O O
atm O O
alleles O O
of O O
jewish O O
moroccan O O
or O O
tunisian O O
origin O O
. O O

we O O
show O O
that O O
the O O
less O O
severe O O
phenotype O O
in O O
these O O
patients O O
is O O
caused O O
by O O
some O O
degree O O
of O O
normal O O
splicing O O
, O O
which O O
occurs O O
as O O
an O O
alternative O O
product O O
from O O
the O O
insertion-containing O O
allele O O
. O O

interestingly O O
, O O
brca2 O O
also O O
includes O O
a O O
motif O O
similar O O
to O O
the O O
granin O O
consensus O O
at O O
the O O
c O O
terminus O O
of O O
the O O
protein O O
. O O

we O O
conclude O O
that O O
cys2010 O O
is O O
essential O O
for O O
normal O O
dimerization O O
of O O
vwf O O
subunits O O
through O O
disulfide O O
bonding O O
of O O
carboxyl-terminal O O
domains O O
and O O
that O O
a O O
heterozygous O O
mutation O O
in O O
the O O
corresponding O O
codon O O
is O O
responsible O O
for O O
defective O O
multimer O O
formation O O
in O O
type B-SD O
iid I-SD O
von I-SD B-SD
willebrand I-SD I-SD
disease I-SD I-SD
. O O

these O O
homologies O O
suggest O O
that O O
pten O O
may O O
suppress O O
tumor B-M B-M
cell O O
growth O O
by O O
antagonizing O O
protein O O
tyrosine O O
kinases O O
and O O
may O O
regulate O O
tumor B-M B-M
cell O O
invasion O O
and O O
metastasis B-DC O
through O O
interactions O O
at O O
focal O O
adhesions O O
. O O

the O O
pax3-fkhr O O
protein O O
has O O
been O O
shown O O
to O O
function O O
as O O
a O O
transcriptional O O
activator O O
. O O

in O O
the O O
present O O
study O O
, O O
we O O
used O O
the O O
sodiumbisulfite O O
conversion O O
method O O
to O O
detect O O
cytosine O O
methylation O O
in O O
representative O O
exons O O
of O O
rb1 O O
. O O

however O O
, O O
one O O
or O O
more O O
additional O O
genes O O
may O O
yet O O
be O O
found O O
that O O
explain O O
some O O
proportion O O
of O O
hereditary B-SD B-SD
breast I-SD I-SD
cancer I-SD I-SD
. O O

using O O
a O O
specific O O
radioimmunoassay O O
, O O
we O O
determined O O
colchicine O O
concentrations O O
in O O
the O O
serum O O
and O O
breast O O
milk O O
of O O
4 O O
patients O O
at O O
various O O
time O O
points O O
, O O
following O O
oral O O
administration O O
of O O
the O O
drug O O
. O O

alleles O O
positively O O
associated O O
with O O
iddm B-SD B-SD
in O O
ins O O
region O O
were O O
the O O
same O O
as O O
those O O
positively-associated O O
with O O
iddm B-SD O
in O O
caucasian O O
population O O
, O O
although O O
positively-associated O O
alleles O O
are O O
very O O
common O O
retroviral-mediated O O
allele O O
frequencies O O
retroviral-mediated O O
. O O

canavan B-SD B-SD
disease I-SD I-SD
is O O
inherited O O
as O O
an O O
autosomal O O
recessive O O
trait O O
that O O
is O O
caused O O
by O O
the O O
deficiency B-SD B-SD
of I-SD I-SD
aspartoacylase I-SD I-SD
retroviral-mediated O O
aspa O O
retroviral-mediated O O
. O O

no O O
correlation O O
between O O
the O O
location O O
of O O
frameshift O O
or O O
nonsense O O
mutations O O
and O O
phenotypic O O
features O O
, O O
including O O
age O O
at O O
diagnosis O O
, O O
the O O
number O O
of O O
tumor B-M B-M
foci O O
, O O
and O O
manifestation O O
of O O
nonocular B-DC B-DC
tumors I-DC I-DC
was O O
observed O O
. O O

ao-gld B-M O
mutations O O
, O O
including O O
those O O
found O O
here O O
, O O
are O O
located O O
in O O
the O O
n-terminus O O
retroviral-mediated O O
i66m O O
, O O
g270d O O
, O O
535-573del O O
retroviral-mediated O O
or O O
c-terminus O O
retroviral-mediated O O
l618s O O
retroviral-mediated O O
of O O
the O O
galc O O
enzyme O O
, O O
whereas O O
the O O
reported O O
mutations O O
in O O
the O O
infantile O O
form O O
retroviral-mediated O O
if-gld B-SD O
retroviral-mediated O O
are O O
in O O
the O O
central O O
domain O O
. O O

mutation O O
analysis O O
in O O
retroviral-mediated O O
families O O
of O O
german O O
, O O
swiss O O
and O O
turkish O O
descent O O
by O O
single-strand O O
conformation O O
polymorphism O O
and O O
sequencing O O
resulted O O
in O O
the O O
detection O O
of O O
seven O O
novel O O
and O O
10 O O
known O O
mutations O O
. O O

1 O O
of O O
rat O O
chromosome O O
retroviral-mediated O O
, O O
and O O
qa4-qa5 O O
of O O
syrian O O
hamster O O
chromosome O O
retroviral-mediated O O
. O O

one O O
patient O O
was O O
found O O
to O O
have O O
no O O
alternative O O
pathway O O
activity O O
but O O
a O O
low O O
normal O O
classical O O
pathway O O
. O O

genetic O O
linkage O O
between O O
sjs B-SD O
and O O
chromosomal O O
region O O
1q36-34 O O
has O O
been O O
observed O O
in O O
several O O
families O O
, O O
but O O
the O O
gene O O
has O O
not O O
yet O O
been O O
identified O O
. O O

atm O O
, O O
the O O
gene O O
mutated O O
in O O
the O O
inherited B-DC O
human I-DC O
disease I-DC O
retroviral-mediated O O
retroviral-mediated O O
ataxia-telangiectasia O O
< O O
, O B-SD
is O O
a O O
member O O
of O O
a O O
family O O
of O O
kinases O O
involved O O
in O O
dna O O
metabolism O O
and O O
cell-cycle O O
checkpoint O O
control O O
. O O

more O O
than O O
retroviral-mediated O O
% O O
of O O
all O O
known O O
missense O O
mutations O O
were O O
localized O O
in O O
the O O
amino-terminal O O
stretch O O
of O O
the O O
wasp O O
gene O O
product O O
; O O
this O O
region O O
contained O O
a O O
mutational O O
hot O O
spot O O
at O O
codon O O
retroviral-mediated O O
. O O

lpp O O
, O O
the O O
preferred O O
fusion O O
partner O O
gene O O
of O O
hmgic O O
in O O
lipomas B-DC B-DC
, O O
is O O
a O O
novel O O
member O O
of O O
the O O
lim O O
protein O O
gene O O
family O O
. O O

results O O
. O O

for O O
rt-pcr O O
products O O
, O O
only O O
the O O
translated O O
portion O O
of O O
the O O
gene O O
was O O
screened O O
. O O

the O O
possibility O O
of O O
the O O
latter O O
cosegregating O O
as O O
a O O
separate O O
autosomal O O
dominant O O
gene O O
can O O
not O O
be O O
ruled O O
out O O
. O O

the O O
instability O O
of O O
the O O
retroviral-mediated O O
repeat O O
appears O O
to O O
depend O O
on O O
its O O
size O O
as O O
well O O
as O O
on O O
the O O
sex O O
of O O
the O O
transmitting O O
parent O O
. O O

in O O
the O O
japanese O O
population O O
, O O
however O O
, O O
there O O
has O O
been O O
no O O
report O O
demonstrating O O
the O O
contribution O O
of O O
iddm2 O O
to O O
the O O
pathogenesis O O
of O O
iddm B-SD B-SD
. O O

both O O
genes O O
were O O
colocalized O O
to O O
the O O
c-d O O
band O O
of O O
mouse O O
chromosome O O
9 O O
, O O
the O O
proximal O O
end O O
of O O
retroviral-mediated O O
. O O

retroviral-mediated O O
ng O O
/ O O
ml O O
, O O
which O O
were O O
similar O O
to O O
those O O
found O O
in O O
the O O
serum O O
retroviral-mediated O O
parallel O O
concentration O O
time O O
curves O O
retroviral-mediated O O
. O O

to O O
identify O O
the O O
genetic O O
basis O O
of O O
c9 B-SD B-SD
deficiency I-SD I-SD
, O O
we O O
developed O O
an O O
approach O O
using O O
exon-specific O O
pcr O O
and O O
direct O O
dna O O
sequencing O O
. O O

programmed O O
cell O O
death O O
retroviral-mediated O O
or O O
apoptosis O O
retroviral-mediated O O
is O O
a O O
physiological O O
process O O
essential O O
to O O
the O O
normal O O
development O O
and O O
homeostatic O O
maintenance O O
of O O
the O O
immune O O
system O O
. O O

we O O
have O O
searched O O
for O O
germ-line O O
rb1 O O
mutations O O
in O O
retroviral-mediated O O
patients O O
with O O
hereditary B-SD B-SD
retinoblastoma I-SD I-SD
. O O

mutations O O
at O O
the O O
retroviral-mediated O O
end O O
of O O
apc B-SD O
are O O
known O O
to O O
be O O
associated O O
with O O
a O O
relatively O O
mild O O
form O O
of O O
the O O
disease O O
, O O
called O O
attenuated B-SD B-SD
adenomatous I-SD I-SD
polyposis I-SD I-SD
coli I-SD I-SD
retroviral-mediated O O
aapc B-SD B-SD
retroviral-mediated O O
. O O

transporter-facilitated O O
uptake O O
of O O
serotonin O O
retroviral-mediated O O
5-hydroxytryptamine O O
or O O
5-ht O O
retroviral-mediated O O
has O O
been O O
implicated O O
in O O
anxiety B-DC B-SD
in O O
humans O O
and O O
animal O O
models O O
and O O
is O O
the O O
site O O
of O O
action O O
of O O
widely O O
used O O
uptake-inhibiting O O
antidepressant O O
and O O
antianxiety O O
drugs O O
. O O

retroviral-mediated O O
% O O
for O O
the O O
185delag O O
mutation O O
and O O
retroviral-mediated O O
. O O

the O O
high O O
frequencies O O
of O O
disease-associated O O
alleles O O
in O O
the O O
general O O
population O O
suggest O O
that O O
iddm2 O O
locus O O
is O O
not O O
responsible O O
for O O
the O O
low O O
incidence O O
of O O
iddm B-SD B-SD
in O O
japanese O O
. O O

in O O
all O O
three O O
siblings O O
, O O
we O O
demonstrated O O
the O O
presence O O
of O O
anergic O O
cd3 O O
+ O O
retroviral-mediated O O
retroviral-mediated O O
double O O
negative O O
, O O
retroviral-mediated O O
dn O O
retroviral-mediated O O
retroviral-mediated O O
t O O
cells O O
; O O
moreover O O
, O O
a O O
chronic O O
lymphocyte O O
activation O O
was O O
found O O
, O O
as O O
demonstrated O O
by O O
the O O
presence O O
of O O
high O O
levels O O
of O O
hla-dr O O
expression O O
on O O
peripheral O O
cd3 O O
+ O O
cells O O
and O O
by O O
the O O
presence O O
of O O
high O O
levels O O
of O O
serum O O
activation O O
markers O O
such O O
as O O
soluble O O
interleukin-2 O O
receptor O O
retroviral-mediated O O
sll-2r O O
retroviral-mediated O O
and O O
soluble O O
cd30 O O
retroviral-mediated O O
scd30 O O
retroviral-mediated O O
. O O

these O O
observations O O
support O O
a O O
new O O
mechanism O O
for O O
vhl-mediated O O
transcriptional O O
repression O O
via O O
a O O
direct O O
inhibitory O O
action O O
on O O
sp1 O O
and O O
suggest O O
that O O
loss O O
of O O
sp1 O O
inhibition O O
may O O
be O O
important O O
in O O
the O O
pathogenesis O O
of O O
von B-SD B-SD
hippel-lindau I-SD I-SD
disease I-SD I-SD
and O O
rcc B-SD B-SD
. O O

g6pd O O
activity O O
was O O
detected O O
in O O
samples O O
obtained O O
from O O
biopsies O O
on O O
the O O
quadriceps O O
muscle O O
of O O
seven O O
males O O
and O O
one O O
female O O
. O O

using O O
3-race O O
analysis O O
of O O
hmgic O O
fusion O O
transcripts O O
in O O
lipoma B-M O
cell O O
line O O
li-501 O O
/ O O
sv40 O O
, O O
ectopic O O
genetic O O
sequences O O
were O O
obtained O O
, O O
which O O
by O O
cash O O
retroviral-mediated O O
chromosome O O
assignment O O
using O O
somatic O O
cell O O
hybrids O O
retroviral-mediated O O
and O O
fish O O
retroviral-mediated O O
fluorescence O O
in O O
situ O O
hybridization O O
retroviral-mediated O O
analysis O O
were O O
found O O
to O O
originate O O
from O O
chromosome O O
segment O O
3q27-q28 O O
. O O

the O O
quantitative O O
distribution O O
of O O
vhl B-M B-M
mrna O O
within O O
fetal O O
tissues O O
reflected O O
that O O
seen O O
by O O
in O O
situ O O
hybridization O O
and O O
the O O
ratio O O
of O O
the O O
two O O
vhl B-M B-M
isoforms O O
was O O
similar O O
between O O
tissues O O
. O O

association O O
studies O O
in O O
two O O
independent O O
samples O O
totaling O O
retroviral-mediated O O
individuals O O
revealed O O
that O O
the O O
5-htt O O
polymorphism O O
accounts O O
for O O
3 O O
to O O
4 O O
percent O O
of O O
total O O
variation O O
and O O
retroviral-mediated O O
to O O
9 O O
percent O O
of O O
inherited O O
variance O O
in O O
anxiety-related B-DC O
personality I-DC O
traits I-DC O
in O O
individuals O O
as O O
well O O
as O O
sibships O O
. O O

extracts O O
of O O
these O O
cells O O
repaired O O
certain O O
substrates O O
containing O O
extra O O
nucleotides O O
, O O
but O O
were O O
deficient O O
in O O
repair O O
of O O
those O O
containing O O
mismatches O O
or O O
other O O
extra O O
nucleotides O O
. O O

a O O
defect O O
at O O
the O O
retroviral-mediated O O
splice O O
donor O O
site O O
of O O
intron O O
15 O O
of O O
the O O
c6 O O
gene O O
explains O O
the O O
low O O
molecular O O
weight O O
of O O
the O O
c6 O O
protein O O
and O O
is O O
probably O O
responsible O O
for O O
its O O
low O O
expressed O O
concentration O O
. O O

mutations O O
were O O
detected O O
in O O
retroviral-mediated O O
% O O
of O O
the O O
cases O O
. O O

furthermore O O
, O O
endogenous O O
vegf O O
mrna O O
levels O O
were O O
suppressed O O
in O O
permanent O O
rcc B-M B-M
cell O O
lines O O
expressing O O
wt-vhl O O
, O O
and O O
nuclear O O
run-on O O
studies O O
indicated O O
that O O
vhl O B-M
regulation O O
of O O
vegf O O
occurs O O
at O O
least O O
partly O O
at O O
the O O
transcriptional O O
level O O
. O O

we O O
have O O
determined O O
the O O
genomic O O
organization O O
of O O
chrna4 O O
, O O
which O O
consists O O
of O O
six O O
exons O O
distributed O O
over O O
approximately O O
retroviral-mediated O O
kb O O
of O O
genomic O O
dna O O
. O O

none O O
of O O
these O O
tumours B-DC B-DC
showed O O
abnormal O O
migration O O
patterns O O
. O O

upon O O
partial O O
cdna O O
cloning O O
, O O
features O O
of O O
the O O
genetic O O
organization O O
of O O
lpp O O
were O O
established O O
. O O

the O O
remaining O O
mutation O O
is O O
a O O
missense O O
mutation O O
retroviral-mediated O O
cys61gly O O
retroviral-mediated O O
in O O
the O O
zinc-binding O O
motif O O
. O O

no O O
association O O
was O O
found O O
between O O
the O O
presence O O
of O O
bilateral O B-SD
breast B-SD I-SD
cancer I-SD I-SD
or O O
the O O
number O O
of O O
breast B-SD B-SD
cancers I-SD I-SD
in O O
a O O
family O O
and O O
the O O
detection O O
of O O
a O O
brca1 O O
mutation O O
, O O
or O O
between O O
the O O
position O O
of O O
the O O
mutation O O
in O O
the O O
brca1 O O
gene O O
and O O
the O O
presence O O
of O O
ovarian B-SD B-SD
cancer I-SD I-SD
in O O
a O O
family O O
. O O

an O O
extended O O
homology O O
search O O
revealed O O
a O O
distant O O
relationship O O
of O O
this O O
stretch O O
to O O
the O O
vasodilator-stimulated O O
phosphoprotein O O
retroviral-mediated O O
vasp O O
retroviral-mediated O O
, O O
which O O
is O O
involved O O
in O O
the O O
maintenance O O
of O O
cyto-architecture O O
by O O
interacting O O
with O O
actin-like O O
filaments O O
. O O

genetic O O
analysis O O
of O O
the O O
family O O
with O O
two O O
sibs O O
affected O O
by O O
sjs B-SD O
type I-SD O
2 I-SD O
showed O O
evidence O O
against O O
linkage O O
to O O
chromosome O O
1p36-34 O O
. O O

a O O
wide O O
variety O O
of O O
a-t B-M B-M
mutations O O
, O O
most O O
of O O
which O O
are O O
unique O O
to O O
single O O
families O O
, O O
were O O
identified O O
in O O
various O O
ethnic O O
groups O O
, O O
precluding O O
carrier O O
screening O O
with O O
mutation-specific O O
assays O O
. O O

x-linked B-SD B-SD
adrenoleukodystrophy I-SD I-SD
retroviral-mediated O O
ald B-SD B-SD
retroviral-mediated O O
is O O
a O O
genetic B-DC B-DC
disease I-DC I-DC
associated O O
with O O
demyelination B-DC B-DC
of I-DC I-DC
the I-DC I-DC
central I-DC I-DC
nervous I-DC I-DC
system I-DC O
, O O
adrenal B-DC B-DC
insufficiency I-DC I-DC
, O O
and O O
accumulation O O
of O O
very O O
long O O
chain O O
fatty O O
acids O O
in O O
tissue O O
and O O
body O O
fluids O O
. O O

dgge O O
detected O O
retroviral-mediated O O
of O O
the O O
retroviral-mediated O O
classical O O
galactosemia B-M B-M
alleles O O
. O O

whereas O O
heterozygotes O O
suffer O O
from O O
iris B-SD B-SD
hypoplasia I-SD I-SD
, O O
homozygous O O
mice O O
lack O O
eyes O B-CM
and O I-CM
nasal O I-CM
cavities O I-CM
and O I-CM
exhibit O I-CM
brain B-DC B-DC
abnormalities I-DC I-DC
. O O

in O O
order O O
to O O
test O O
this O O
hypothesis O O
, O O
we O O
have O O
studied O O
samples O O
of O O
single O O
sperm O O
from O O
three O O
individuals O O
heterozygous O O
at O O
the O O
dm B-M B-M
locus O O
, O O
each O O
with O O
one O O
allele O O
larger O O
and O O
one O O
allele O O
smaller O O
than O O
retroviral-mediated O O
retroviral-mediated O O
repeats O O
. O O

a O O
wide O O
spectrum O O
of O O
mutations O O
, O O
ranging O O
from O O
point O O
mutations O O
to O O
large O O
deletions O O
, O O
have O O
been O O
described O O
in O O
the O O
retinoblastoma B-M B-M
gene O O
retroviral-mediated O O
rb1 O O
retroviral-mediated O O
. O O

voltage-dependent O O
blocks O O
by O O
intracellular O O
and O O
extracellular O O
iodide O O
help O O
to O O
distinguish O O
two O O
distinct O O
ion O O
binding O O
sites O O
within O O
the O O
hclc-1 O O
conduction O O
pathway O O
. O O

myotonic B-SD B-SD
dystrophy I-SD I-SD
, O O
or O O
dystrophia B-SD O
myotonica I-SD O
retroviral-mediated O O
dm B-SD B-SD
retroviral-mediated O O
, O O
is O O
an O O
autosomal B-DC B-DC
dominant I-DC I-DC
multisystem I-DC I-DC
disorder I-DC I-DC
caused O O
by O O
the O O
expansion O O
of O O
a O O
retroviral-mediated O O
trinucleotide O O
repeat O O
in O O
the O O
3 O O
untranslated O O
region O O
of O O
the O O
dmpk O O
protein O O
kinase O O
gene O O
on O O
chromosome O O
19q13 O O
. O O

musculus O O
/ O O
m O O
. O O

the O O
positions O O
of O O
retroviral-mediated O O
conserved O O
amino O O
acids O O
could O O
be O O
determined O O
by O O
multiple O O
sequence O O
alignment O O
. O O

atm-deficient B-M O
thymocytes O O
undergo O O
spontaneous O O
apoptosis O O
in O O
vitro O O
significantly O O
more O O
than O O
controls O O
. O O

atm-deficient B-M O
mice O O
are O O
retarded O O
in O O
growth O O
, O O
do O O
not O O
produce O O
mature O O
sperm O O
, O O
and O O
exhibit O O
severe O O
defects O B-SD
in O O
t O O
cell O O
maturation O O
while O O
going O O
on O O
to O O
develop O O
thymomas B-SD O
. O O

32 O O
respectively O O
, O O
and O O
these O O
frequencies O O
do O O
not O O
differ O O
significantly O O
between O O
patient O O
and O O
control O O
groups O O
. O O

fish O O
studies O O
in O O
a O O
patient O O
with O O
sporadic B-SD O
aniridia I-SD B-SD
and O O
t O O
retroviral-mediated O O
retroviral-mediated O O
; O O
retroviral-mediated O O
retroviral-mediated O O
retroviral-mediated O O
retroviral-mediated O O
; O O
retroviral-mediated O O
retroviral-mediated O O
. O O

the O O
atm O O
protein O O
is O O
a O O
single O O
, O O
high-molecular O O
weight O O
protein O O
predominantly O O
confined O O
to O O
the O O
nucleus O O
of O O
human O O
fibroblasts O O
, O O
but O O
is O O
present O O
in O O
both O O
nuclear O O
and O O
microsomal O O
fractions O O
from O O
human O O
lymphoblast O O
cells O O
and O O
peripheral O O
blood O O
lymphocytes O O
. O O

the O O
fourth O O
patient O O
carried O O
a O O
compound O O
heterozygous O O
mutation O O
of O O
535-573del O O
and O O
l618s O O
. O O

in O O
addition O O
, O O
15 O O
papillary B-SD B-SD
renal I-SD I-SD
cell I-SD I-SD
tumours I-SD I-SD
and O O
ten O O
renal B-SD B-SD
oncocytomas I-SD I-SD
, O O
which O O
are O O
characterized O O
by O O
genetic O O
changes O O
other O O
than O O
loss O O
of O O
chromosome O O
3p O O
sequences O O
, O O
were O O
analysed O O
for O O
mutation O O
of O O
the O O
vhl B-M B-M
gene O O
. O O

the O O
mouse O O
wasp O O
gene O O
, O O
the O O
homolog O O
of O O
the O O
gene O O
mutated O O
in O O
wiskott-aldrich B-SD B-SD
syndrome I-SD I-SD
, O O
has O O
been O O
isolated O O
and O O
sequenced O O
. O O

the O O
level O O
of O O
the O O
137-bp O O
pcr O O
product O O
containing O O
the O O
insertion O O
was O O
lowest O O
in O O
two O O
patients O O
who O O
showed O O
a O O
later O O
onset O O
of O O
cerebellar B-SD B-DC
ataxia I-SD I-DC
. O O

c O O
. O O

by O O
1 O O
year O O
, O O
these O O
mice O O
have O O
no O O
behavioral B-DC O
abnormalities I-DC B-DC
and O O
morphometric O O
analysis O O
at O O
retroviral-mediated O O
retroviral-mediated O O
one O O
animal O O
retroviral-mediated O O
and O O
9 O O
retroviral-mediated O O
two O O
animals O O
retroviral-mediated O O
months O O
age O O
revealed O O
no O O
changes O O
. O O

retroviral-mediated O O
cm O O
distal O O
to O O
d9mit99 O O
and O O
1 O O
. O O

the O O
haplotype O O
has O O
been O O
found O O
in O O
combination O O
with O O
a O O
number O O
of O O
other O O
haplotypes O O
containing O O
defective O O
genes O O
that O O
lead O O
either O O
to O O
c6 B-CM O
or I-CM O
retroviral-mediated O O
retroviral-mediated O O
c7 O O
deficiency O O
< O O
, O B-SD
but O I-SD
with O O
different O O
consequences O O
. O O

retroviral-mediated O O
retroviral-mediated O O
p O O
= O O
. O O

trinucleotide O O
repeat O O
expansion O O
at O O
the O O
myotonic B-M B-M
dystrophy I-M I-M
locus O O
reduces O O
expression O O
of O O
dmahp O O
. O O

an O O
exception O O
is O O
brca1 O O
, O O
which O O
contributes O O
to O O
a O O
significant O O
fraction O O
of O O
familial B-CM B-CM
breast I-CM I-CM
and I-CM I-CM
ovarian I-CM I-CM
cancer I-CM I-CM
, O O
but O O
undergoes O O
mutation O O
at O O
very O O
low O O
rates O O
in O O
sporadic B-CM O
breast I-CM B-CM
and I-CM I-CM
ovarian I-CM I-CM
cancers I-CM I-CM
. O O

deletion O O
of O O
small O O
nuclear O O
ribonucleoprotein O O
polypeptide O O
n O O
retroviral-mediated O O
snrpn O O
retroviral-mediated O O
in O O
prader-willi B-SD B-SD
syndrome I-SD I-SD
detected O O
by O O
fluorescence O O
in O O
situ O O
hybridization O O
: O O
two O O
sibs O O
with O O
the O O
typical O O
phenotype O O
without O O
a O O
cytogenetic O O
deletion O O
in O O
chromosome O O
15q O O
. O O

3 O O
cm O O
proximal O O
to O O
d9mit102 O O
. O O

chromosomal O O
mapping O O
in O O
an O O
interspecific O O
m O O
. O O

a O O
favorable O O
codon O O
bias O O
for O O
the O O
mutated O O
codon O O
with O O
consequently O O
increased O O
translation O O
rates O O
is O O
postulated O O
as O O
the O O
mechanism O O
. O O

the O O
risk O O
for O O
ovarian B-SD B-SD
cancer I-SD I-SD
was O O
2 O O
. O O

mutations O O
of O O
the O O
brca1 O O
gone O O
in O O
humans O O
are O O
associated O O
with O O
predisposition O O
to O O
breast B-CM B-CM
and I-CM I-CM
ovarian I-CM I-CM
cancers I-CM I-CM
. O O

no O O
mutation O O
was O O
observed O O
in O O
exons O O
25-27 O O
, O O
although O O
this O O
region O O
contains O O
two O O
retroviral-mediated O O
codons O O
. O O

the O O
von B-M B-M
hippel-lindau I-M I-M
tumor I-M I-M
suppressor O O
gene O O
product O O
interacts O O
with O O
sp1 O O
to O O
repress O O
vascular O O
endothelial O O
growth O O
factor O O
promoter O O
activity O O
. O O

consistent O O
with O O
cellular O O
defects O O
of O O
at B-M B-M
patients O O
, O O
the O O
retroviral-mediated O O
/ O O
- O O
cells O O
are O O
hypersensitive O O
to O O
gamma-irradiation O O
and O O
defective O O
in O O
cell-cycle O O
arrest O O
following O O
radiation O O
, O O
correlating O O
with O O
a O O
defective O O
up-regulation O O
of O O
retroviral-mediated O O
. O O

3 O O
percent O O
, O O
whereas O O
in O O
patients O O
with O O
dcc-negative B-SD O
tumors I-SD B-DC
, O O
the O O
survival O O
rate O O
was O O
retroviral-mediated O O
. O O

reduced O O
incorporation O O
of O O
inorganic O O
sulfate O O
into O O
macromolecules O O
was O O
found O O
in O O
all O O
three O O
. O O

methods O O
clinical O O
information O O
, O O
family O O
histories O O
, O O
and O O
blood O O
for O O
dna O O
analysis O O
were O O
obtained O O
from O O
retroviral-mediated O O
women O O
with O O
breast B-SD B-SD
cancer I-SD I-SD
. O O

to O O
guard O O
against O O
the O O
possible O O
problem O O
of O O
differential O O
pcr O O
amplification O O
rates O O
based O O
on O O
the O O
lengths O O
of O O
the O O
alleles O O
, O O
the O O
sperm O O
were O O
also O O
typed O O
at O O
another O O
closely O O
linked O O
marker O O
whose O O
allele O O
size O O
was O O
unrelated O O
to O O
the O O
allele O O
size O O
at O O
the O O
dm B-M B-M
locus O O
. O O

the O O
human O O
complement O O
c9 O O
gene O O
: O O
identification O O
of O O
two O O
mutations O O
causing O O
deficiency O B-SD
and O O
revision O O
of O O
the O O
gene O O
structure O O
. O O

retroviral-mediated O O
for O O
all O O
models O O
considered O O
, O O
and O O
no O O
statistically O O
significant O O
difference O O
from O O
. O O

our O O
results O O
indicate O O
that O O
dmpk O O
may O O
be O O
necessary O O
for O O
the O O
maintenance O O
of O O
skeletal O O
muscle O O
structure O O
and O O
function O O
and O O
suggest O O
that O O
a O O
decrease O O
in O O
dmpk O O
levels O O
may O O
contribute O O
to O O
dm B-M B-M
pathology O O
. O O

human O O
orythrocytes O O
that O O
are O O
homozygous O O
for O O
the O O
duarte B-SD O
enzyme I-SD O
variant I-SD O
of I-SD O
galactosemia I-SD B-SD
retroviral-mediated O O
d O O
/ O O
d O O
retroviral-mediated O O
have O O
a O O
characteristic O O
isoform O O
on O O
isoelectric O O
focusing O O
and O O
50 O O
% O O
reduction O O
in O O
galactose-1-phosphate O O
uridyltransferase O O
retroviral-mediated O O
galt O O
retroviral-mediated O O
enzyme O O
activity O O
. O O

no O O
additional O O
introns O O
were O O
detected O O
in O O
exons O O
retroviral-mediated O O
and O O
10 O O
. O O

a O O
fragment O O
of O O
retroviral-mediated O O
b O O
was O O
cloned O O
and O O
used O O
as O O
a O O
probe O O
to O O
screen O O
a O O
mouse O O
liver O O
cdna O O
library O O
. O O

this O O
treatment O O
is O O
transient O O
and O O
can O O
not O O
be O O
effectively O O
re-administered O O
due O O
to O O
the O O
presence O O
of O O
neutralizing O O
antibodies O O
directed O O
against O O
the O O
recombinant O O
adenoviral O O
vector O O
. O O

a O O
further O O
four O O
families O O
who O O
do O O
not O O
have O O
this O O
insertion O O
have O O
been O O
identified O O
. O O

in O O
order O O
to O O
test O O
this O O
possibility O O
we O O
have O O
analyzed O O
four O O
heterozygotes O O
for O O
class O O
i O O
g6pd O O
mutations O O
two O O
with O O
g6pd O O
portici O O
retroviral-mediated O O
1178g O O
-- O O
a O O
retroviral-mediated O O
and O O
two O O
with O O
g6pd O O
bari O O
retroviral-mediated O O
1187c O O
-- O O
t O O
retroviral-mediated O O
. O O

apoptosis O O
has O O
recently O O
been O O
recognized O O
as O O
a O O
mode O O
of O O
cell O O
death O O
in O O
huntington B-SD B-SD
disease I-SD I-SD
retroviral-mediated O O
hd B-SD B-SD
retroviral-mediated O O
. O O

no O O
brca1 O O
or O O
brca2 O O
mutations O O
were O O
detected O O
in O O
these O O
five O O
families O O
. O O

exposure O O
of O O
normal O O
human O O
cells O O
to O O
gamma-irradiation O O
and O O
the O O
radiomimetic O O
drug O O
neocarzinostatin O O
had O O
no O O
effect O O
on O O
atm O O
protein O O
levels O O
, O O
in O O
contrast O O
to O O
a O O
noted O O
rise O O
in O O
retroviral-mediated O O
levels O O
over O O
the O O
same O O
time O O
interval O O
. O O

within O O
the O O
kidney O O
, O O
vhl B-M O
mrna O O
was O O
differentially O O
expressed O O
within O O
renal O O
tubules O O
suggesting O O
that O O
the O O
vhl B-M B-M
gene O O
product O O
may O O
have O O
a O O
specific O O
role O O
in O O
kidney O O
development O O
. O O

type O O
iii O O
collagen O O
is O O
crucial O O
for O O
collagen O O
i O O
fibrillogenesis O O
and O O
for O O
normal O O
cardiovascular O O
development O O
. O O

